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Abstract 
 
Laura Christine Sparks 
DEVELOPMENT AND CHARACTERIZATION OF PHOSPHOLIPID ENCAPSULATED 
QUANTUM DOT CONSTRUCTS FOR BIOLOGIC APPLICATIONS 
The American Cancer Society predicts that 577,190 cancer-related deaths and 1,638,910 newly 
diagnosed cases of cancer will occur in 2012.  As these statistics show, cancer is a prevalent and 
devastating health issue; determined by the Mayo Clinic to be the second leading cause of death 
in the United States. Skin cancer is the most common form of cancer in the United States.  In 
2012 more than 68,000 Americans will be diagnosed with melanoma, 48,000 will be diagnosed 
with an early form of the disease that has not yet reached the lower levels of the epidermis, and 
more than 2 million people will be treated for basal cell or squamous cell skin cancer. Early and 
accurate detection is the most reliable way to ensure a positive outcome and the ultimate survival 
of the patient.  As the most aggressive form of skin cancer, survival of melanoma is especially 
connected to early detection. Current methods for the initial detection of potential cancerous 
masses and lesions rely on visual examination, palpitation, and biopsy. Accurate determination 
of the presence of cancerous cells in a biopsy is especially difficult at the early stages when only 
a small percentage of cells in the biopsied mass show the morphological traits associated with 
being cancerous.  This circumstance often results in a false negative (FN), delaying the necessary 
treatment until the cancer has reached a more developed stage.  Developing more accurate 
methods for the detection of cancerous cells within a biopsy would aid in alleviating this 
problem. An improvement to the conventional method of visually examining biopsied tissues for 
the presence of cells with abnormal morphologies can be offered by utilizing the model of 
functionalized quantum dot (QD) constructs.   
v 
 
 Quantum dots are nano-particles composed of semi-conducting materials that fluoresce at 
discrete wavelengths when irradiated by a high energy UV source.  QD constructs are cadmium-
selenium/zinc-sulfide (CdSe/ZnS) quantum dots encapsulated within a bovine derived milk 
phospholipid micelle. QD constructs provide a potential mechanism for the identification of 
cancerous cells within a biopsy. Appreciating the scope of the clinical problem and 
understanding the potential of QDs, the objective of this thesis is to develop a primary model for 
the solubilization, encapsulation, and primary phospholipid functionalization of two distinct sizes 
of CdSe/ZnS QDs. The first stage of this thesis optimized the currently utilized protocol for 
synthesizing cadmium-selenium (CdSe) quantum dots to develop a set of parameters for 
consistently producing white fluorescing CdSe cores (WFCs) and CdSe/ZnS QDs of 505nm and 
555nm (+/- 10nm).  The application of synthesis times, temperatures, and quenching methods 
were employed to achieve this. The second stage developed a phospholipid encapsulation 
method for the initial functionalization and suspension of the hydrophobic QDs in aqueous 
media via encapsulation within phospholipid micelles. The final stage of this thesis focused on 
the successful introduction of the QD constructs into keratinocyte cells. Calcein and Ethidium 
homodimer-1 stains were applied to determine cell viability, Histochoice was applied as a 
fixative, and Hoechst staining was employed for cell nuclei identification. Analysis using 
confocal microscopy suggests successful attachment of QD constructs, in  0.1% w/v keratinocyte 
media, to the exterior of  keratinocyte cell membranes with a 30% average cell survival rate at 24 
hours after sample introduction.  Future research investigating the interaction of QD constructs 
with biologic mediums of greater physiological complexity, as well as application of a secondary 
functionalization, are the next steps on the path toward achieving a viable mechanism for 
targeting and identifying cancerous cells within a biopsy.  
vi 
 
Acknowledgements 
 I would like to thank Dr. Lily Laiho for her support both on and off the thesis field. Your 
work ethic, positive attitude, and seemingly endless energy are an inspiration. I value all of the 
conversations we have had, whether they were related to my thesis, introducing me to the 
wonder that is Grammar Girl, giving me objective and honest assessments throughout my search 
for employment, helping me to believe that lack of job experience doesn’t equate to lack of 
merit, or simply sharing your views on some of the random idiosyncrasies of life.  I sincerely 
thank you. I would also like to thank Dr. Savage, both as an advisor and professor. You made 
materials engineering an interesting and favorite subject; in my next life I plan on majoring in it. 
I especially appreciate your willingness to humor me and listen to my constant ramblings about 
lab organization. Dr. Jimenez, your excitement for trying something novel has been contagious. 
You never failed to provide support and words of encouragement, both for this scholastic life and 
the next, affording me a fun experience I will always treasure. 
 Many of my peers contributed their time, knowledge, and skills helping me to set up and 
prepare integral components of this thesis, I would like to particularly thank Carl Dargitz, the 
keratinocyte cell keeper and master culture custodian with unending patience, Davis Carlin, 
Patrick McBride, Josh Angell, and Susan Harada for their conversations and tutorials, and 
Andrea Lambausch for always providing me with phospholipids, fresh cream, and tails of sheep 
keeping shenanigans. 
 The continued support of my physics family over the last two years has been tremendous; 
the carnivals, brunches, baby showers, birthday parties, and department functions have all made 
me feel so very fortunate to be a part of such a tremendous group of people. Alison and Robin, 
from both near and far, you have been with me, filling my journey with laughter, sharp 
vii 
 
exclamations, truth, and absolute joy; Vi amo tanto.  Roger and the Road Runners of SLO, you 
gave me a much needed outlet and a damn fun group of people, making the miles fly by and the 
ice baths completely worth it. Kari, my oldest and dearest friend, my sister in all ways but one, I 
thank you for everything that you have been for me; you always bring me back to my center. 
Jaime, forever my partner in conscientious objecting and wine drinking, thank you for giving me 
so many great escapes; Live Long and Prosper friend. My guys and gals in La Verne, you are the 
epitome of what friends and love and family should be, you keep me grounded and I am forever 
grateful that I have always had you to come home to. Mom and Dad, you are my rock, my soul 
mates, my shining example of what hard work, dedication, honor, and a deep soul can 
accomplish. I thank you endlessly. 
 
 
 
 
 
 
 
 
 
 
 
 
 
viii 
 
TABLE OF CONTENTS 
LIST OF TABLES ……………………………………………………………………………..xiii 
LIST OF FIGURES ……………………………………………………………………………..xv 
LIST OF EQUATIONS ………………………………………………………………………...xix 
CHAPTER 1 – INTRODUCTION ……………………………………………………………….1 
1.1 Motivation ………………………………………………………………………………...1 
1.2 Cancer …………………………………………………………………………………….4 
 1.2.1 Diagnosis of Skin Cancer ………………………………………………………..….6 
 1.2.2 UV Radiation ……………………………………………………………………….8 
1.3 The Epidermis ……………………………………………………………………..……...9 
1.4 Phospholipids ……………………………………………………………………………11 
1.5 Quantum Dots ……………………………………………………………..…………….13 
 1.5.1 Quantum Confinement and the Bohr Exciton Radius …………………………….18 
 1.5.2 Biologic Applications …………………………………………………….……….21 
1.6 Overview of Thesis Goals ………………………………………………………….……22 
 
CHAPTER 2 – DEVELOPMENT AND EVALUATION OF CdSe/ZnS QUANTUM DOTS ..24 
 
2.1 Introduction ………………………………………………………………………...………..24 
 
2.2 Method for CdSe Core and ZnS Quantum Dot Synthesis …………………………………..27 
 
 2.2.1 Synthesis of CdSe Cores …………………………………………………………..27 
 
  2.2.1.1 Experimental Variables Investigated for the General Synthesis of CdSe  
   
  Cores …………………………………………………………………………….28 
  
  2.2.1.2 Synthesis of White Fluorescing CdSe Cores (WFCs) ………………..…29 
 
 2.2.2 Synthesis of ZnS Coated Quantum Dots ………………………………………….30 
ix 
 
 
  2.2.2.1 Temperature Variation of CdSe/ZnS Synthesis ………………………..31 
  
2.3 Results ………………………………………………………………………………………32 
 
 2.3.1 Synthesis of CdSe Cores ………………………………………………………….32 
  
  2.3.1.1 Experimental Variables Investigated for the General Synthesis of CdSe  
   
  Cores …………………………………………………………………………….32 
  
  2.3.1.2 Temporal Effects on CMW, Intensity, and FWHM of CdSe Cores ……34 
  
  2.3.1.3 Temporal Wavelength Shifts in White Fluorescing CdSe Cores ……….39 
 
 2.3.2 Synthesis of ZnS Coated Quantum Dots….……………………………………….42 
 
  2.3.2.1 ZnS Coating Synthesis Temperature Variation …………………………42 
 
2.4 Discussion …………………………………………………………………………………...46 
 
 2.4.1 Synthesis of CdSe Cores …………………………………………………………..46 
 
  2.4.1.1 Experimental Variables Investigated for the General Synthesis of CdSe  
 
  Cores …………………………………………………………………………….47 
 
  2.4.1.2 Synthesis of White Fluorescing CdSe Cores ……………………………48 
 
  2.4.1.3 Temporal Wavelength Shifts in White Fluorescing CdSe Cores ……….48 
 
 2.4.2 Synthesis of ZnS Coated Quantum Dots ………………………………………….48 
  
  2.4.2.1 ZnS Coating Synthesis Temperature Variation …………………………49 
 
CHAPTER 3 – QUANTUM DOT CONSTRUCT SYNTHESIS ………………………………50 
 
3.1 Introduction ……………………………………………………………….....................50 
 
3.2 Method for Solubilization and Phospholipid Encapsulation of CdSe/ZnS QDs ………..50 
 
  3.2.1 QD Precipitation …………………………………………….....................50 
 
  3.2.2 QD Suspension in CHCl3…………………………………..………………53 
   
x 
 
  3.2.3 Phospholipid Concentration, Suspension, and Encapsulation …………….53 
 
   3.2.3.1 Experimental Trials – Round One and Two …………………….53 
 
   3.2.3.2 Final Encapsulation Method …………………………………….58 
 
3.3 Results …………………………………………………………………………………...60 
 
  3.3.1 QD Precipitation …………………………………………………………..60 
 
  3.3.2 QD Suspension into CHCl3 ………………………………………………..60 
 
  3.3.3 Phospholipid Concentration, Suspension, and Encapsulation …………….61 
 
   3.3.3.1 Experimental Trials – Round One and Two ………....................61 
 
   3.3.3.2 Final Encapsulation Method …………………………………….71 
 
3.4 Discussion ……………………………………………………………………………….72 
 
  3.4.1 QD Precipitation …………………………………………….....................72 
   
  3.4.2 Phospholipid Concentration, Suspension, and Encapsulation …………….73 
 
   3.4.2.1 Experimental Trials – Round One and Two …………………….73 
 
   3.4.2.2 Final Encapsulation Method …………………………………….75 
 
CHAPTER 4 – INTRODUCING QUANTUM DOT CONSTRUCTS INTO A                          
   BIOLOGIC MEDIUM ………………………………………………………….77 
 
4.1 Introduction ……………………………………………………………….…………......77 
 
4.2 Methods …………………………………………………………….………………..…..78 
  
  4.2.1 QD Construct Introduction into Keratinocytes Cell Cultures ………..……78 
 
   4.2.1.1 QD Construct Control and Test Solutions – R1……………..…...79 
 
   4.2.1.2 QD Construct Control and Test Solutions – R2……………..…...83 
 
   4.2.1.3 Duration of Keratinocyte Trial – R1 ………………….…………86 
 
   4.2.1.4 Duration of Keratinocyte Trial – R2 ……………….……………87 
 
  4.2.2 Implementation of White Light Optical Imaging ……………….………...88 
xi 
 
 
   4.2.2.1 Optical Imaging – R1 …………………………………………....90 
  
   4.2.2.2 Optical Imaging – R2 ……………………………………………91 
 
  4.2.3 Fluorescence Staining ……………………………………………………..92 
 
   4.2.3.1 Calcein/EthD-1 Live/Dead Cell Viability Stain – R1and R2 …..94 
 
   4.2.3.2 Histochoice/Hoechst Nucleus Stain – R2 ……………………….95 
 
  4.2.4 Confocal and DIC Imaging ………………………………………………..96 
 
   4.2.4.1 Keratinocyte Cell Viability – R1 ………………………………..96 
 
   4.2.4.2 Keratinocyte Cell Viability – R2 ………………………………..97 
 
4.3 Results …………………………………………………………………………………...99 
 
  4.3.1 QD Construct Introduction into Keratinocyte Cell Cultures ……………...99 
  
   4.3.1.1 QD Construct Control and Test Solutions – R1 …………………99 
 
   4.3.1.2 QD Construct Control and Test Solutions – R2 ……………….102 
 
   4.3.1.3 Optical Imaging – R1 …………………………………………..103 
 
   4.3.1.4 Keratinocyte Cell Viability and Cell-QD Construct  
    Interaction – R1 ………………………………………………...105 
 
   4.3.1.5 Optical Imaging – R2 …………………………………………..113 
 
   4.3.1.6 Keratinocyte Cell Viability and Cell-QD Construct  
    Interaction – R2 ……………………………………………......116 
 
4.4 Discussion ……………………………………………………………………………...123 
 
  4.4.1 QD Construct Introduction into Keratinocyte Cell Cultures …………….123 
 
   4.4.1.1 QD Construct Control and Test Solutions – R1 ……………….123 
 
   4.4.1.2 QD Construct Control and Test Solutions – R2 ……………….124 
 
   4.4.1.3 Optical Imaging – R1 …………………………………………..125 
 
   4.4.1.4 Optical Imaging – R2 …………………………………………..126 
xii 
 
 
   4.4.1.5 Keratinocyte Cell Viability and Cell-QD Construct  
    Interaction – R1……………………………………………...….127 
   
   4.4.1.6 Keratinocyte Cell Viability and Cell-QD Construct  
    Interaction – R2 ………………………………………………...127 
 
CHAPTER 5 – DISCUSSION AND CONCLUSIONS ……………………………………….130 
5.1 Overview and Summary ……………………………………………………………….130 
5.2 Challenges, Limitations, and Future Work …………………………………………….131 
5.3 Conclusion ……………………………………………………………………………..132 
 
LIST OF REFERENCES ………………………………………………………………………134 
APPENDIX A - ABBREVIATIONS ………………………………………………………….143 
APPENDIX B – PROTOCOLS AND EXPERIMENTAL DETAILS…………………………144 
  
 Appendix B.1 Cal Poly Standard CdSe/ZnS Synthesis Protocol and Fluorescence 
 Analysis Procedure ………….…………………………………………………………144 
 Appendix B.2 Absorbance Measurement Procedure …………………………………..164 
 Appendix B.3 Wavelength Specific CdSe and CdSe/Zn Synthesis ……………………168 
 Appendix B.4 Precipitation and Resuspension of CdSe/ZnS Quantum Dots ………….171 
 Appendix B.5 Quantum Yield Calculation…….……………………………………….173 
 
 Appendix B.6 Solubilization and Phospholipid Encapsulation of CdSe/ZnS Quantum  
   Dots…..…………………………………………………………………179 
 Appendix B.7 Introduction of QD Construct Test Solutions to Keratinocyte Cell  
   Cultures………………………………………………………...........….181 
 Appendix B.8 Fluorescent Staining – Histochoice and Hoechst ………………………184 
 Appendix B.9 Fluorescent Staining – Calcein EthD-1 ………………………………...186 
xiii 
 
LIST OF TABLES 
 
Table 2.1 Effects of Temperature on CMW, Intensity, and FWHM for 30, 60, and 90s Samples    
     Cooled in Air…………………………………………………………………………..33 
Table 2.2 Two Sample t-test of Effects of Temperature on CMW, Intensity, and FWHM for  
      Each Reaction Time Point……………………………...…………………………….34 
Table 2.3 Averages of, and Standard Deviations for, the CMW, Intensity, and FWHM of CdSe   
     samples for 30, 60, and 90s Reaction Times. Left: averages. Right: standard  
     deviations ……………………………………………………………………………..35 
Table 2.4 Single Factor ANOVA Test p-values for CMW, Intensity, and FWHM of CdSe  
     Cores at Reaction Times of 30, 60, and 90s……………………………………..……37 
Table 2.5 Two Sample t-test p-values Corresponding to the Effects of Quenching in  
     Acetone vs. Air for Three Sets of CdSe Core Synthesis Reactions………………...…39 
Table 2.6 CMW, Intensity, and FWHM Values for WFCs Coated at 70°C and 160°C…………43 
Table 2.7 Averages and Standard Deviations of CMW, Intensities, and FWHMS of WFCs       
      Coated at 70°C and 160°C…………………………………………………………....43 
Table 3.1 Concentration and Ratio Test Parameters Applied with 2.5mg/mL Trial ……………54 
Table 3.2 PL Encapsulation and Evaporation Parameters……………………………………….55 
Table 3.3 Comparison of QD samples in CHCl3 and QD/PL samples in CHCl3……………..…61 
Table 4.1 Summary of Round One QD Construct Control and Test Solutions …………………81 
Table 4.2 Summary of Round Two QD Construct Control and Test Solutions……………...….84 
Table 4.3 Keratinocyte Trial Time Points in Round Two…………………………………….....88 
Table 4.4 Progression of Changes in Fluorescence Spectrum During Synthesis of QD  
     Construct Solution 42612wEN.2a……………...…………………………………....100 
xiv 
 
Table B.5.1 Concentration and Dilution Calculation Table …………………………………...175 
Table B.5.2 Sample Data for Calculating the Area Under a Fluorescence Spectral Peak …….176 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xv 
 
LIST OF FIGURES 
 
Figure 1.1 The eight stages of tumor growth and expansion leading up to metastasis…………....5 
Figure 1.2 The epidermal and dermal layers of the skin ……………………………………...…..7 
Figure 1.3 The electromagnetic spectrum…………………………………………………………8 
Figure 1.4 The five layers of the epidermis ……………………………………………….…….10 
Figure 1.5 Phospholipid molecular structure and aqueous aggregation tendencies……………..11 
Figure 1.6 Phospholipid fatty acid chain attachments to QD surface……………………………13 
Figure 1.7 Bands gaps of conduction and valence bands………………………………………..14 
Figure 1.8 Atomic orbital electron lowest energy configuration for silicon…………………….15 
Figure 1.9 Discrete energy levels to continuous energy bands …………………………………17 
Figure 1.10 QD size, Bohr exciton radius, band gap and atomic energy levels……………..….19 
Figure 1.11 Electron confinement and energy state densities …………………………………..20 
Figure 1.12 QD size, band gap energy and photon emission wavelength relationship…….……21 
Figure 2.1 CdSe sample quenching configuration ………………………………………………29 
Figure 2.2 CdSe core sample division for ZnS shelling temperature tests……………...……….32 
Figure 2.3 Comparison of reaction temperature on CdSe core synthesis ……….......................33 
Figure 2.4 Comparison of reaction time on CdSe core synthesis ……………………………….35 
Figure 2.5 Fluorescence spectrum of CdSe core solutions for 30, 60, amd 90s reaction times...36 
Figure 2.6 Digital image of 0 and 60s averaged CdSe core sample sets under UV…………….37 
Figure 2.7 Fluorescence spectrums of 0 and 60s averaged CdSe core sample sets …………….38 
Figure 2.8 Typical WFCs fluorescence spectra …………………………………………………40 
Figure 2.9  Fluorescence spectra of temporal shift of WFCs day 1 ……………………………..41  
Figure 2.10 Fluorescence spectra of temporal shift of WFCs day 23…………………..……..…41 
xvi 
 
Figure 2.11 Fluorescence spectra of temporal shift of WFCs day 1 to day 23………………..…42 
Figure 2.12 Comparison of 70°C and 160°C ZnS shelling temperatures ……….………………44 
Figure 2.13 Qualitative comparison of ZnS shelling temperatures……………………………...45 
Figure 2.14 Averaged fluorescence spectrum of white fluorescing starting CdSe cores ……….45 
Figure 2.15 Averaged fluorescence spectrum of green fluorescing starting CdSe cores ……….46 
Figure 3.1 QD precipitation progression ………………………………………………………..53 
Figure 3.2 Evaporation test of QD phospholipid test solutions …………………………………57 
Figure 3.3 QDs suspension in ODE and EtOH ………………………………………………….60 
Figure 3.4 Re-suspension of QDs in CHCl3. …………………...……………………………….61 
Figure 3.5 Phospholipid test solution fluorescence scattering …………………………………..62 
Figure 3.6 Fluorescence spectra of phospholipids test solutions - 100ms integration…….…….63 
Figure 3.7 Fluorescence spectra of phospholipids test solutions - 500ms integration…………..63 
Figure 3.8 Fluorescence spectra of the filtered encapsulation test solutions ………..………….64 
Figure 3.9 Image series QD: phospholipid ratio trials in suspension …………………………...65 
Figure 3.10 Image series QD: phospholipid ratio trials pre-evaporation..………….……………65 
Figure 3.11 Image series QD: phospholipid ratio trials post-evaporation………….……………66 
Figure 3.12 Confocal image QD phospholipid control test solutions…….……………………...67 
Figure 3.13 Confocal image of 2.5:0.5mL QD phospholipid test solution ……………………...67 
Figure 3.14 Confocal image of 2.5:1.0mL QD phospholipid test solution ……………………...68 
Figure 3.15 Confocal image of 3.5:0.5mL QD phospholipid test solution …………………..….68 
Figure 3.16 Encapsulation progression of test trial set D………………………………………..70 
Figure 3.17 Encapsulation progression of test trial sets A, B, C, and D ……………………..…70 
Figure 3.18 Trial B2 encapsulation solution……………………………………..………………70 
xvii 
 
Figure 3.19 QD phospholipid mixture pre-evaporation………………………………………….71 
Figure 3.20 Change in QD construct solution viscosity during synthesis……………………….72 
Figure 4.1 Four-well slide configurations. ………………………………………………………80 
Figure 4.2 Fluoresence progression of CdSe/ZnS sample 42612wQD.2a ….…………………..83 
Figure 4.3 Fluorescence progression of CdSe/ZnS sample 42612oEN.1a …………..………….84 
Figure 4.4 Neonatal foreskin keratinocytes (NFK) colonization………………………………...89 
Figure 4.5 Sequence of Cell Culture – Test Solution Interaction and Imaging …………………91 
Figure 4.6 Excitation emission spectra of  Calcein (495/515) and EthD-1 (495/635)………….93 
Figure 4.7 Excitation emission spectra of Hoechst 34580 stain…………………………………94 
Figure 4.8 Adaptation of four-well with thick specimen slide base……………………………..98 
Figure 4.9 Fluorescence spectrum of CdSe combination core sample (42612wCMBO.2) ..….100 
Figure 4.10 Fluorescence spectrum of QD construct synthesis solution progression……...…..101 
Figure 4.11 Fluorescence spectrum: Effects of phospholipid concentration……….…………..101 
Figure 4.12 QD construct test solutions ……………………………………………………… 102 
Figure 4.13 Fluorescence spectra of QD construct test solutions ……………………………...103 
Figure 4.14 Optical image series of R1 well a1.1 (fresh media control)……………………….104 
Figure 4.15 Optical image series of R1 well b1.3 (keratinocyte media test)…………………..105 
Figure 4.16 Confocal image series of well b1.3 (processed krt media control)…………….….106 
Figure 4.17 Confocal image series of well b1.1 (fresh krt media control) …………………….106 
Figure 4.18 Image series of well b2.6 (PL krt filtered) pre-introduction of test solutions …….107 
Figure 4.19 Image series of well b2.7 (PL krt NF) pre-introduction of test solutions…............108 
Figure 4.20 Image series of well b3.10 (QD PL krt filtered) pre-introduction of test solutions.109 
Figure 4.21 Digital image of well b3.10 as seen with wide-field fluorescence laser ………....110 
xviii 
 
Figure 4.22 Confocal image of a seemingly burst cell in well b3.10 (QD PL krt filtered) ……110 
Figure 4.23 Series of L/D filter confocal images of well a3.9 (QD PL krt filtered)…………...111 
Figure 4.24 Digital image of well a3.9, representative of the series A1-4 in figure 4.23 ….….111 
Figure 4.25 Image series of b3.12 (QD PL krt NF) pre-introduction of test solutions………....112 
Figure 4.26 Multiple focal plane confocal images of well a3.11 (QD PL krt NF) …………….113 
Figure 4.27 Digital image of well a3.12 (QD PL krt NF) under wide-field fluorescence……...113 
Figure 4.28 R2 cell culture pre-introduction of the test solutions…………...………..………..115 
Figure 4.29 R2 cell culture post-introduction of the test solutions……………………...….…..116 
Figure 4.30 Confocal image of keratinocyte control with L/D and DIC dilters ……………….117 
Figure 4.31 Comparison of control versus QD-construct test solution for QD signature….......118 
Figure 4.32 Series of confocal images taken of R2 b1.4 (QD construct B 0.2 micron filter)….118 
Figure 4.33 Series of DAPI QD filter images of R2 b2.5 (QD construct B 0.45 micron filter)..119 
Figure 4.34 Series of DAPI QD filter images of R2 b2.6 (keratinocyte control media)…….....120 
Figure 4.35 Series of DAPI QD filter images of R2 b2.7 (QD construct B 0.45 micron filter)..120 
Figure 4.36 Series of confocal filter images of R2 c2.5 (QD construct B 0.45 micron filter)…121 
Figure 4.37 Series of confocal filter images of R2 c2.6, 7, 8 QD identification ………………122 
Figure 4.38 Series of DAPI QD filter images of R2 c1.1 (keratinocyte control media)…….....123 
Figure 4.39 Digital image of well b3.10 (QD PL krt filtered) under wide-field fluorescence ...125 
Figure B.5.1 Corresponding O.D. and wavelength values on an absorbance spectrum………..176 
 
 
 
 
xix 
 
LIST OF EQUATIONS 
 
      (
 
  
) (
  
  
 )     Equation B.5.1 ………………………………...177 
 
     (
 
  
) (
   
  
) (
  
  
 )    Equation B.5.2 ………………………………...178 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
 
Chapter 1 – Introduction 
 
1.1 Motivation 
 According to the 2012 cancer statistics conducted by the American Cancer Society it is 
expected that 1,638,910 new cases of cancer will be diagnosed in 2012 (1).  Additionally it is 
expected that 577,190 deaths will occur within the diagnosed population currently living with 
cancer (1). As these statistics show, cancer is a prevalent and devastating health issue and the 
second leading cause of death in the United States (2). Cancerous tumors can grow quickly, 
increasing their rate of cell proliferation, and metastasize to other areas of the body. If gone 
undetected, until the later stages of development, it is often too late for the patient to survive (3).  
The most common type of cancer found in the United States is skin cancer (4).  In 2012 more than 
68,000 Americans will be diagnosed with melanoma, 48,000 will be diagnosed with an early form 
of the disease that has not yet reached the lower levels of the epidermis, and more than 2 million 
people will be treated for basal cell or squamous cell skin cancer (4).  
 Early and accurate detection is the most reliable way to ensure a positive outcome and the 
ultimate survival of the patient (5).  As the most aggressive form of skin cancer, once metastasis 
has occurred, survival of melanoma is especially connected to early detection (6). Current methods 
for the initial detection of potential cancerous masses and lesions rely on visual examination, 
palpitation, and for the most prevalent forms of cancer, annual screenings (5). Once the presence of 
cancerous tissue has been ascertained by a physician a biopsy is performed for confirmation. Initial 
confirmation of cancerous cells is based on visual inspection of the cells under a microscope by a 
pathologist (7). In cases where an initial assessment is used as the basis for dictating which 
treatment options will be followed, it is important that the evaluation of the biopsy be accurate. 
Accurate determination of the presence of cancerous cells in a biopsy is especially difficult at the 
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early stages when only a small percentage of cells in the biopsied mass show the morphological 
traits associated with being cancerous.  This circumstance often results in a false negative (FN), 
delaying the necessary treatment until the cancer has reached a more developed stage (8). 
 This propensity for FNs in the early stages of cancer development indicates there is a need 
for an ulterior method of identification that would recognize even a single cancerous cell. 
An improvement to the conventional method of visually examining biopsied tissues for the 
presence of cells with abnormal morphologies can be offered by utilizing the model of 
functionalized quantum dot (QD) constructs. QD constructs provide a mechanism in which 
cancerous cells present within a biopsy sample could potentially be detected.   
 Quantum dots made soluble and functionalized to target enzymes associated with specific 
cellular receptors are currently being used as replacements for organic fluorphores in biologic 
applications of cellular tagging and tissue mapping (9-13). Applying this same methodology 
toward targeting enzymes that are associated with the initial stages of growth and proliferation 
specific to cancerous cells provides a platform for detecting the onset of cancer at the initial phase 
of cellular manifestation; developing the capability to detect the presence of cancerous cells at their 
earliest stages of development, before the tumor reaches the stage of metastization, would greatly 
increase patient outcome and survival. In the last decade there have been several approaches for 
targeting cancer cells utilizing QDs. One such approach explored by Gao et al. in 2004 involved 
the encapsulation of QDs with an amphiphilic tri-block polymer and multifunctionalization of the 
encapsulated QDs with a prostate-specific membrane antigen (PSMA), a cell surface marker 
associated with prostate epithelial cells (9).  In the Gao approach anti-body conjugation of the 
polymer encapsulated QDs was used for in vivo active tumor targeting.  In 2008 an investigation 
into the creation and use of proximity activated nanoparticles utilizing a QD base and a 
fluorescently labeled cleavable peptide substrate modeled in an in vitro environment was 
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conducted by Smith et al. (10).  Smith’s group synthesized carboxylated CdSe/ZnS QDs 
bioconjugated with a cleavable peptide substrate specific to matrix metalloproteases (MMPs). The 
goal of each of these methods was to develop a method for cancer targeting, drug delivery, and 
imaging using QDs. 
 The purpose of this thesis was to develop a base model for the solubilization, encapsulation, 
and primary functionalization of QDs using phospholipids as both the encapsulation and 
functionalization component.  The methods for phospholipid encapsulation of QDs described in the 
following chapters were developed using the phospholipid encapsulation methods outlined by Fan 
and Carion in their 2002 and 2007 papers detailing the use of such constructs in applications of in 
vivo imaging.  It is proposed that the basic method for the phospholipid encapsulation of QDs 
described in this thesis can be further modified to target additional cellular components through a 
secondary functionalization. These secondary functionalized QD constructs would provide a useful 
method for targeting and imaging cells of interest for future in vitro and in vivo studies. Further, 
secondary functionalization could then be fine-tuned to effectively create cell specific targeting 
constructs with the potential for use as an efficient and consistent mechanism for seeking out and 
confirming the presence of cancerous cells in in vitro studies. 
 This introduction will begin by presenting a fundamental overview of the physiology and 
stages of the development of cancerous cells, focusing specifically on melanoma. General 
components of the characteristic properties of UV radiation, as well as particular aspects pertaining 
to the effects of UV radiation on epidermal tissue, will also be discussed as well as a brief overview 
of epidermal physiology. Additionally, the chemical properties and biological interactions of 
phospholipids, and the physics related to the behavior of quantum dot will be provided. 
Understanding the chemical and biological interactions characteristic of phospholipids will give 
meaningful insight into the purpose for each step of the QD construct development process.  
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Although a detailed knowledge of the physics behind the behavior of quantum dots is not essential 
for their creation, it is, I believe, a valuable and thoroughly interesting aspect of the process and 
therefore should not be neglected for the sake of brevity. Finally, in this introduction a concise 
summary of some of the alternative biologic applications for which QDs are currently being used 
will be provided in order to give a proper appreciation for the diverse and complex environment 
into which this thesis attempts to delve.  
1.2 Cancer 
 Tumor is the general term used to describe a number of diseases that are characterized by 
the rapid and uncontrolled division of mutated cells.  The source of this abnormal growth of body 
tissue is called the neoplasm (14). Normal cell cycles contain stages of controlled cell growth and 
proliferation as well as coordinated cell death referred to as apoptosis. The natural proliferation 
cycle of cells exists to create replacements for old or damaged cells and to compensate for non-
pathological deficits which may occur. Cells that are old or damaged undergo a natural and 
automatic cell death thereby letting newer cells take over their biologic processes (14).  The control 
for each of these processes is encoded in the DNA within the cell’s genes. The balance of cell 
proliferation and apoptosis is altered as a result of multiple mutations in the DNA code over time 
(15). As a consequence of this prolonged imbalance a tumor develops. Classifying the cell as 
cancerous pertains to it having the characteristic of being malignant. A malignant tumor will 
infiltrate adjacent tissues as well as exhibit cell detachment from its initial location of origin, the 
neoplasm, move through blood vessels and the lymphatic system, and migrate to tissues and organs 
throughout the rest of the body (16).  Tumors that do not exhibit these invasive characteristics are 
referred to as benign. This process of migration and infection is called metastasis. Metastasis is the 
greatest threat to the health and survival of the patient and is subsequently the most detrimental 
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characteristic of cancer (17).  Although metastasis of a melanoma can occur quickly, it is not 
immediate. There are eight defined stages of metastasis beginning with the primary tumor. 
 
Figure 1.1 The eight stages of tumor growth and expansion leading up to metastasis (17). 
 
 The first stage is characterized by the primary growth of the neoplastic cells; at this stage 
the tumor expands. Proliferation and angiogenesis dominate the second stage. In order for the 
tumor to expand beyond a diameter of 2mm vascularization must occur. For every increase in the 
amount of cellular proliferation a corresponding increase in new capillary formation must also 
occur (18). Following capillary development tumor cells will begin to detach from the primary 
mass and penetrate the surrounding healthy tissue eventually reaching a blood vessel (19).  Once 
the blood vessel has been reached the cancer cells are transported throughout the body and proceed 
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to attach to the capillary beds of other tissues and organs where the metastasizing tumor cell will 
breach the endothelial cell barrier and invade (19,20). 
 There are a number of risk factors associated with developing cancer, they fall into two 
categories: environmental and genetic. Environmental factors encompass anything not strictly 
considered to be genetic. Some examples of environmental factors are chemicals, food, infection, 
radiation, obesity, cigarette smoking, stress, artificial tanning, and sunlight (21). Skin cancer is 
especially associated with UV damage as the result of long term sun exposure (4). Genetic factors 
include fair skin, previous melanoma, and a family history of cancer. Several genetic mutations in 
genes responsible for controlling cell growth can lead to tumor development. These mutations, 
such as BRCA1 and BRCA2 mutations related to breast and ovarian cancer, have been found to be 
hereditary (22). 
1.2.1 Diagnosis of Skin Cancer 
 Current methods for assessing the type of tumor cell, benign or malignant, start with a 
biopsy. Skin biopsies are implemented in one of four ways. The choice of biopsy type is dependent 
upon the initial visual assessment of the lesion. Shave biopsies involve the use of a thin blade to 
shave off the uppermost layer of the area in question. Punch biopsies implement a sharp hollow 
circular tool to extract a thick section of the skin containing the first few top layers. An incisional 
biopsy employs a scalpel to remove a partial section of the growth and an excisional biopsy uses a 
scalpel to remove all of the growth including a portion of the surrounding tissue (4).  
 Each of the three types of skin cancer are a the result of mutations within a specific type or 
layer of the epidermis: squamous cell carcinoma develops from mutations in the keratinocytes of 
the stratum spinosum, basal cell carcinoma results from mutations of cells within the stratum 
basale, and cancerous melanoma develops from mutations within melanocyte cells.  
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Figure 1.2 The epidermal and dermal layers of the skin with a magnified view of the epidermal 
layer in which the squamous cell, basal cell, and melanocyte reside (21). 
 
Of these three, basal cell carcinoma (BSC) is the most common but also the least dangerous (23). 
BSC is classified as a non-melanoma cancer as a result of its extremely low probability for 
metastasis (24). BSC develops in the stratum basale, a single layer of stem cells and keratinocytes 
intermixed with melanocytes and tactile cells. The stratum basale layer is the deepest layer of the 
epidermis, resting on the basement membrane just above the dermis. In cases of BSC, the lesion 
begins as a “small shiny bump” and upon enlargement will acquire a depression at its center. If 
allowed to progress the lesion will eventually invade the dermis (24). Squamous cell carcinoma 
(SCC) presents as rough, scaly, flat, reddish patches and most often affects those of fair 
complexion and extended chemical or sun exposure over their lifetime (25).  SCC develops in the 
keratinocytes of the stratum spinosum and without treatment may eventually metastasize to the 
lymph nodes (24). Melanoma is the deadliest skin cancer as a result of its high rate of metastasis 
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and is therefore the leading cause of skin disease related death, but constitutes only 5% of the total 
cases of skin cancer (26, 24). Melanoma is caused by mutations in the melanocytes ordinarily 
responsible for producing the pigment melanin.  
1.2.2 UV Radiation 
 The electromagnetic (EM) spectrum encompasses the entire range of known radiation 
energies starting with the most energetic forms, gamma, x-ray, and UV, and progressing to the least 
energetic forms such as infrared and radio waves (27).  The energy radiated from a source is 
directly linked to the wavelength of the emitted radiation measured in units of nanometers (nm). 
The longer the wavelength of the emitted radiation, the lower the associated energy of the emitted 
radiation, conversely, a shorter wavelength of emitted radiation will result in a higher energy and 
therefore the more harmful the effects of the emitted radiation. 
 
Figure 1.3 The electromagnetic spectrum (28). 
 
 The EM spectrum range, in order of lowest to highest energy, is: radio waves, microwaves, 
infrared, visible, ultraviolet (UV), x-rays, and gamma rays (27). The UV range of the spectrum can 
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be further divided into near UV (UVA), far UV (UVB), and extreme UV (UVC) (36, 37). The most 
prevalent source of UV radiation is the sun. UVC radiation has a wavelength between 100 -290 nm 
and is completely blocked from reaching the surface of the Earth as a result of the ozone layer of 
the atmosphere absorbing the radiation (37). UVB rays, 290-320nm, are partially absorbed by the 
ozone layer and are therefore partially transmitted to the surface. UVA, (320-400nm) rays pass 
through the ozone layer without any attenuation and are thereby fully transmitted to the surface of 
the Earth (37). Although UVB radiation has been determined to be the more carcinogenic of the 
two, extended exposure to both UVA and UVB radiation, results in damage to DNA thereby 
causing mutations which may lead to the formation of melanomas (38).  
1.3 The Epidermis  
 The skin is the largest organ of the human body, making up roughly 15% of total body 
weight and covering a surface area of 1.5 to 2.0m
2
 in adults (24). Skin is composed of two layers, 
the epidermis and the dermis; the epidermis being the outermost of the two. One of the main 
functions of the epidermis is to act as a barrier to the harmful effects of UV radiation (24). In this 
capacity the epidermis protects the deeper tissue layers form exposure to the damaging UVA and 
UVB rays. The epidermis consists of a series of cell layers, each containing keratinocyte cells in 
various states of growth and viability. Keratinocytes make up the majority of the cells found in the 
epidermis, approximately 90%, and are named as a result of their primary function of synthesizing 
keratin (24, 39). 
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Figure 1.4 The five layers of the epidermis and the cells that comprise each layer (39). 
 
 Keratinocytes, originating in the stratum basale layer as a product of stem cell and 
keratinocyte cell mitosis, migrate upwards through each subsequent layer of the epidermis toward 
the surface where the replace damaged or dead epidermal cells in a 30 to 40 day cycle of 
regeneration (24).During the migration process the shape and function of the keratinocyte cells 
changes. As they move up through the layers they become flatter and produce a lipid-filled 
membrane-coating vesicle that aids in waterproofing the epidermal surface (24). Continued 
exposure of epidermal cells to UV radiation can lead to mutations, which over time can begin 
affecting the cells ability to control proliferation leading to the formation of cancerous lesions.   
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1.4 Phospholipids 
 The plasma membranes of cells separate intracellular components from extracellular 
components as a means of maintaining the environment necessary for cellular function. The plasma 
membrane is composed of a phospholipid and phosphoglyceride bilayer integrated with a variety of 
associated proteins (40). A phospholipid is an amphiphilic molecule comprised of a polar 
hydrophilic head and two non-polar hydrophobic acyl fatty chains (40). The hydrophobic heads of 
the phospholipid are positioned outward creating both the intracellular and extracellular surfaces of 
the membrane. The hydrophilic acyl fatty chains are directed inward and embedded within the 
membrane layer.  
 
Figure 1.5 Phospholipid molecular structure and aggregation formation in the presence of water 
(41). 
 
 The species designation of phospholipid is dependent upon the particular alcohol either 
attached to or forming the primary backbone of the molecule. In the case of phosphatidylcholine 
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(PC), phosphatidylserine (PS), phosphatidylinositol (PI) and phosphatidylethanolamine (PE), their 
alcohols are attached to the glycerol backbone of the molecule. Unlike PC, PS, PI, and PE, the 
alcohol of the phospholipid sphingomyelin (SP) is the backbone of the molecule (40). The 
phospholipid composition of the membranes allows for diffusion within the plane of the membrane 
(40).  It is this quality, promoting the integration of other phospholipid based structures, that can be 
exploited in the effort to tag and map tissue using phospholipid encapsulated QDs constructs. 
Additionally phospholipids can be altered to contain specific functional headgroups such as poly 
ethylene glycol (PEG) and amines (-NH2) to increase the biocompatibility of the phospholipids and 
provide additional sites for further bioconjugation (11). As a result of the amphiphilic nature of the 
phospholipids, one hydrophobic end and one hydrophilic end, they are especially useful as a 
material for encapsulating the normally toxic and hydrophobic inorganic CdSe/ZnS QDs.  The 
amphiphilic characteristic inherent to phospholipids makes it possible for them to attach to the QDs 
on one end and interact with an aqueous environment on the other end.   Typically when 
phospholipids are suspended in a polar nonorganic substance such as water they will spontaneously 
associate to form bilayers like those illustrated in Figure 1.6 (42). When suspended in an organic 
substance, such as chloroform, phospholipids become soluble at room temperature and their 
hydrophobic fatty acid chains can readily attach to the like-wise hydrophobic surface of the QD. 
Multiple attachments of phospholipids in this manner result in a QD that is completely 
encapsulated and therefore able to become soluble in aqueous solvents. 
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Figure 1.6 Phospholipid fatty acid chain attachments to QD surface. 
 
1.5 Quantum Dots 
 All materials can be characterized by their tendency to either promote the movement of 
electrons through their mass, or to inhibit the movement of electrons through their mass; their 
degree of electrical conductivity (43). Those that promote the movement of electrons are referred to 
as conductors and those that inhibit the movement of electrons are referred to as insulators. 
Intermediary between insulators and conductors are materials classified as semi-conductors.  The 
distinguishing characteristic between insulators, conductors, and semi-conductors is the size of 
their respective band gaps. 
 The band gap describes the energy needed to be absorbed by an electron in order for that 
electron to be excited to the conduction band, as well as the energy released by the electron when it 
de-excites back to its ground state in the valence band. The relative ease of promoting an electron 
from the valence band to the conduction band determines the electrical conductivity of the material 
(43). The Fermi energy denotes the highest energy level occupied by an electron when at absolute 
zero. Understanding the connection between atomic orbitals, electron energies, valence shells, and 
band gaps is integral to understanding the fundamental phenomenon responsible for the unique 
emission behavior exhibited by quantum dots. 
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Figure 1.7 Variation of band gaps between the conduction and valence bands of insulators, 
semiconductors, and conductors. 
 
 Insulators have empty conduction bands and a valence band full of electrons tightly bound 
to their atoms by ionic or covalent bonds (44).  Covalent bonding, the sharing of valence electrons 
between neighboring atoms, occurs in materials composed of a single element or similar elements; 
ionic bonding is the complete transfer of an electron from one atom, an electron donating metal, to 
another atom, an electron accepting non-metal (45). The presence of these strong bonds between 
the electron and the atom result in a large band gap, an inhibition to electrical conduction, 
necessitating the need for a significant amount of energy to induce an electron to transition to the 
higher energy conduction band. In the case of pure diamond 6 to 7 eV is required to excite a single 
electron into the conduction band (44). Conductors possess little to no band gap between their 
valence and conduction bands and often the highest available, but unoccupied, energy levels of the 
valence band will overlap with the lowest empty energy levels of the conduction band. This 
overlap causes the electrons within the partially filled valence band to move freely within the 
material promoting conductivity (44).  
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 Semiconductors are a type of material characterized by their inhibition of electron 
movement at low temperatures and their promotion of electron movement as more energy is put 
into the material, often in the form of an increase in temperature from absolute zero, but also as the 
result of incident radiation (45). The central property that defines a material as conducting, 
semiconducting, or insulating is the band gap of the material.  The band gap of the material is an 
intrinsic property of the bulk material.  The change in this intrinsic material property relative to the 
number of constituent atoms, bulk state or nano-scale, is key to the fluorescent property of quantum 
dots. 
 The Aufbau principle describes the characteristic preference of electrons to occupy the 
lowest energy state possible (46). As such, electrons will fill the inner most atomic energy levels of 
an atom first. Each electron occupies a specific atomic orbital, within a specific energy shell, and 
the further out the energy shell is from the nucleus of the atom the greater the energy attributed to 
the electrons occupying that shell (47).The highest energy level occupied by an electron, when it is 
in its non-excited ground state, is the valence shell. Electrons occupying the valence shell are called 
valence electrons.  
 
Figure 1.8 Electron atomic orbital lowest energy configuration for silicon (48). 
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 Valence electrons have the greatest probability of being promoted to a higher energy level 
(45). It is from the position of lowest energy, the valence shell, that an electron may be excited into 
a higher, and as yet unoccupied, energy. Excitation will occur if the electron is acted upon, and 
absorbs, an amount of energy equal to or greater than the difference in energy between the valence 
shell and the next higher energy level. The exact number of electrons permitted in each energy 
level and the minimum possible energy of an atom can be determined by coupling the aufbau 
principle with Pauli Exclusion Principle which states, “No two electrons in a quantum system can 
occupy the same quantum state” (49).  Combining these two principles, unperturbed electrons will 
always occupy states of lowest energy and no more than two electrons can simultaneously occupy 
an atomic orbital, provides information on the exact energy of the highest energy valence electron.  
Knowing the exact energy of the highest energy valence electron, while also knowing the energy of 
the nearest unoccupied orbital, yields the effective band gap energy. In bulk form, the discrete 
energy states of the individual atom are replaced by the continuous valence and conduction energy 
bands (50). The Pauli Exclusion Principle prevents any two electrons form occupying the same 
quantum energy state, therefore, when multiple atoms are in close proximity, or bounded to one 
another, the discrete energy levels of the individual atoms form a band of multiple degenerate 
orbitals of the same energy for which the corresponding electrons can reside (47). Figure 1.9 shows 
an illustration of this progression from discrete energy levels to continuous energy bands. 
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Figure 1.9 Progression from discrete energy levels to continuous energy bands during aggregation 
of individual atoms to form bulk material (47). 
  
 For a material to be considered a nano-material its largest dimension must be no bigger than 
100nm, conversely, a material that is larger than 100nm with respect to its smallest dimension will, 
for the purposes of this thesis, be considered a bulk material (45).  Quantum dots are nano-crystals 
composed of semiconducting material, which as the result of their small nano-scale size, 1-10nm, 
exhibit properties that are not observed in the larger bulk material. QDs have the same elemental 
composition and atomic arrangement as the corresponding bulk material; however, their size causes 
the number and arrangement of atomic energy levels available to electrons to be altered.  
 The valence and conduction bands found in the bulk material are the result of the 
interaction of the electron energy levels in the constituent atoms from which the bulk material is 
comprised. In the case of a bulk material, where thousands or millions of atoms are bound to one 
another, energy levels of individual atoms are forced to interact with energy levels of their 
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surrounding neighbors. Interaction between the electron energy levels of each atom and its nearest 
neighbors are what create the continuous valence and conduction bands found in bulk materials 
rather than the discrete energy levels in atoms (47). Understanding the parallels between the energy 
bands that exist in the bulk material and the energy shells that exist in individual atoms will 
facilitate a general understanding of the quantum mechanical effects that are a consequence of the 
diminished size of QDs.  
1.5.1 Quantum Confinement and the Bohr Exciton Radius 
 QDs have the same elemental composition and atomic arrangement (1) on the nano scale as 
the corresponding bulk material, however, decreasing the physical size of a material has several 
interrelated consequences: the number of atoms within the material is decreased, less bulk material 
means less space for the electron-hole pair to move in thus causing confinement of the electron, 
and the number of energy levels available to the electrons decreases and discrete atomic energy 
levels form rather than continuous energy bands. 
 In semiconducting bulk materials, when a photon possessing an energy greater than or 
equal to the band gap energy is absorbed, an electron will be excited in to the conduction band.  
The promotion of the electron from the ground state into a higher energy state results in a 
positively charged hole.  Until the electron is de-excited and recombines with the hole, the pair can 
move about the bulk material but will remain within a prescribed distance of one another as a result 
of the Coulomb attraction between them (40). The distance between the electron and the hole is a 
unique characteristic intrinsic to each material referred to as the Bohr exciton radius.  
 In the case of CdSe cores the average distance between the electron and corresponding hole is 
5.6nm (51). If a CdSe crystal smaller than this distance is synthesized the energy is constrained and 
quantum confinement of the energy will develop.  A continued decrease in the size of the QD 
relative to the natural electron-hole distance causes an increase in the amount of confinement and 
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subsequently an increase in the band-gap energy. Increases in the band gap energy result in a 
transition from the continuous energy bands of the bulk material back toward the discrete energy 
levels seen in atoms. This atom-like resemblance of the discrete energy levels of QDs has 
promoted use of the term “artificial atom” when referring to QDs (51). 
 
 
Figure 1.10 Relationship between size, Bohr exciton radius, band gap and composition of atomic 
energy levels. 
 
 The progression of electron movement restriction leading to quantum confinement can be 
accomplished in two ways: physical reduction in the size of the material or trapping the material 
between layers of a second material with a larger band gap energy. As the physical size of the 
material is decreased, composed of fewer and fewer atoms, the energy states of the atoms are no 
longer as compressed, they lose the continuous quality found in the band gaps of the bulk material, 
they start to spread out and become more discrete. A standard illustration for the change in energy 
states of a material as the size of the material decreases is given in Figure 1.11. In the bulk 
material, referred to as 3D, the energy state is continuous, the electron can move in all three 
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dimensions. By restraining the electron transitions in one dimension, either by the physical removal 
of the bulk material or by using a secondary material with a larger band gap, the electrons are now 
confined to two dimensions. This confinement alters the manner in which the electron energy states 
interact, creating distinctions between each energy state. As we continue on, the states become 
more well-defined until finally they exhibit the same discrete quality as individual atoms. 
 
 
Figure 1.11 Progression of energy state densities as a result of increased electron energy 
confinement. 
 
 This transition toward discrete energies associated with a reduction in the size of the 
material is directly related to the aforementioned Bohr exciton radius. When the size of the material 
is less than the distance of the exciton radius, the electron’s wave-function is constrained and the 
subsequent effect is an increase in the band gap (52). As the size decreases, the electron wave 
function becomes ever-more confined, as the electron wave function becomes ever-more confined 
the band gap energy increases, and as the band gap energy increases the energy needed to excite an 
electron from the valence to the conduction band also increases; each of which result in the 
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increased energy of the emitted photon. Keeping these relationships in mind, the connection 
between QD size and photon emission wavelength can be made. Relative to the electromagnetic 
spectrum, the higher the energy of the emitted photon the more shifted toward the blue end of the 
spectrum and the lower energy more toward the red. Figure 1.12 illustrates this connection between 
QD size and emission wavelength. The basic break down being, small QDs have bigger band gap 
energies, bigger band gap energies result in higher energy emitted photons, therefore the energy of 
the emitted photon is directly related to the size of the QD; by synthesizing QDs of a specific size 
you can tune the wavelength of emitted light.  
 
 
Figure 1.12 Relationship of QD size band gap energy and photon emission wavelength. 
 
1.5.2 Biologic Quantum Dot Applications 
 Current Biomedical QD applications for QDs include membrane labeling, fluorescent 
microscopy, antibody tagging, genomic analysis, metabolic analysis, and diagnosis of metabolic 
processes (10-13, 53, 54). QDs are promising substitutes for organic fluorophores in many of the 
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biologic applications involving membrane labeling, fluorescent microscopy, and antibody tagging. 
One of the most prominent advantages of using QDs over their organic counterparts is the QDs 
reduced tendency to photo-bleach and the possibility for exciting multiple QDs of different 
emission wavelengths with the same excitation source. This capability to use a single excitation 
source for multiple QDs facilitates imaging of samples in which there are several components of 
interest. QDs are being used in genomic applications as well. Samples containing different 
combinations of QDs with distinct emission spectra conjugated to different DNA probes are mixed 
in a solution with a target DNA containing complementary sequences (55).  The hope is that this 
process can be fine-tuned for detecting the presence of genetic defects. Similarly, viral analysis can 
be undertaken using what is referred to as QD bar codes - ten different QD colors could 
conceptually provide 45 different QD pair combinations (56, 57).  The discrete wavelengths of QD 
emission make this possible, specifically tailoring them through functionalization to target multiple 
sites upon a tumor increasing the probability of detecting even the smallest amounts of cancerous 
cells. QD-fluorescent dye conjugates are also proposed as tools in the diagnosis of metabolic 
processes. They provide a way to monitor the proteolytic activity of extracellular matrix 
metalloproteinases (58, 59). These examples are a small sample of the variety of biologic 
applications in which the use of QDS has started to become common place; a range of applications 
that is increasing every day. 
 
1.6 Overview of Thesis Goals and Deliverables 
 This introductory chapter has served as a vehicle for providing the foundational knowledge 
and background pertinent to this thesis. The clinical problem of detecting and diagnosing cancer at 
the earliest stages of development is, in cases of the most aggressive forms of cancer, paramount to 
patient survival. False negatives which may occur during the examination of biopsied lesions are 
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counterproductive to the goal of early detection. Current methods relying on visual examination of 
biopsied samples viewed under a microscope are inadequate for detecting small populations of the 
abnormal cells indicative of cancer. A more adequate method of detection is required; 
functionalized QD constructs are a mechanism which can be employed to fill this need. QD 
constructs have the potential to not only identify and target cancerous cells, but eventually to also 
be used simultaneously as drug delivery devices.  
 The purpose of this thesis was to develop a foundational method for the solubilization and 
primary functionalization of QDs to be used in biologic tagging.  This was accomplished through 
encapsulation of QDs of different emission wavelengths within phospholipid micelles. To achieve 
this, CdSe QDs were synthesized using the standard Cal Poly QD synthesis protocol with minor 
modifications in synthesis temperature and reaction time to achieve QDs of the desired emission 
wavelengths. These CdSe QDs were then coated in ZnS shells at a variety of synthesis 
temperatures to once again produce QDs with an emission wavelength specific to the necessary 
testing parameters. Fluorescence spectra were used to assess the center max wavelengths (CMWs), 
intensities, and full width at half max associated with each batch of synthesized QDs. Choice of 
QDs to be encapsulated and used in the keratinocyte cell culture trials was dictated by the emission 
wavelengths of the fluorescent stains applied to the keratinocyte cultures: Calcein at 517nm and 
Ethidium homodimer-1 at 635nm. The QDs were then encapsulated in phospholipid micelles and 
introduced to the keratinocyte cultures of varying periods of time. This thesis offers a first method 
for the solubilization and primary phospholipid functionalization of QDs for introduction to 
keratinocyte cells that can be further modified for future applications. 
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Chapter 2 – Development and Evaluation of CdSe/ZnS Quantum Dots  
 
2.1 Introduction 
 In 1970 Japanese physicists Esaki and Tsu were the first to produce crystalline superlattices 
possessing near perfect match of lattice constants leading to the creation of a two dimensional 
structure with previously unseen electronic properties (60, 61). Also in the early 1970s researchers 
at AT&T Bell Laboratories and IBM began making 2D quantum wells using semiconducting 
materials (62). In 1984 Miller et. al. at AT&T Bell Laboratories in New Jersey published research 
on the shifts in optical absorbance experimentally found in GaAs-AlGaAs quantum well structures 
contrasting the effects with bulk semiconductors as a “consequence of quantum confinement 
carriers” (63). Louis E. Brus of AT&T Bell Laboratories discovered quantum dots in colloidal 
solutions, at the same time Efros and Ekimov at the A.F. Ioffe Physical-Technical Institute in St. 
Petersburg Russia were also developing semiconducting nanocrystal technology, first discovered in 
a glass matrix, which was later christened “quantum dots” by Mark A. Reed in 1988 (64, 65). In 
the early 1990s the field nanocrystal research was expanding and synthesis using both top down 
and bottom up techniques were being employed by multitudes of researchers.  
 The top down approach involves working with a macroscopic volume of material and 
gradually and precisely decreasing its size, either through mechanical or chemical means, until the 
nanoscale, approximately 100nm, has been reached.  The top down process is akin to that of a 
whittler slowly shaving down a hunk of wood into a delicately carved miniature rocking chair (66). 
The top down approach to synthesizing QDs, though effective, is time consuming and expensive 
(67).  
 Bottom up approaches include self-assembly, colloidal synthesis, and guided attachment of 
colloidally synthesized QDs through plasma lithography (67). Self-assembly of QDs can be 
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achieved by electron beam lithography, a physical mechanism by which an electron beam etches 
grooves into a substrate that are then filled by the semiconducting material, molecular beam 
epitaxy (MBE) where the semiconducting materials are heated to the point of vaporization and 
condensed and reacted on a substrate, or metal-organo chemical vapor deposition (MOCVD), a 
chemical mechanism in which the atomic deposition of one semiconducting material is applied on 
to a substrate of a second semiconducting material (68). Through natural processes involving the 
energetic stability associated with lower energy states the deposited material forms nanometer 
sized beads on the surface of the substrate.  The final QD nanocrystals are produced by layering the 
beads with a semiconducting material possessing a band gap larger than that of the bead material 
(69). An added benefit to self-assembled or colloidally synthesized QDs using a bottom up 
approach, aside from faster synthesis time and decreased cost of materials, is that the resulting QDs 
have smaller diameters, and subsequently stronger quantum confinement potentials, than QDs 
synthesized using one of the top down approaches (69). 
 By the late 1990s the synthesis had shifted away from using the initial toxic and air-reactive 
chemicals toward “green synthesis” utilizing still biologically toxic but less hazardous and more 
stable reagents. Interest in the field of nanocrystals and quantum dots and their varied applications 
has grown exponentially over the last three decades as is evident from the number of related 
research published in journals; almost none pre-1980 to over 3500 per year by 2009 (64). Although 
research continues in both the top down and bottom up synthesis of quantum dots, the bottom up 
approach has overtaken in popularity.  
 As mentioned in Chapter 1, a variety of different starting materials are available and have 
been utilized for the synthesis of QD nanocrystals. Both the top down and the bottom up methods 
create QD nanocrystals that are composed of atoms from groups II – IV or III – V elements that are 
found in the periodic table, such as CdSe, CdTe, CdS, and ZnSe for groups II – IV, and InP and 
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InAs for groups III – V (70).  Of the many available semiconducting materials, the CdSe/ZnS 
core/shell combination has been in use in the colloidal synthesis of QDs the longest, since 1996 
(71). The most well-known and commonly used protocols for the colloidal synthesis of quantum 
dots use the “green synthesis” variety of Cd/Se compounds as the semiconducting starting material 
(72).  The number of readily accessible articles outlining the numerous variations on the original 
protocol developed by Murray et al (73) is evidence of the interest and developing usefulness of 
QD involved applications.  
 A standard CdSe core synthesis procedure from the 2005 paper “A Safer, Easier, Faster 
Synthesis for CdSe Quantum Dot Nanocrystal” written by Nordell et. al. had been previously 
developed for use at Cal Poly by Aarron Lichtner in 2009 (74). The procedure was later expanded 
upon to include a ZnS coating step for increased quantum yield and stability. The currently used 
ZnS coating protocol was initially developed from literature by Cal Poly graduate student Sabrina 
Bruce-Akman in 2010 and later refined by Josh Angell in 2011. The effects of altering the non-
reagent related parameters for synthesizing CdSe cores and applying the standard ZnS coating 
procedure were further investigated and modified for the purposes of this thesis.  The previously 
developed Cal Poly standard synthesis procedure, in its entirety, can be found in appendix B.1 or 
Josh Angell’s 2011 thesis Synthesis and Characterization of CdSe – ZnS Core – Shell Quantum 
Dots for Increased Quantum Yield. The previously developed bottom up colloidally synthesized 
CdSe/ZnS QD Cal Poly procedure was modified to achieve the QDs with the necessary emission 
wavelengths for tagging and mapping a biologic using phospholipid encapsulated QD constructs.  
For the purpose of tagging and mapping a biologic it was essential to have at least two sizes of 
QDs; to have QDs with two distinct and distinguishable emission wavelengths. For this reason 
knowledge of, and familiarity with, the QD synthesis process was necessary for maintaining a 
continuous supply of QDs for use in the phospholipid encapsulation procedure. Likewise it was 
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important that the synthesis of the QDs be consistent and well documented.  From the initial 
procedure, optimized protocols for the synthesis of white CdSe cores and shelled CdSe/ZnS QDs 
with emission wavelengths of 505nm (+/- 10nm) and 555nm (+/-) 10nm were developed. The 
resulting synthesized CdSe/ZnS QDs were used in the encapsulation procedure described in 
chapter 3. 
 
2.2 Methods 
2.2.1 Synthesis of CdSe cores 
 Synthesis of the CdSe cores applied the same reagents and amounts of reagents as described 
in the standard Cal Poly protocol. Each of the precursors, selenium trioctylphosphine (Se-TOP) and 
cadmium (Cd), were synthesized following the steps in the protocol, with only slight modifications 
pertaining to the method for measuring out appropriate quantities of each of the dry reagents. The 
standard procedure weighed out 33mg of selenium powder or 13mg of the cadmium oxide powder, 
into a plastic weigh-boat and then transferred the powder into a 50mL round bottom flask. The 
method used in this thesis was to directly transfer the powder into the two neck 50mL round 
bottom reaction flask. The standard synthesis of the Se-TOP precursor yields a 5.4mL volume of 
the precursor. The Se-TOP precursor for this work was synthesized in quintuple batches to reduce 
the variation across the multiple CdSe core synthesis procedures. Se-TOP precursor older than five 
days was discarded for use in core synthesis beyond the initial experimental trials. The size of the 
Cd precursor batch was dependent on the size and number of samples to be extracted. For one or 
two samples, of 5mL each, a single batch was made; for extractions of three or more samples a 
double batch was made.  During the initial testing of synthesis parameters, a quintuple batch of Cd 
precursor was made and divided up into 10mL volumes for synthesis of the CdSe cores using a 
stock solution.  This was done in an effort to eliminate additional variables during testing of 
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experimental parameters. For both the Se-TOP and Cd precursor synthesis, all reagents were 
purged with nitrogen gas and vented simultaneously for a period of ten minutes. After combination 
of all reagents into the reaction flask the Nitrogen and vent needles were removed to prevent 
evaporation of the solution. For synthesis of the CdSe cores the Cd precursor was heated to the 
desired reaction temperature and upon reaching the reaction temperature the room temperature Se-
TOP precursor was added. The ratio of Cd to Se-TOP precursor used in each synthesis was the 
10mL of Cd to 1mL of Se-TOP prescribed in the standard protocol.  At the desired reaction times 
of 0, 30, 60, or 90 seconds CdSe samples were extracted, using a non-disposable glass syringe, and 
deposited into the appropriate sample vials. After each CdSe sample had cooled qualitative 
examination of the sample was performed by exposure of the sample to a generic black light. 
Quantitative data was then obtained using an Ocean Optics USB4000 Spectrometer to take 
fluorescence readings of each sample. 
 2.2.1.1 Experimental Variables Investigated for the General Synthesis of CdSe Cores 
 Four variables were manipulated in the synthesis of the CdSe cores: temperature, reaction 
time, receptacle volume, and quenching. The temperature of the Cd precursor at the time of Se-
TOP injection was altered from the standard 225°C typically used, to 220, 215, and 210°C. Two 
consequences resulted from the change in temperature; the obvious and primary effect was a 
decrease in the temperature at the time of Se-TOP injection. A secondary effect was a reduction in 
the time that the Cd precursor was exposed to heat before injection. It took less time for the Cd 
precursor to heat up to 220, 215, or 210°C, approximately 4 minutes less for each five degree 
interval, providing a reduction in the overall time of exposure to heat. The reaction time of the 
CdSe core synthesis was defined as the time from complete injection of the Se-TOP into the heated 
Cd until the beginning of extraction into the glass syringe. Samples were extracted at times of 0, 
30, 60, and 90 seconds. The receptacle volume ranged from 2mL to 15mL with vial diameters of 1, 
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1.5, 2, and 2.5cm. Variation of sample vial size was investigated to determine if heat dissipation 
could be improved.  A variety of vial arrangements and configurations were designed that would 
provide alternate sample distributions for cooling. Along with altering the volumes of samples as a 
method to assist in heat dissipation, quenching methods were investigated. Comparisons of the 
differences in center max wavelength (CMW), peak intensity, and full width at half max (FWHM) 
of the fluorescence spectrums for samples cooled in air, the standard, and acetone were made for 
three time points: 30, 60, and 90 seconds. Quenching with acetone was carried out by flushing the 
outside of the vials with acetone. For a period of one minute the sample vials were lowered into 
and raised out of an acetone bath in 5 second intervals and then submerged for 3 minutes. On 
occasion if the vials were submerged longer than 3 minutes the CdSe solution inside would develop 
a slushy consistency.  
 
 
Figure 2.1 Three sample vial arrangement used to test the effects of volume size on CdSe 
fluorescence spectra. From left to right: 15mL 2.5cm, 2mL 1cm, and 10mL 1.5cm diameter glass 
sample vials in an acetone bath. 
 
 2.2.1.2 Synthesis of White Fluorescing CdSe Cores (WFCs) 
 The same four variables were manipulated in the synthesis of the white fluorescing CdSe 
cores (WFCs). The two parameters particularly focused on were reaction time and quenching.  
30 
 
The entire process of extracting the sample from the reaction flask to injecting it into the glass 
sample vial averaged 10 seconds. Reaction times varied between 0 and 15 seconds. 
A 5cc glass syringe was used for extraction of the WFC samples. Practice and patience was 
required to remove the sample as quickly as possible. The glass extraction syringe was positioned 
in the second neck of the reaction flask and upon full injection of the Se-TOP precursor into the 
heated Cd precursor a 3-5mL sample was extracted and injected into 1-5 sample vials. After one 
minute of flushing with acetone, the vials were left submerged in an acetone bath for 3 minutes. 
2.2.2 Synthesis of ZnS Coated Quantum Dots 
 The process used for the coating of the CdSe cores with ZnS shells applied the same 
reagents and amounts of reagents as described in the standard Cal Poly protocol. The ZnS 
precursor was synthesized following the steps in the standard protocol. The standard protocol did 
not specify a specific CdSe core solution to ZnS precursor ratio to be used. For the purposes of this 
thesis a standard ratio of 5mL CdSe to 1mL of ZnS was applied.  In the modified procedure 5mL of 
CdSe core solution was added to a 50mL round bottom reaction flask; a magnetic spin vane and 
temperature probe were also placed in the reaction flask. The CdSe core solution was mixed at the 
synthesis heat, either 160 or 110°C, in a silicon (Si) oil bath for ten minutes. 1mL of the ZnS 
precursor was added in a slow consistent drop-wise fashion over a period of 2 minutes. The 
reaction was then let to proceed for an additional 8 minutes. At the conclusion of the reaction time 
the solution was removed from the Si oil bath and cooled to 60°C at which point 1mL of butanol 
was quickly added.  The flask was then agitated side to side for 2 minutes. After each CdSe/ZnS 
sample had cooled, qualitative examination of the sample was performed by exposure of the 
sample to a generic black light. Quantitative data was then obtained using an Ocean Optics 
USB4000 spectrometer to take fluorescence and absorbance readings of each sample. 
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 2.2.2.1 Temperature Variation of CdSe/ZnS Synthesis  
 The effect of temperature on CMW during the synthesis of CdSe/ZnS QDs was investigated 
by comparing QDs synthesized at 70°C, and 110°C in addition to the standard protocol synthesis 
temperature of 160°C. In the comparison of the CMW of QDs synthesized at 70°C  relative to 
those synthesized at 160°C, 4 WFC samples were coated at 70°C and 4 WFC samples were coated 
at 160°C. The final CMWs, intensities, and FWHMs of the samples coated at 70°C were compared 
to those coated at 160°C by employing a two sample t-test. Figure 2.2 gives a schematic division of 
the ten previously synthesized CdSe core samples used for the comparison of the effects of QDs 
shelled at110°C and at 160°C. The ten samples consist of 5 CdSe samples fluorescing white and 
five CdSe samples fluorescing green at 541nm with an intensity of 5800 counts and a FWHM of 
44nm, that were combined within each set, creating two subsets each. The resulting sets provided 
two WFCs shelled at110°C and at 160°C, and two 541nm samplesshelled at110°C and at 160°C 
using the aforementioned shelling process. The CMWs of the resulting eight samples were then 
compared to the original corresponding CdSe core solution and to each other.  
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Figure 2.2 Schematic of the division of the ten previously synthesized CdSe core samples used for 
the comparison of the effects of QDs shelled at110°C and at 160°C. 
 
2.3 Results 
2.3.1 Synthesis of CdSe Cores 
 2.3.1.1 Experimental Variables Investigated for the General Synthesis of CdSe Cores 
 The receptacle volume only affected the outcome of the WFCs when the smallest and 
greatest volumes were compared and as a result of other possible contributing factors, could not be 
quantitatively demonstrated. The data in Table 2.1 are the CMW, Intensity, and FWHM averages 
of 23 different CdSe core samples used to compare the effects of the reaction temperature. Each 
average was taken using a minimum of three samples and a maximum of five samples. The visual 
representation of the data is given in Figure 2.3. Using the values from all of the samples for each 
time point, the standard deviation was calculated, using a p-value of 0.05, and applied as a 
comparison of the averages for each time point in the form of error bars. Using standard deviation 
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as a measure of the degree to which each parameter was affected by the synthesis temperature, it 
was initially concluded that for CdSe cores synthesized at 30, 60, and 90s time points, and cooled 
in air, there was no statistically significant difference in the CMW, intensity, or FWHM.  
Table 2.1 Effects of Temperature on CMW, Intensity, and FWHM for 30, 60, and 90s Samples 
Cooled in Air. 
 
 
 
 
Figure 2.3 Comparison of the effects of reaction temperature on the average CMWs, intensities, 
and FWHMs of synthesis time points of 30, 60, and 90s samples cooled in air. 
 
 In addition to calculating the standard deviation from all of the samples for each time point, 
a two sample t-test, assuming asymmetric variance, was conducted to compare the effects of 
temperature on the CMW, intensity, and FWHM for each time point of CdSe samples cooled in air. 
Table 2.2 gives the two-tail p-values associated with each t-test using an alpha of 0.05 and a 
confidence interval of 95%. All of the t-test p-values were above the alpha value of 0.05 and 
therefore the null hypothesis, which indicates the means for each sample group were equal, could 
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not be rejected.  Based on this, it was again concluded that the temperature difference of 10°C at 
the time of injection of the Se-TOP precursor did not have a statistically significant effect on the 
CMW, intensity, or FWHM for time points of 30, 60, and 90s. 
 
Table 2.2 Two Sample t-test of Effects of Temperature on CMW, Intensity, and FWHM for Each 
Reaction Time Point. 
 
 
 
 2.3.1.2 Temporal Effects on CMW, Intensity, and FWHM of CdSe Cores 
 A series of synthesis, conducted at reaction temperatures of 215 and 225°C, were performed 
to determine the effect that the duration of the reaction had on the CMW, intensity, and FWHM of 
the CdSe cores.  Data for the CMW, Intensity, and FWHM averages of 23 different CdSe core 
samples that were used to compare the effects of the reaction times are given in Table 2.3. Each 
average was taken using a minimum of three samples and a maximum of five samples. The visual 
representation of the data is given in Figures 2.4 and 2.5.  As a result of applying t-tests, it was 
previously determined that temperature did not play a statistically significant role in determining 
CMW, intensity or FWHM for 30, 60, and 90s reaction time points; for this reason all of the data 
points from both the 215 and the 225°C synthesis were used. The averages for the CMW, intensity, 
and FWHM of each time point were compared and a value for the standard deviation was 
calculated. The standard deviation was then applied in the form of error bars. The resulting data 
appeared to support the conclusion that there was a significant statistical difference in the CMW, 
Quench 
Medium
Time      
(s)
Samples 
at 215 °C
Samples 
at 225 °C
CMW   
p-value
Intensity  
p-value
FWHM  
p-value
Air 30 5 3 0.41 0.98 0.06
Air 60 5 3 0.99 0.86 0.33
Air 90 4 3 0.98 0.98 0.45
35 
 
and intensity of the CdSe cores which was dependent on the reaction time, but not a significant 
difference in the FWHM associated with each reaction time.  To further support this conclusion a 
single factor ANOVA test was conducted.  
Table 2.3 Averages of, and Standard Deviations for, the CMW, Intensity, and FWHM of CdSe 
samples for 30, 60, and 90s Reaction Times. Left: averages. Right: standard deviations. 
 
 
 
 
Figure 2.4 Combined reaction time data for 215 and 225°C, quenched in air, averaged for each 
reaction time point. Standard deviations were calculated for each series of samples corresponding 
to individual reaction time points. 
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Figure 2.5 Fluorescence spectrum of CdSe core solutions for 30, 60, amd 90s reaction times. 
 
 A single factor ANOVA test was employed to determine the effect of different time points 
on the CMW, Intensity, and FWHM. Using the resultant p-values from the ANOVA tests it was 
concluded that the null hypothesis, that the means were equal within a 0.05 alpha value, could not 
be rejected for the FWHM; there was no statistically significant difference between the FWHM for 
each of the different reaction times. However, there was a statistically significant difference for the 
intensity and CMW of the reaction times with p-values of 0.003 and 2E-6 respectively. These 
values support the conclusion that the reaction time of the CdSe core synthesis plays an integral 
role in determining the CMW and intensity of the CdSe core solution. 
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Table 2.4 Single Factor ANOVA Test p-values for CMW, Intensity, and FWHM of CdSe Cores at 
Reaction Times of 30, 60, and 90s. 
 
 
  
 A series of CdSe core synthesis were conducted to illustrate the dramatic change in CMW 
that different reaction times could elicit. Ten different CdSe core samples were synthesized at 0 
and 60s, five samples for each reaction time, using the same starting Cd and Se-TOP stock 
solutions. Figures 2.6 is a digital image of the series as it appears under a generic black light. 
Figure 2.7 gives a corresponding fluorescence spectrum comparing the averaged spectrums of the 
series. 
 
 
Figure 2.6 Digital image of CdSe core samples synthesized at 0 (white fluorescing) and 60 seconds 
(green fluorescing) viewed under black light. 
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8 8 7 2.00E-06 0.003 0.86
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Figure 2.7 Fluorescence spectrums of averaged CdSe core sample sets synthesized at 0 (white 
fluorescing) and 60 seconds (green fluorescing). 
 
 A series of comparisons were conducted using 24 CdSe samples to compare the effects of 
quenching samples in acetone versus the standard procedure that employed no additional 
quenching measures; the standard procedure was classified as quenching in air. A two sample t-test 
was used for the comparison of acetone versus air in three different synthesis arrangements: 30s 
reaction time point at an injection temperature of 215°C, 60s reaction time point at an injection 
temperature of 215°C, and a 60s reaction time point at an injection temperature of 225°C. The 
resulting p-values, corresponding to an alpha of 0.05, were used to determine the significance of 
the data and are given in Table 2.5.  The only variable that showed a statistically significant 
difference, p-value less than 0.05, was the intensity for the sample set with the 30s reaction time 
synthesized at 215°C.  There are three explanations for this: the sample sized used was too small to 
yield an accurate representation of the effects and/or the effects are only significant at smaller 
reaction times, or the results are accurate.  Each sample set contained a minimum of three samples, 
as three samples are traditionally the very minimum number required to conduct a legitimate t-test; 
it is possible that a larger sample set would alter the corresponding p-values. If the effect of 
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quenching with acetone is only significant at shorter reaction times, including data from samples 
synthesized at a reaction time of 15 seconds could aid in supporting such a conclusion. If the data is 
accurate as is, then the conclusion based on the p-values is that quenching with acetone only has a 
significant effect on the intensity of CdSe cores synthesized at reaction time points of 30s, noting 
that a comparison of all the intensity p-values may indicate a the existence of a possible trend for 
increased effects as reaction times are shortened. 
 
Table 2.5 Two Sample t-test p-values Corresponding to the Effects of Quenching in Acetone vs. 
Air for Three Sets of CdSe Core Synthesis Reactions. 
 
 
 
 2.3.1.3 Temporal Wavelength Shifts in White Fluorescing CdSe Cores 
 Reaction times for the synthesis of white fluorescing cores that varied between 0 and 15 
seconds still produced samples that fluoresced with white light, however, the spectrums of each 
sample varied. The more time that passed between injection and extraction the more prominent the 
primary peak. Figure 2.8 illustrates this effect using two representative samples of WFCs 
synthesized at 0 and 15s. A pattern was observed, but not quantitatively tested, indicating a 
possible link between higher temperatures at the time of injection, combined with immediate 
removal of small samples and rapid quenching, increasing the presence of the 500nm peaks relative 
to the other contributing wavelengths. This qualitatively observed alteration produced a solution 
that was a pale grey blue color. 
Temp 
(°C)
Time      
(s)
Samples 
in 
Acetone
Samples 
in Air
CMW   
p-value
Intensity  
p-value
FWHM  
p-value
215 30 3 5 0.36 0.01 0.29
215 60 5 5 0.56 0.08 0.14
225 60 3 3 0.15 0.94 0.06
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Figure 2.8 Typical fluorescence emission spectra for WFCs synthesized at reaction times of 0 and 
15s. 
 
 It was found that over time the majority of WFCs shifted in fluorescence from a crisp white 
to a neon peach.  The transition is quantitatively illustrated by the shift in peak position, shape and 
intensity. The fluorescence spectrums taken on the day of synthesis, Figure 2.9, show the two 
typical spectrum shapes associated with WFCs: a primary peak at 475nm with a wide rolling tail 
from 500 to 700nm (blue to green visible light spectrum range), and a large non-descript series of 
wide rounded hills (orange to red visible light spectrum range). The fluorescence spectrum of the 
same samples, taken 23 days later and show in Figure 2.10, show a significant increase in the 
primary peaks at 475nm, as well as the development of a second peak between 620 and 630nm. It 
is the development of this second peak in the range of the visible spectrum associated with red, 620 
– 750nm, in addition to the 475nm peak associated with blue and cyan, 450 – 495nm, that produces 
the orange appearance of the CdSe solution. The degree of the shift is better illustrated in figure 
2.11 where the spectrums for both day 1 and day 23 have been overlapped.  
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Figure 2.9 Fluorescence spectra of four different WFC solutions taken on the day of synthesis. 
 
 
Figure 2.10 Fluorescence spectra of four different WFC solutions taken 23 days after synthesis. 
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Figure 2.11 Series of four WFC samples synthesized on 2/8, the fluorescence spectrum taken, and 
then taken again 23 days later on 3/2. The initial spectrum of each sample is in a dark color and the 
corresponding 23 day time point in a lighter shade of the same color. 
 
2.3.2 Synthesis of ZnS Coated Quantum Dots 
 2.3.2.1 ZnS Coating Synthesis Temperature Variation 
In the first round of trials the effect of the CdSe/ZnS synthesis temperature on CMW, intensity, and 
FWHM was investigated by applying a synthesis temperature of 70°C and comparing the results to 
those of the standard protocol synthesis temperature of 160°C. A two sample t-test, assuming 
unequal variances, was performed using an alpha of 0.05 to determine if there was a statistically 
significant difference between the means of the CMW, intensity, and FWHM as a result of the 
CdSe/ZnS synthesis temperature. Table 2.6 shows the fluorescence emission values for each 
sample with the corresponding averages, standard deviations and p-values given in Table 2.7. A bar 
chart showing a direct comparison of the average CMWs, intensities, and FWHMs of each 
synthesis temperature are given in Figure 2.12 with the error bars for each bar that of the 
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corresponding standard deviation. The p-values calculated for the CMW and intensity, both 0.004, 
support the conclusion that decreasing the CdSe/ZnS synthesis temperature of WFCs from 160°C 
to 70°C has a statistically significant difference on the final CMW and intensity values.  The 
associated p-value of the FWHM, 0.255, indicates that the null hypothesis cannot be rejected; it 
supports the conclusion that CdSe/ZnS synthesis temperature does not affect the final FWHM of 
WFCs. 
Table 2.6 CMW, Intensity, and FWHM Values for WFCs Coated at 70°C and 160°C. 
 
 
Table 2.7 Averages and Standard Deviations of CMW, Intensities, and FWHMS of WFCs       
      Coated at 70°C and 160°C. 
 
 
 
Sample
Temp 
(°C)
CMW 
(nm)
Intensity 
(counts)
FWHM 
(nm)
32512QD.30 70 522 36000 32
32512AC.15 70 505 49000 31
41012wQD.0a 70 482 51000 36
32412QD.15B 70 515 42000 34
32412QD.15A 160 569 7400 30
42812gQD.1a 160 560 3600 37
41012wQD.0b 160 550 7300 39
42612wQD.2a 160 547 3000 41
Temp 
(°C)
CMW 
(nm)
Intensity 
(counts)
FWHM 
(nm)
avg 70 506 44500 33
st. dev. 70 17 6856 2
avg 160 557 5325 37
st. dev. 160 10 2351 5
p-value 0.004 0.004 0.255
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Figure 2.12 Comparison of the average CMWs, Intensities, and FWHMs of each synthesis 
temperature with the error bars for each corresponding to the associated standard deviation. 
 
 In the second round of trials the effect of the CdSe/ZnS synthesis temperature on CMW was 
investigated by applying a synthesis temperature of 110°C in addition to the standard protocol 
synthesis temperature of 160°C. As a result of each sample set only containing 2 samples for each 
temperature, only qualitative methods were applied for the assessment of the QD end products 
synthesized at 110°C and 160°C. A visual comparison the fluorescence emission produced by the 
QDs synthesized at 110°C and 160°C of each sample set, shown in Figure 2.13, was used as a 
qualitative assessment as to the effect of each coating temperature. In both sample sets, white and 
541nm, it was concluded that lower coating temperatures produced QDs with shorter wavelengths. 
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Figure 2.13 Qualitative comparison of ZnS shelling temperatures. Left: white fluorescing starting 
CdSe, 0a shelled at 160°C, 0b shelled at 110°C. Right: green fluorescing starting CdSe, 60a shelled 
at 160°C, 60b shelled at 110°C. 
 
 
Figure 2.14 Averaged fluorescence spectrum of white fluorescing starting CdSe, 160°C (CMW: 
540nm; intensity: 19500 counts; FHWM: 39nm), and 110°C (CMW: 495nm; intensity: 37500 
counts; FHWM: 43nm), ZnS shelling temperatures.  
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Figure 2.15 Averaged fluorescence spectrum of green fluorescing starting CdSe (CMW: 541nm; 
intensity: 5800 counts; FHWM: 44nm, 160°C (CMW: 560nm; intensity: 12900 counts; FHWM: 
54nm), and 110°C (CMW: 555nm; intensity: 49000 counts; FHWM: 46nm), ZnS shelling 
temperatures.  
 
2.4 Discussion 
2.4.1 Synthesis of CdSe Cores 
 Transference of the dry reagents directly into the 50mL round bottom flask, by-passing the 
use of the plastic weigh-boats, was done to reduce the discrepancy between the amount of powder 
weighed out and the amount that made it into the flask. The selenium powder had a tendency to 
adhere to the plastic and the cadmium oxide powder, as a result of static electricity, tended to 
bounce out of the weigh-boat during transferring.  It was found that quick and precise movements, 
on the part of the chemist, during the transfer of the powders from their regent containers to the 
reaction flasks, made using the weigh-boats unnecessary. 
 During the many CdSe core synthesis procedures Se-TOP precursor solutions of different 
ages, ranging from 1 to 14 days, were used.  After many applications of the different ages of the 
Se-TOP precursors, all in conjunction with the use of fresh Cd precursor, it was concluded that Se-
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TOP solutions were best used within five days of their synthesis and would consistently give poor 
results if used more than 10 days after their initial synthesis. Unlike the Se-TOP precursor, the Cd 
precursor returned better results when made in batches no bigger than twice the amount of the 
starting values.  
 2.4.1.1 Experimental Variables Investigated for the General Synthesis of CdSe Cores 
 A potential method for investigating volume-related effects, in an effort to synthesize CdSe 
cores within the 450 -500nm range, would be to implement the use of long thin glass tubing as a 
receptacle for which to inject the sample.  This tubing could then be submerged in an ice bath 
which, along with its reduced diameter, would increase the rate of heat extraction from the sample. 
Manipulation of the temperature at the time of the Se-TOP injection was initially thought to be a 
possible mechanism for fine-tuning the CMW of the CdSe cores. Although the data would indicate 
otherwise, it still may be a parameter to be further investigated for CdSe synthesis involving 
reaction time points of longer than 90s. Additionally synthesis temperatures higher than 225°C or 
lower than 215°C may show a statistically significant effect on the CMW, intensity, and FWHM of 
CdSe cores. 
 A change in emission wavelength relative to changes in the size of the QD is an inherent 
characteristic readily accepted in the synthesis of QDs. Likewise duration of synthesis is related to 
QD size and therefore QD emission wavelength.  The purpose of testing the effect of different 
reaction time points was not to reinvent the wheel, but rather to quantitatively determine the effect 
of reaction times of small 30 second increments on CMW, intensity, and FWHM. The data 
supported the conclusion that reaction times have a logarithmic effect on the CMW of CdSe cores; 
the greatest change in CdSe emission wavelength is seen within the first two minutes. Further 
experimentation investigating which variable, reaction temperature or reaction time, is more 
influential at longer time points should be explored.  
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 2.4.1.2 Synthesis of White Fluorescing CdSe Cores 
 The process for synthesizing of WFCs was stumbled upon while attempting to synthesize 
blue QDs. It was reasoned early on in the CdSe core synthesis experiments that if the duration of 
the reaction led to CdSe cores of increased diameter, and therefore an increased emission 
wavelength, that a reduction in the duration of the reaction would have the opposite effect. The 
initial motivation was to produce the ever elusive blue emission wavelength; the result was a range 
of wavelengths in s single sample, creating the emission of white light. As a result of the peaks 
present in the fluorescence spectrums corresponding to the 15s time points, it is postulated that if a 
size selection filtration of the 15s WFCs was employed it may be possible to acquire a solution 
consisting of QDs emitting in the 475 – 500nm range in the visible spectrum associated with blue 
light. 
 2.4.1.3 Temporal Wavelength Shifts in White Fluorescing CdSe Cores 
 The phenomenon of spectral shift frequently seen in the WFCs, and in one case WFCs that 
had been ZnS coated and still initially maintained their white emission, appears to be a result of the 
lowered synthesis temperature in both the CdSe core and ZnS coating procedures. Although 
spectral shifts of ZnS coated WFCs were not measured in the data presented, a visual comparison 
of several samples indicated a similar shift. The shift in CdSe cores was seen in samples 
synthesized below 215°C; the shift was observed in the WFCs coated with ZnS using synthesis 
temperatures below 70°C  
2.4.2 Synthesis of ZnS Coated Quantum Dots 
 Using a standard ratio of 5mL of CdSe core solution to 1mL ZnS precursor for use in every 
shelling procedure introduces unknown variability. In Josh Angell’s thesis the ratios chosen were 
dependent on the average diameter calculated for the CdSe cores.  This same approach was not 
applied and therefore may have contributed to the inconsistencies seen in the intensities of the QD 
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emission peaks. Although no quantitative data was provided, it was noted during ZnS synthesis 
trials that WFC samples tended to show better results using the standard 5 to 1mL CdSe core to 
ZnS precursor.   
 2.4.2.1 ZnS Coating Synthesis Temperature Variation 
 The purpose for pursuing lower ZnS coating temperatures, such 70°C and 110°C, had been 
to test the hypothesis that a gradient of ZnS coating temperatures could be used as an alternative 
method for achieving QDs with smaller emission wavelengths shifts. It was discovered that this 
was in fact true; lower coating temperatures did result in smaller shifts in CMW. An additional 
side-effect, quantitatively supported, was an increase in intensity when these lower ZnS synthesis 
temperatures were applied to WFCs. A qualitative assessment of the fluorescence emission spectra 
in Figure 2.14 leads to the conclusion that it is very likely that lower ZnS synthesis temperatures 
may affect all CdSe solutions in the same way; lowering their shift in CMW and increasing their 
intensity. 
 A straight forward, albeit generic method, that could be employed in future experiments, 
with respect to CdSe to ZnS ratios during the shelling process, would be to adjust only the amount 
of ZnS precursor injected for each sample of CdSe core. Applying this approach to several 
samples, categorizing the CdSe cores based on their emission wavelength, would be a first step in 
experimental determining the relationship between CdSe and ZnS ratios. An additional approach 
would be to use WFC as the initial sample and apply the primary parameter, reaction time, 
associated with the WFC synthesis procedure as a second variable.  
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CHAPTER 3 – Quantum Dot Construct Synthesis  
 
3.1 Introduction  
 The emission characteristics associated with QDs make them an attractive tool for imaging 
in biologic mediums. The tunable quality of the emission wavelengths of QDs, along with their 
resistance to photo-bleaching, makes them a valuable device for use as biologic tags over their 
organic counterparts. An added benefit to using QDs over organic fluorophores is the wide range of 
excitation wavelengths that can be used to excite multiple QDs, making it possible to use a single 
source to simultaneously excite a variety of QDs. All of these advantageous qualities however, are 
useless for application in biologic mediums if the QDs remain hydrophobic. For QDs to be 
available for use in biologic applications they must first be made water soluble. There are multiple 
methods for achieving this including bioconjugation, ligand exchange, and polymer wrapping. The 
method investigated in this thesis was the encapsulation of the hydrophobic QDs inside of a 
hydrophilic phospholipid micelle. Phospholipids were the method of QD encapsulation chosen in 
light of the fact that the ultimate goal was to introduce the solubilized QDs into EpiDerm skin 
substitutes.  The introduction of the QDs would be done by applying methods developed by Russell 
et.al. pertaining to the interaction of phospholipids within the skin substitutes. It is hoped that the 
following encapsulation method will be applied in future endeavors involving the EpiDerm skin 
substitutes.  
 
3.2 Methods  
3.2.1 QD Precipitation 
 After the procedure for coating the CdSe cores in a ZnS shell was completed, the QDs were 
left suspended in octadecane.  Octadecane (ODE) is a straight chain molecule of the alkane family 
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with an 18 carbon backbone. Alkanes are insoluble in polar solvents such as water, PBS, or cell 
and tissue culturing media; alkanes are hydrophobic (75). As part of the alkane family of 
hydrocarbons, ODE is also hydrophobic.  This quality makes it an excellent solvent for the QDs 
but a poor solvent for phospholipids. Phospholipids are, however, readily soluble in organic 
solvents such as chloroform (76). As such, the QDs needed to be suspended in chloroform before 
their introduction to the phospholipids. This was accomplished by precipitation of the QDs out of 
the ODE and then resuspension of the QDs into chloroform.  The method used for the precipitation 
of the QDs was developed by Tommy Garting and utilized centrifugation and ethanol in concert 
(77). Ethanol (EtOH) acts as an anti-solvent, a medium in which the QDs are insoluble. This along 
with ethanol’s characteristic density of 0.790 g/mL, greater than ODE’s density of 0.777 g/mL, 
removed the QDs from the ODE and created a pellet of QDs in the tip of the centrifuge tube (78).  
 Typically two centrifuge tubes were used, into each were placed 3 mL of CdSe/ZnS QDs 
suspended in ODE. If a large QD sample, greater than 6mL, was to be precipitated then the sample 
was uniformly distributed across an even number of centrifuge tubes. Previous precipitation 
methods used a single tube containing a QD sample that was then balanced in the centrifuge by a 
tube containing a volume of water equal in weight to the volume of the QD sample. The 
precipitation process consisted of adding to the centrifuge tube containing the QDs, a volume of 
EtOH of at least 3 mL, but no more than twice that relative to the volume of the QD contents. The 
addition of the EtOH caused the contents of the tube to develop an oil-in-water appearance as a 
result of the immiscibility of the ODE and the EthOH; Figure 3.1A illustrates this condition. After 
addition of the ethanol the centrifuge tube was capped and shaken. The solution was centrifuged 
for a length of 10 minutes at a rate of 4000 RPM. After centrifugation the supernatant was 
removed. Removal of the supernatant was done using a 3mL syringe and needle and removing the 
uppermost portion first. A method of removal working from the top down was performed to ensure 
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the complete removal of the ODE.  As a result of ODE having a lower density than EtOH, it would 
inevitably remain in the top layer of the supernatant. Removal of the supernatant from the lower 
portion of the liquid results in a residue of ODE being left behind and greatly hinders the complete 
evaporation and quality of the precipitate. Repeated addition of ethanol, centrifugation, and 
removal of the subsequent QD-free supernatant with a 3mL syringe, resulted in the eventual 
isolation of the QDs in the tip of the centrifuge tube as shown in Figure 3.1B. Each volume of 
removed supernatant was expelled into the same waste vial.  The vial was then held up to a black 
light to determine if any QDs had been inadvertently removed as shown in Figure 3.1C. If the vial 
was positive for the presence of QDs, the waste solution was divided equally into centrifuge tubes 
and spun down for a secondary precipitation of the QDs. Once the QDs appeared to be firmly set in 
the tip of the tube, the tubes were inverted and the viscosity of the QD precipitate was used as a 
qualitative assessment as to the successful removal of all ODE.  If there was any movement of the 
precipitate out of the tip of the centrifuge tube, an additional set of the previously cited 
precipitation steps was conducted. After isolation, the centrifuge tubes containing the precipitated 
QDs were left in the fume hood for a minimum of 24 hours to ensure that the QD precipitate was 
dry and free from any residual solvent before their re-suspension in chloroform. Occasionally a 
black precipitate would form in the tip of the tube. This black precipitate was carefully removed. 
The entire step by step protocol for the precipitation of QDs out of ODE is given in Appendix B.4.   
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Figure 3.1  A visual representation of the steps involved in precipitation: A – QDs in ODE with 
EtOH added; B – precipitated QDs with supernatant; C – QDs in supernatant waste;                   D – 
precipitated QDs; E – precipitated QDs under black light; F- black precipitate. 
 
3.2.2 QD Suspension into CHCl3  
 After the QD precipitate had a minimum of 24 hours in the fume hood the QD precipitate 
was inspected for consistency of color. Occasionally a small particle of black precipitate was 
detected in the tip.  This black particulate was attributed to precipitation of selenium out of the core 
CdSe composite. Into each centrifuge tube 1.5mL of chloroform was added.  This resulted in a total 
of 3mL of suspended QDs. The suspension was then visually inspected for signs of saturation. If 
saturation was apparent, QDs were precipitating out of the chloroform, an additional amount of 
chloroform was added in increments of 0.5 mL until a consistent solution of suspended QDs was 
achieved.  
3.2.3 Phospholipid Concentration, Suspension, and Encapsulation 
 3.2.3.1 Experimental Trials – Round One and Two 
 Multiple steps were involved in creating phospholipid encapsulated QDs that could be 
suspended in an aqueous media. The course of action taken was to determine an appropriate 
phospholipid concentration, an optimal phospholipid to QD ratio, and a successful method of 
evaporation that would remove the solvent and suspend the phospholipid encapsulated QDs into 
the aqueous media. The saturation tolerance for dissolving phospholipids in chloroform is much 
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higher than the saturation tolerance of PBS or keratinocyte media.  This fact had to be taken into 
account when choosing a PL to solvent ratio in the initial step that would yield the desired PL 
concentration. The appropriate PL to solvent ratio was determined by designing a series of 
experiments that tested the effects of all of the parameters involved in the encapsulation-
evaporation process on raising or lowering the saturation points of the PL in each solvent. The 
solvent, PL concentration within the solvent, ratio of PL to QDs, ratio of suspended PL/QDs with 
respect to the solution they were to be evaporated into, the application of heat to the mixture, 
enclosing the reaction, and the use of agitating the mixture were all tested. A sample arrangement 
of the parameters tested, using 2.5 mg/mL as the PL concentration, is given in Table 3.1. This 
arrangement of tests was duplicated using the additional concentrations of PL in solvent of 1, 5, 
and 10 mg/mL.  
Table 3.1 PL Concentration and Ratio Test Parameters Applied with 2.5mg/mL Trial 
Trial PL/solvent 
(mg/mL) 
solvent QD/CHCl3 
(mL) 
PL/CHCl3 
(mL) 
A 2.5 PBS 1 3 
A 2.5 PBS 1 2 
A 2.5 PBS 1 1 
B 2.5 CHCl3 1 3 
B 2.5 CHCl3 1 2 
B 2.5 CHCl3 1 1 
C 2.5 CHCl3 1 3 
C 2.5 CHCl3 1 2 
C 2.5 CHCl3 1 1 
D 2.5 CHCl3 1 3 
D 2.5 CHCl3 1 2 
D 2.5 CHCl3 1 1 
  
 During the initial test trials each variation of the solutions containing phospholipids were 
investigated for possible contributions of the phospholipids to the fluorescence spectrum as a result 
of auto-fluorescence. Solutions of phospholipids at multiple concentrations and in multiple 
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solvents, such as CHCl3, CHCl3:MeOH, keratinocyte media at different filtration levels, and PBS 
were investigated. Additionally the fluorescence spectrums of QDs, before and after the 
introduction of the phospholipids, were also generated as a method for assessing the effect that the 
phospholipids had on the CMW and FWHM of the test solutions. 
 Four arrangements of the evaporation test parameters were then designed using each of the 
three different ratios of QDs to PLs. with a PL concentration of 2.5mg/mL as shown in Table 
3.2.The four different sets of evaporation steps were labeled A, B, C, and D. Set A used 10mL of a 
2.5mg/mL solution of PL/PBS in a 1:1, 1:2, and 1:3 ratio of QD/CHCl3: PL/PBS, evaporated 
during heating at 60°C. Set B used 10mL of a 2.5mg/mL solution of PL/CHCl3 in a 1:1, 1:2, and 
1:3 ratio of QD/CHCl3: PL/PBS, added 2mL of PBS, and then evaporated during heating at 60°C. 
Set C used the same concentrations and ratios as set B, but attempted to evaporate the CHCl3 first, 
then add 2mL PBS and heat at 60°C. Set D also used the same concentrations and ratios as set B, 
but added the 2mL of PBS and attempted to evaporate without heat employing only the air current 
generated inside the fume hood.  
Table 3.2 PL Encapsulation and Evaporation Parameters 
Trial  
A Evaporation during heating at 60°C 
B Add 2mL PBS, evaporation during heating at 60°C 
C Evaporate, add 2mL PBS, heat at 60°C 
D Add 2mL PBS, evaporation, NO heat 
 
 During this time a series of slides were prepared using samples with a variety of QD/PL 
concentrations that had been suspended in CHCl3:MeOH, then had 2mL of PBS added, heated for a 
period of 10 minutes at 55C, and then left to evaporate in the hood for 2 days. These slides were 
then imaged with a confocal microscope, using filter Qdot565, and the images for each 
concentration qualitatively analyzed.  
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 A second round of trials was employed specifically to investigate methods for increasing 
the rate of evaporation of the chloroform and promoting the suspension of the phospholipid 
encapsulated QDs (QD constructs) into an aqueous media. Among the multiple strategies 
investigated were the application of nitrogen gas, a magnetic spine vane, closed vials with vent 
needles versus open vials, and the size of the evaporation container. In all of these tests the vials 
were exposed to heat by being submerged in a 55°C silicon oil bath. Nitrogen gas was applied to 
test two methods for increasing the evaporation rate: agitation and increased flow over the surface 
of the solution. The nitrogen needle was placed both below the surface of the solution and 1 cm 
above the surface with a flow rate high enough to disturb the solution but not eject it out of the vial.  
A magnetic spin vane was placed inside of the solution and set to spin at 300 RPM in an effort to 
expose the higher density chloroform to air flow as well as to continually mix the solution, 
maintaining an even distribution of QD constructs.  As a result of the long duration necessary to 
achieve of evaporation seen in the first round of encapsulation trials, capping the vials with rubber 
septums into which vent needles were placed, as shown in Figure 3.3, was investigated. This 
method employed to promote evaporation of the CHCl3 by increasing the pressure in the vial while 
maintaining a consistent temperature and reducing the evaporation of the PBS.  
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Figure 3.2 Arrangement of three vials containing QD construct solutions with rubber septums and 
vent needles. 
 
Increasing the size of the evaporation container, to increase the size of the surface area exposed to 
air flow, was accomplished by placing the test solution into a 50mL glass beaker with a 5cm 
diameter. The discovery in chapter 2, of CHCl3 degrading the plastic cuvettes, was used as an 
initial determination for the presence of CHCl3 within the evaporating test solution. Although use 
of the cuvette could not definitively determine the absence of chloroform, placing a cuvette into the 
solution of interest, and noting its appearance 5 minutes after exposure, could positively confirm 
the continued presence of chloroform. 
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 3.2.3.2 Final Encapsulation Method 
 The final protocol for the phospholipid encapsulation of QDs, and their suspension into an 
aqueous media via evaporation, was developed by incorporating the factors that were deemed 
successful from the initial round of trials. These factors were then altered to accommodate the 
desired PL/keratinocyte media concentration of 10mg/mL or 1.0 % w/v that was used in the 
Russell et. al. paper. The first step was choosing a CdSe/ZnS sample, created using the process 
described in chapter 2, which had an appropriate CMW and FWHM for imaging with fluorescent 
stains without overlap of the emission spectrums. For round one (R1) of the keratinocyte trials the 
CdSe/ZnS QD chosen was 42612wQD.2a with a CMW of 551nm and FWHM of 42nm, which 
provided an emission that fell between the wavelengths emitted by the Calcein and EthD-1 
fluorescent stains used for testing cell viability: 515 and 635nm respectively. The 10mL QD 
sample was divided evenly into four centrifuge tubes, 2.5mL into each tube. Each tube then 
received 5mL of EtOH, was placed into the centrifuge, and spun at 4000 RPM for 10 minutes. 
 After centrifugation the supernatant was removed from each tube, working from the top of 
the liquid down. Another 5mL of EtOH was added to each tube and a second centrifugation at 4000 
RPM for 10 minutes was performed. The tubes were then inverted and the supernatant poured out 
leaving the precipitated QDs in the tip of each tube.  All four uncapped tubes were placed 
horizontally in the fume hood with their open ends pointed toward the fume hood door for 
maximum exposure to air flow. Fourteen hours later the dry tubes were determined to be dry. 
 After being removed from the fume hood, 1.25mL of CHCl3 was added to each tube for a 
total of 5mL of QD suspended in CHCl3. A PL/CHCl3 solution with a concentration of 10mg/mL 
was made by dissolving 100mg of milk phospholipid powder (Phospholipid Concentration 700, 
Finterra Ltd, Edgercumbe) into 10mL of CHCl3. The amount of 10mg/mL PL/CHCl3 to be made 
was dependent on the amount of keratinocyte media into which it would be evaporated: 10mL. 
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Using an amount of PL/CHCl3 equal to the amount of keratinocyte media maintained the desired 
10mg/mL concentration in the final product. Together this combination created a final ratio of 1mL 
of QD/CHCl3 for every 20mg of PL. In the past test trials a 1: 2 ratio of QD/CHCl3: PL/CHCL3 
[2.5mg/mL] was used resulting in a final ratio of 1mL of QD/CHCl3 for every 5mg of PL. To 
maintain this past ratio it would have been necessary to have added 20mL of QD/CHCl3. The 5mL 
of QD/CHCl3 and 10mL of 10mg/mL PL/CHCl3 were combined in a 50mL glass beaker. Added to 
this was 10mL of keratinocyte media. A magnetic spin vane, 2.5cm in length, was place into the 
beaker with the mixture. The beaker was then placed at an angle into a silicon oil bath set at 50°C 
and 200 RPM. The beaker was removed twenty two minutes after being placed into the silicon oil 
bath.  
 UV-VIS spectroscopy was used to determine the influence of the encapsulation process on 
the center max wavelength (CMW), FWHM, and intensity of each QD sample used in the 
encapsulation. This progression of shifts in the characterization parameters provided a quantitative 
method for analyzing and predicting final wavelength and intensity measurements. Starting with 
the CMW, FWHM, and intensity of the CdSe core sample, and continuing to record the same 
characterization parameters of the CdSe/ZnS QD sample in ODE, the CdSe/ZnS QD sample in 
CHCl3, the QD:PL:CHCl3, and the final encapsulated QD:PL construct, provided a linear  
progression of the shifts in the characterization parameters as a direct consequence of each step in 
the encapsulation procedure.  Additional UV-VIS spectrometer data, of control samples, were 
utilized to determine the influence of the components specific to each step on the characterization 
parameters. These same UV-VIS characterization parameters were applied to samples of CHCl3, 
PBS, and variety of PL concentrations in CHCl3 and PBS, all of which added an additional 
dimension of understanding as to the influence of each step on the final CMW, FWHM, and 
intensity outcomes. 
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3.3 Results 
3.3.1 QD Precipitation 
 Complete precipitation of the QDs out of ODE was determined based on a qualitative 
assessment of the centrifuge tubes. The conclusions resulting from the examination of the texture, 
transparency, and viscosity of the centrifuged QDs dictated the success of the precipitation and 
whether an additional round of centrifugation was needed.  After the first centrifugation the 
QD/ODE/EtOH solution in the tube had the appearance of image A in Figure 3.4; the majority of 
the QDs toward the bottom of the tube but still not precipitated into a solid pellet at the tip. After 
removal of the supernatant, the addition of an equal amount of EtOH and vigorous shaking of the 
capped tube redistributed the QDs throughout the solution as shown in images B and C of Figure 
3.3. 
 
Figure 3.3 QDs suspension in ODE and EtOH after the first series of centrifugation steps. A – after 
the first centrifugation, before the removal of the supernatant. B – after the addition of EtOH with 
vigorous shaking in white light. C - after the addition of EtOH with vigorous shaking in UV. 
 
3.3.2 QD Suspension into CHCl3  
 In instances where saturation was apparent, QDs were precipitating out of the chloroform as 
shown in Figure 3.4, an additional amount of chloroform was added in increments of 0.5 mL until a 
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consistent solution of suspended QDs was achieved. It was not always immediately apparent that 
the chloroform was saturated. On average the final solution was 3mL in total. 
 
 
Figure 3.4 A – Re-suspension of QDs in CHCl3. B – Saturation of QDs re-suspended in CHCl3. 
 
3.3.3 Phospholipid Concentration, Suspension, and Encapsulation 
 3.3.3.1 Experimental Trials – Round One and Two 
 The saturation point of phospholipids in PBS and keratinocyte media was determined to be 
10mg/mL with the application of heating the mixture to 52° and vigorous agitation by shaking the 
capped vial. The saturation point of phospholipids in chloroform was not ultimately determined, 
but as the chloroform continued to dissolve an amount of 35mg/mL, more than three times that of 
the aqueous mediums, further dilutions were not deemed necessary.   
Table 3.3 Comparison of QD samples in CHCl3 and QD/PL samples in CHCl3 
Sample Solvent CMW 
(nm) 
Intensity 
(counts) 
FWHM 
range (nm) 
FWHM 
(nm) 
31912QD1.M45m CHCl3 583 48000 571-598 27 
31912QD1.M45s CHCl3 586 47000 574-599 25 
31912EN1.M45m CHCl3 575 56000 556-590 34 
31912EN1.M45s CHCl3 577 45000 560-592 32 
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Figure 3.5 A representative image of 0.45 micron filtered 10mg.mL PL/keratinocyte media 
solution scattering the UV source in the fluorescence detector. 
  
 Possible phospholipid related auto-fluorescence issues were investigated with respect to the 
wavelength at which auto-fluorescence might have occurred. It was concluded that when combined 
with QDs in CHCl3 the emission of the PL solutions were negligible in range of the QD 
wavelength of interest. Therefore, although auto-fluorescence was confirmed quantitatively by UV-
VIS spectroscopy, its influence on the ability to detect the presence of the encapsulated quantum 
dots was deemed negligible. Fluorescence spectra characteristic of solutions containing 
phospholipids exhibited dominating peaks at the wavelength of the emission source: 388nm. Peaks 
at 500 and 660nm were also routinely detected. The size and intensity of each peak was influenced 
by the solvent in which the PL was dissolved.  
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Figure 3.6 Fluorescence spectra of phospholipids at different concentrations, in different medias 
taken at an integration time of 100ms; the source peak from scattering occurring at 388nm. 
 
 
Figure 3.7 Fluorescence spectra of phospholipids at different concentrations, in different medias 
taken at an integration time of 500ms; the source peak from scattering occurring at 388nm. 
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For better visualization, the relative size of the fluorescence emission peaks for the solutions with 
QD constructs and those with only phospholipids the horizontal axis was decreased to only include 
a range of 450 to 650nm.  It was this range of wavelengths that was pertinent to determining if the 
auto-fluorescence emission of the phospholipid solutions made a significant contribution to the QD 
construct emission peaks. It was concluded that the contribution of the phospholipids to the final 
emission peak of the QD constructs was negligible. Figure 3.9 shows a representative example of 
the two solutions in direct comparison. 
 
 
Figure 3.8 Fluorescence spectra of the 0.45 and 0.2 micron filtered [10mg/mL] PL/keratinocyte 
solutions relative to QD/PL/keratinocyte solutions.  
  
 An initial evaporation test was performed on solutions of varying concentrations of QD/PL/ 
CHCl3:MeOH and PBS. This initial test was conducted using a minimal application of heat, 10 
minutes at 55°, and an extended evaporation time, 2 days, to determine if evaporation alone would 
produce a final QD construct product using a technique similar to the one described in the Carion 
et.al. paper. The series of steps was documented and the corresponding images are given in Figures 
3.9, 10, and 11. Figure 3.10 shows the solutions after the addition of PBS and 30 minutes of 
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vigorous shaking. The final volume of each test solution had decreased at the end of the two day 
evaporation period, but a significant proportion of the CHCl3:MeOH remained and still contained 
the majority of the QD constructs, with a thin layer of constructs formed in the middle layer as 
illustrated in Figure 3.11. This result pointed to the need for a method of internal agitation of the 
solution to be introduced. 
 
 
Figure 3.9 Different concentrations of PL [(3.3, 3.3, 5.0, 10.0) mg/mL] and QD sample 
330QD3.3M45 suspended in CHCl3MeOH. Left: white light. Right: UV. 
 
 
Figure 3.10 Addition of 2 mL PBS in to each: both in white light and UV. The addition of the PBS 
was done before evaporation and heating. PBS created an emulsified appearance. Left: white light. 
Right: UV. 
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Figure 3.11 After 10min of heating at 55C and 2 days of evaporation in the hood. Left: white light. 
Middle: UV. Right: Schematic representation of final solution composition. A- PBS.         B – QD 
constructs. C- QD constructs suspended in CHCl3:MeOH. 
  
 Confocal microscopy was used to qualitatively assess how the different concentrations of 
PL in solvent, and the different ratios of PL to QD in each solution, effected the composition of the 
QD constructs. Samples of CHCl3, PBS, and [2.5mg/mL] concentration of PL/PBS were taken as 
controls for comparison. The smeared quality of the larger aggregates of phospholipids, figures 
3.13, and 3.15 are an effect of  the increased concentrations of PL within each solvent, as well as 
decreased ratios of QD to PL resulting in less volume of QDs for every milligram of PL, all 
resulted in a less uniform and more globular appearance of the QD constructs. Comparison of the 
control solutions containing [2.5mg/mL] PL/PBS with the test solution consisting of 2.5mL of 
[3.3mg/mL] PL/CHCl3:MeOH and 1.0 mL of 31912QD1.M45m in CHCl3:MeOH shows little 
difference between the two.  The lack of difference introduces an uncertainty as to the degree to 
which the QDs were successfully encapsulated. Successful encapsulation of QDs within the 
phospholipid micelles was later confirmed using the fluorescence microscope (images not shown) 
and the confocal microscope to image the test solutions in the first round of keratinocyte trials. 
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Figure 3.12 Controls: A- [2.5mg/mL] PL/PBS at 20X. B - [2.5mg/mL] PL/PBS at 100X. C – 
[2.5mg/mL] PL/CHCl3 at 20X. D – PBS control 
 
 
 
Figure 3.13 A solution of 2.5mL of [3.3mg/mL] PL/CHCl3:MeOH and 0.5 mL of the QD sample 
31912QD1.M45m. At precipitation 31912QD1.M45m had been re-suspended in 3.0:1.5 
CHCl3:MeOH at 20X 
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Figure 3.14 A solution of 2.5mL of [3.3mg/mL] PL/CHCl3:MeOH and 1.0 mL of the QD sample 
31912QD1.M45m. At precipitation 31912QD1.M45m had been re-suspended in 3.0:1.5 
CHCl3:MeOH at 20X. 
 
 
 
Figure 3.15  A solution of 3.5mL of [10mg/mL] PL/CHCl3:MeOH and 0.5 mL of the QD 
sample 31912QD1.M45s. At precipitation 31912QD1.M45s had been resuspended in 3.0:1.5 
CHCl3:MeOH at 20X 
  
 In the series of evaporation tests conducted to determine the most successful set of 
parameters to employ in the final encapsulation and evaporation procedure, it was found that 
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application of the nitrogen below the surface of the solution resulted in the creation of dried out 
strings of QD constructs; defeating the goal of acquiring an even distribution of QDs within the 
aqueous liquid. Evaporation times in the first round of trials were upwards of 4 hours and it was not 
discernible whether the remaining liquid was PBS or chloroform. Capping the glass vials with 
septums and adding a vent needle to increase the pressure within the vial decreased the amount of 
time that was required to reduce the volume of clear liquid within the vial, but did not answer the 
question as to what the identity of the remaining liquid. A preliminary test for determining the 
presence of chloroform was to expose a plastic disposable cuvette to the solution in question for a 
period of 5 minutes. If the surface of the plastic in contact with the solution degraded, the presence 
of chloroform was confirmed. Increasing the diameter of the container used during evaporation 
increased the rate of evaporation of CHCl3 when used in concert with a magnetic spin vane set to a 
minimum of 200RPM. Applying heat to the solution also increased the rate of evaporation. 
 A visual representation of the progression of sample D from the first round of encapsulation 
tests is given in Figure 3.16.  The progression starts with the original sample, 32412QD23.15A, 
suspended in CHCl3 with PL shown in white light and UV, through to its appearance after testing 
had concluded.  The three vials of sample D never individually achieved full evaporation of CHCl3, 
however, after combining all three and applying the final encapsulation method the CHCl3 was 
fully evaporated and the QD constructs suspended into PBS. 
70 
 
 
Figure 3.16 Encapsulation progression of set D. From top to bottom: 32412QD23.15A suspended 
in CHCl3 with PL in white light, in UV light, addition of 2mL PBS in white light, in UV light, final 
state post-evaporation in white light, and in UV light. 
 
 
Figure 3.17 Encapsulation progression of sets A, B, C, and D from left to right. Top: white light. 
Bottom: UV light. 
 
 
Figure 3.18 Encapsulation trial 2B. Starting solution of 2mL 2.5mg/mL of PL/CHCl3: 1mL 
324QD123.60a in CHCl3: 2mL PBS in an open vial heated at 55°C. 
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 3.3.3.2 Final Encapsulation Method 
             The solution of 5mL of QD/CHCl3 and 10mL of 10mg/mL PL/CHCl3 appeared consistent 
throughout. The mixture resulting from the addition of the keratinocyte media to the QD/PL/CHCl3 
formed two separate layers as illustrated in Figure 3.19. The bottom layer of the mixture is the 
higher density QD/PL/CHCl3 solution and the top layer is the lower density aqueous keratinocyte 
media. As the image on the left indicates, there is complete separation of the two layers. Over time 
the viscosity of the solution thickened until a substance the consistency of yogurt was formed. A 
series of images depicting the change in the mixtures appearance and viscosity is given in Figure 
3.20. Twenty two minutes after being placed into the silicon oil bath all remaining clear liquid had 
been absorbed or evaporated. 
 
 
Figure 3.19 Pre-evaporation combination of 5mL of QD/CHCl3: 10mL of 10mg/mL PL/CHCl3: 
10mL keratinocyte media in white light (left) and UV light (right) 
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Figure 3.20 Mid-evaporation of 5mL of QD/CHCl3: 10mL of 10mg/mL PL/CHCl3: 10mL 
keratinocyte media at 5, 10, and 15 minutes from left to right. 
 
 
3.4 Discussion 
3.4.1 QD Precipitation 
 Typically only two rounds of precipitation steps were necessary to achieve a solid 
precipitate in the tip of the centrifuge tube; on occasion three rounds.  It was discovered through 
the many precipitations that if more than three rounds were required, the results of products further 
down the line were often less than desirable. For this reason any attempt at precipitation that did 
not yield a solid precipitate in the tip of the tube by the third round was discarded unless the QD 
sample was of particular importance.  
 The previous method of precipitation involved placing the entire QD sample in one tube 
and using a second tube of water, equal in weight to the QD sample, to act as a balance during 
centrifugation, was found to be tedious and overly time consuming.  As a result of the 12mL 
maximum capacity of each centrifuge tube, handling QD samples of more than 5mL, which would 
have required 10mL of EtOH, resulted in 4, 5, and 6 rounds of the precipitation steps to achieve a 
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solid precipitate in the tip of the tube. As an antidote to this problem, the multiple centrifuge tube 
method was used. Not only did this decrease the time necessary to precipitate the QDs, but multiple 
samples, up to six, could be simultaneously centrifuged as long as care was taken to ensure that all 
tubes contained equal volumes of mixtures.   
 With regard to the formation of black precipitates in the tip of the centrifuge tubes, it was 
concluded that the black particulate that sometimes formed was selenium. It was determined to be 
selenium because of the resemblance of the precipitate to the starting material used in the synthesis; 
selenium powder was the only component that was also black.  Precipitation of selenium had 
occurred for one of two reasons: the initial precipitated sample had been that of unshelled and 
therefore unstable CdSe cores, or the initial precipitate was of a shelled sample that had not been 
consistently and effectively shelled leading to the same outcome. In carefully and consistently 
synthesized CdSe/ZnS QDs the black precipitate was a rare occurrence. 
 
3.4.2 Phospholipid Concentration, Suspension, and Encapsulation 
 3.4.2.1 Experimental Trials – Round One and Two 
 Fluorescence spectra of PL in a variety of solvents showed both an element of auto-
fluorescence in the 500 and 660nm peaks as well as scattering of the source at 388nm.  The peak 
from the source was so large as to be larger than what the spectrum would accommodate, however, 
this peak was only significant when the solvent was either PBS or keratinocyte media or contained 
MeOH.  The solutions consisting of only PL and CHCl3, no matter the concentration of PL, had a 
relatively insignificant peak at 388nm.  
 Confocal microscope images obtained using the Qdot565 filter were used as a qualitative 
assessment of the encapsulation process for different concentrations of PL in solvent and different 
ratios of PL to QD. The images of the control solutions support the conclusion that the PLs have a 
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greater affinity for aggregating together as micelles and liposomes when suspended in an aqueous 
solution. The controls also eliminate the possibility that the solvents are introducing any 
particulates. The confocal images in Figures 3.13, 14, and 15 support the conclusion that solutions 
with smaller concentrations of PL and a more equal ratio of PL to QD produce more consistently 
sized and spherical QD constructs. The conclusions made as a result of the initial PL concentration 
tests would have been used in the final method if not for the desire to achieve a 10mg/mL 
concentration of QD constructs in keratinocyte solution for mimicking the media parameters 
described in the Russell et al. paper. 
 The greatest difficulties encountered in the encapsulation process were consistent and 
complete evaporation of the chloroform in a timely manner, and the consistency of the final QD 
construct aqueous solution. Without exposure to the air it was not possible to remove the 
chloroform form the mixture via evaporation. This particular difficulty, the evaporation of the 
CHCL3, was the catalyst for the development of so many evaporation strategies. The densities of 
each element had a significant effect on the development and success of the procedure. The 
solubility of chloroform in water is g/100mL at 20°C: 0.8 making chloroform essentially 
immiscible in water (79). The density of chloroform relative to water is 1.48:1.0 (kg/m
3
) at 20°C. 
When the two solvents were mixed, this attribute caused chloroform to sink to the bottom and for 
the water, PBS, or keratinocyte media to float to the top; water and PBS have equivalent solubility 
and density characteristics relative to chloroform (79).  The immiscibility of chloroform in water 
based solvents, coupled with chloroforms’ density prevented the QD:PL constructs from achieving 
suspension in the upper layer. 
 The three main literature references used in the initial phases of developing the 
encapsulation method laid out in this thesis were Fan et.al., Carion et. al., and Dubertret et. al. (11-
13).  The Fan et. al. paper proposed encapsulation by the introduction of the QD/CHCl3 suspension 
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to an aqueous lipid solution with the application of vigourous stirring to create a micro-emulsion 
that was then to be heated between 40 and 80°C for approximately ten minutes to evaporate off the 
chloroform and transfer the QDs into the aqueous solution. The Dubertret et. al. paper used “a 
mixture of n-poly(ethylene glycol) phosphatidylethanolamine (PEG-PE) and phosphatidylcholine 
(PC) and did not explicitly state there method for encapsulation.  The only indication for what 
process was used to achieve encapsulation was a diagram indicating that after being combined the 
QD/PL solution was evaporated, heated, and then water was added. This was less than helpful and 
all of my tests that applied evaporation and heating before adding the aqueous medium did not 
yield successful results. The Carion et. al. paper was thorough and explicitly detailed each step 
used in their process. It was by far the best source available in the literature. The procedure 
outlined in the Carion paper was quoted as taking 6 hours and utilized equipment and ingredients 
not available at the time of the work for this thesis. It would, however, be a worthwhile method to 
investigate for the future. 
 3.4.2.2 Final Encapsulation Method 
 The deviation of the final encapsulation method, with respect to the ratio of milliliters of 
QD/CHCl3 to milligrams of PL, from the test trials was a result of trying to duplicate the 
concentration of PL in keratinocyte media that was used in the Russell et al. paper.  Ultimately, the 
goal was to introduce the QD constructs into EpiDerm skin substitutes. For this reason using a 
solution that mimicked the original 1% w/v phospholipid/keratinocyte media, like that which had 
been used in the Russell experiments, would eliminate the one variable in the effect of the QD 
constructs on the skin substitutes. It was, however, noticed that compared to the original tests, 
which had optimum results using a ratio of 1mL of QD/CHCl3 for every 5mg of PL, and 2mL 
aqueous media for every 1mL of QD/PL/CHCl3, the final method employed tended to create a 
more coagulated product, which 66% of the time resulted in difficulty during filtering.  The 
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difficulty in filtering stemmed from an increase in the viscosity and uneven distribution of the QD 
constructs throughout the aqueous media. Overall, the final encapsulation method is a process that 
from start to finish can be accomplished in approximately 3.5 hours. 
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Chapter 4 - Introducing Quantum Dot Constructs into a Biologic Medium 
 
4.1 Introduction 
 Upon achieving successful encapsulation of the CdSe/ZnS QDs within phospholipid 
micelles, and evaporating them into an aqueous media, the next step was to introduce the QD 
construct solution into a biologic medium. The biologic mediums chosen for this purpose was 
keratinocyte cell cultures. Introduction of the QD constructs into keratinocyte cell cultures was 
performed to assess two parameters of QD-cell interaction: QD-cell integration and cell health 
post-introduction of QD construct solutions. The success of QD-cell integration was qualitatively 
assessed using the ratio of the number of cells with QD constructs attached to their cellular 
membranes relative to the number of cells without any QD constructs attached to their membranes.  
In addition to attachment of QD constructs to the exterior of cell membranes, the degree of 
integration into the keratinocyte cells was also assessed. The effect of the QD constructs on cell 
health, post-introduction of the test solutions, was measured by a comparison of cell viability, 
proliferation, and morphology from before and after the introduction of the QD constructs test 
solutions. 
 Evaluation of the effects of QD-construct solutions on the health of the keratinocyte cells 
was done using imaging and histology techniques. An optical white light Olympus CKX41 
microscope was employed for the comparison of changes in cell morphology and culture 
appearance and used as a qualitative assessment of the effects of QD construct solutions on cell 
health. Calcein and Ethidium homodimer-1 (EthD-1) live dead (L/D) stains were used in concert 
with confocal and DIC imaging to determine the percentage of live to dead cells within each four-
well chamber.  QD construct adherence to, and integration within, keratinocyte cells was done by 
qualitative inspection of confocal and DIC images.  Histochoice fixative and Hoechst stain (H/H) 
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were used to identify the nucleus of each cell, thereby making it possible to accurately differentiate 
QD constructs exterior to the cell membrane surface relative to QD constructs interior of the cell 
membrane surface.  Application of the Hoechst stain also allowed for distinguishing the 
keratinocyte cells relative to any unwanted contamination sources, such as spores, molds, or fungus 
that may have been present and which the QD constructs may have also interacted with. 
 
4.2 Methods 
4.2.1 QD Construct Introduction into Keratinocytes Cell Cultures 
 The cells to which the QD construct test solutions were applied were Primary Epidermal 
Keratinocytes; normal (non-diseased), human, from neonatal foreskin; supplied by ATCC, product 
number PCS-200-010.  The media for the keratinocytes, also supplied by ATCC, was a base 
solution of dermal cell basal medium with keratinocyte growth kit. The keratinocyte growth kit, 
product number PCS-200-010, included 2 ml of bovine pituitary extract, 0.5 ml rh TGF-alpha, 15 
ml L-glutamine, 0.5 ml hydrocortisone hemisuccinate, 0.5 ml rh insulin, 0.5 ml epinephrine and 0.5 
ml apo-transferin. The cells were thawed from cryopreservation and passed into T75 flasks. The 
cells were incubated at 37°C, 5% CO2, and  95% humidity in the primary incubator, and given 
fresh media every 36 -48 hours (80). All cell culture handling and maintenance, pre-introduction of 
test solutions, was conducted by Carl T. Dargitz.  
 A maximum time point of 24 hours was chosen for the keratinocyte QD construct 
experiments as a consequence of the realities associated the maintenance of an aseptic culture 
environment for the duration of the keratinocyte related trials. The uncertainty for maintaining an 
aseptic environment stemmed from three different factors: the design of the four-well flasks, 
working outside of the laminar flow hood, and using the secondary not aseptically maintained dry 
incubator for incubation post-introduction of the test solutions. Unlike the T75 culture flasks that 
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the cells were initially grown in, the four-well slides are not sealable with a filter-cap. This factor 
increases the likelihood that any environmental contaminants that may be present will likely invade 
the culture and affect the viability of the cells. To combat the constraints of working in a non-
aseptic environment, handling of the keratinocyte cultures was done wearing nitrile gloves sprayed 
down with 70% isopropyl alcohol (IPA).  All surfaces, counter-tops, the incubator shelves and 
door, and the optical microscope stage platform, which the four-well slides containing the 
keratinocyte cultures came in contact with, were also sprayed down with 70% IPA and air dried 
before any contact was initiated.  This in no way ensured that contamination of the cultures would 
be prevented. However, this precaution, along with the short time point of 24 hour post-
introduction of testing of solutions, prevented contamination from reaching levels that would 
detrimentally affect the experimental parameters of interest. 
 4.2.1.1 QD Construct Control and Test Solutions – R1 
 In the first round (R1) of test solutions an extensive set of control solutions were employed 
in an effort to identify the influence of non-QD construct specific variables on the viability of the 
keratinocyte cells. Each step involved in the process of developing the final QD construct test 
solutions contributed variables, which if untested, would introduce sources of unknown influence 
and variability on the cell health and cell-QD construct interaction of the final product. The test 
solutions and test parameters, related to the variables associated with the QD construct solution 
development process, that were investigated in the first round of keratinocyte experiments are 
given in Table 4.1. Figure 4.1 shows representative images of the four-well slides, each containing 
four culture chambers, used in R1 and R2.  
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Figure 4.1 Representations of four-well slide configurations. A. All six four-well slides used in R1 
of keratinocyte trials. B. Schematic diagram of four-well slide without thick specimen slide base. 
C. Four-well slides used in R2. D. Schematic diagram of four-well slide with thick specimen slide 
base. 
  
 Each well-set used in the first round of the keratinocyte trials, a and b, had three four-well 
slides for a total of 12 wells in each set. Within each set, a and b, were three sub-sets, one for each 
slide. Slide one of set a contained wells a1.1-4, slide two contained wells a2.5-8, and slide 3 
contained wells a3.9-12. This same labeling was applied to well-set b. Table 4.1 shows the test 
solutions corresponding to each well, the size of the filter that may have been used to filter the test 
solutions, and the fluorescent stain applied each well. The designation L/D represents the live/dead 
stain, which was composed of Calcein and Ethidium homodimer-1. The first round of keratinocyte 
trial test solutions were created primarily to determine the extent to which each step in the QD 
construct synthesis process affected cell health. Heating the keratinocyte media to 55°C, exposure 
of the keratinocyte media to chloroform during evaporation, the presence and size of phospholipid 
particulates, and filtering to reduce contamination were all variables that could affect change on 
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cell viability and proliferation. Therefore, each well was filled with a test solution that 
corresponded to the variable in question. 
Table 4.1 Summary of Round One QD Construct Control and Test Solutions 
Well  Test Solution Heated 
55°C 
Filter Stain 
a, b1.1 Control - krt media   L/D 
a, b1.2 Control - krt media  X  L/D 
a, b1.3 Control - krt media post-CHCl3 X  L/D 
a, b1.4 Control - krt media/PL post-CHCl3 X  L/D 
a, b2.5  PL/krt [10mg/mL] X 0.45µm L/D 
a, b2.6  PL/krt [10mg/mL] X 0.45µm L/D 
a, b2.7  PL/krt [10mg/mL] X  L/D 
a, b2.8  PL/krt [10mg/mL] X  L/D 
a, b3.9 42612wEN.2a: PL/krt [10mg/mL] X 0.45µm L/D 
a, b3.10 42612wEN.2a: PL/krt [10mg/mL] X 0.45µm L/D 
a, b3.11 42612wEN.2a: PL/krt [10mg/mL] X  L/D 
a, b3.12 42612wEN.2a: PL/krt [10mg/mL] X  L/D 
 
 Four variations of keratinocyte media, applied to wells a, b1.1-1.4, were used as a set of 
controls. Wells a,b1.1 were used as a primary control and wells a,b1.2-4 were used as secondary 
controls. The secondary controls were compared with the primary control, as well as with the 
unadulterated keratinocyte media, to determine the influence of the heat, chloroform exposure, and 
the presence of phospholipids on the media’s ability to function in the expected capacity of cell 
maintenance.  The results of the primary control, as well as that of the secondary controls, were 
used as a baseline for cell viability. The controls were used as a standard of comparison during 
assessment of wells a, b2.5-8 and a, b3.9-12, both of which contained additional components.  
 After attending to the issue of which effects, related to alterations of the keratinocyte media 
during the QD construct synthesis process, had an influence on cell viability, two additional 
elements needed to be addressed with respect to the test solutions: particle size and culture 
contamination. In wells a,b2.5-8, containing only phospholipids in media, the questions 
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investigated pertained to what role the size of the particles played in the interaction between the 
constructs and the cells and what degree of contamination could the test solutions introduce into the 
cell cultures. It was important to determine if the presence of phospholipids alone had a negative 
effect on the cells’ viability and if so, was it merely because they introduced some phospholipid-
specific factor into the environment or were the negative effects the result of the phospholipids 
directly interacting with the cells.  A 0.45µm filter was used to acquire these answers.  Filtering 
was also applied to two of the four solutions containing the phospholipid encapsulated QDs. 
Filtering of the QD construct solutions was not only done for the previously stated reasons, but also 
to determine the effect of filtering on the CMW, intensity, and FWHM of the fluorescence 
emission of the solution.  
 The initial CdSe core sample, 42612wCMBO.2, used in the first step for creating the QD 
construct test solutions, was a combination of five previously synthesized CdSe core samples that 
had originally been synthesized using the modified protocol in Chapter 2. A ZnS coating was 
applied to this combination sample using a shelling temperature of 160°C and producing the 
CdSe/ZnS QD sample labeled 42612wQD.2a.  The encapsulation process documented in Chapter 3 
was then applied to the newly shelled sample to create the hydrophilic QD constructs and transfer 
them into the keratinocyte media. After encapsulation the QD construct, the solution was passed 
through a 0.45 micron filter to aid in removal of any contaminants present within the solution, as 
well as to remove any excess phospholipids that had failed to form a micelle around the QDs. At 
each step during the QD construct synthesis a fluorescence spectra was taken using the Ocean 
Optics USB 4000 fiber optic spectrometer to track the changes in CMW, intensity, FWHM, and 
scattering resulting from the processes and materials of each step.  
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Figure 4.2 Progression of the 42612wQD.2a used in the test solutions in the first round of 
keratinocyte QD construct trials. A. The five individual CdSe composite cores. B.The five 
combined CdSe cores. C. The combined CdSe cores shelled with ZnS at 160°C (550nm: 2800 
counts) 
  
 4.2.1.2 QD Construct Control and Test Solutions – R2 
 Round two of the test solution experiments concentrated on assessing the effects of added 
filtering with 0.2 micron diameter pore filters, as well as using additional staining techniques to 
assess cell viability and cell-QD construct interaction.  Additional filtering, using a 0.2µm filter, 
was imposed to investigate the benefits of using a more rigorous filtering regime. The expected 
benefits of using a smaller filter were a decreased incidence of contaminating components within 
the solution and size selection of the QD constructs suspended in solution. Decreasing the 
contaminants within the solution would prevent the growth of non-cellular components within the 
culture. Reducing the size of the QD constructs could promote the attachment and integration of 
the constructs to the keratinocyte cells. The test solutions, the filters employed, and the stains 
applied to each well-set are given in Table 4.2. Like the test solutions used in R1, the well 
designations indicate each four-well slide and each sub-set of wells. In the second round of 
keratinocyte trials a second staining technique, Histochoice and Hoechst, was employed for 
additional assessment of cell presence and proliferation. Two different QD constructs were used in 
the test solutions: 52312EN45.60b and 42612oEN.1a.   
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Table 4.2 Summary of Round Two QD Construct Control and Test Solutions 
Well  Test Solution Filter Stain 
(a) 
Stain 
(b) 
Stain 
(c) 
a, b, c1.1 Control - krt media  H/H L/D H/H 
a, b, c1.2 42612oEN.1a: PL/krt     [10mg/mL] 0.2µm H/H L/D H/H 
a, b, c1.3  PL/krt                            [10mg/mL] 0.2µm H/H L/D H/H 
a, b, c1.4 52312EN45.60b: PL/krt [10mg/mL] 0.2µm H/H L/D H/H 
a, b, c2.5 42612oEN.1a: PL/krt     [10mg/mL] 0.45µm L/D H/H L/D 
a, b, c2.6 Control - krt media  L/D H/H L/D 
a, b, c2.7 52312EN45.60b: PL/krt [10mg/mL] 0.45µm L/D H/H L/D 
a, b, c2.8  PL/krt                             [10mg/mL] 0.45µm L/D H/H L/D 
 
 Two different QD construct samples were used as test solutions: 42612oEN.1a and 
52312EN45.60b.  The original CdSe core sample used to synthesize 42612oEN.1a was composed 
of four previous CdSe samples: 102511W2.10, 12611AC.30, 2812ARC.1A, and 2812ARC.1B0. 
This new combination sample, 42612oCMBO.1, had been shelled with a ZnS coating at 160°C, 
encapsulated in a 10mg/mL PL/CHCl3 solution, and evaporated into keratinocyte media using the 
protocol from Chapter 3.   
 
 
Figure 4.3  Progression of the 42612oEN.1a used in the test solutions of R2 trials. A. The four 
individual CdSe composite cores. B. The four combined CdSe cores. C. The combined CdSe cores 
shelled with ZnS at 160°C (537nm:7400counts: FWHM 40). 
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 The original CdSe core sample used to synthesize 52312EN45.60b was a combination of 
two previous CdSe samples, 52312AC4.60 and 52312AC5.60, both which were synthesized at 
225°, combined, shelled with a ZnS coating at 110°C, encapsulated in a 10mg/mL PL/CHCl3 
solution, and evaporated into keratinocyte media using the protocol from Chapter 3.  The choice of 
each CdSe/ZnS sample to be used in the synthesis of the QD construct test solutions was made 
based on the CMW and FWHM of each sample relative to the emission wavelengths associated 
with the L/D stains; it was necessary that the emission wavelength of the QD constructs overlap as 
little as possible with the L/D stain emission wavelengths. With the CMW of the emission 
wavelengths for Calcein and EthD-1 being 515 and 635nm respectively, it was important to have a 
QD emission wavelength that would be intermediate between the two with as little overlap as 
possible. The CMW, intensity, and FWHM of 42612oEN.1a and 52312EN45.60b were 537nm: 
7400counts: FWHM 40nm and 564nm: 15200counts: FWHM 44nm respectively. 
 In R2 of the keratinocyte trials the NFK cells were thawed out of cryopreservation state and 
cultured in T75 flasks.  Three days later the cells were passed into 6 four-well slides. As a 
consequence of not having the same four-well slides available that were used in the first round of 
keratinocyte trials, the keratinocytes were passed into the alternate four-well slides with the thick 
specimen slide base.  As a result of low observed confluency, additional cells, from the initial T75 
flasks, were added to the 6 four-well flasks on 3 days after the first passage into the 6 four-well 
slides.  Three feedings of keratinocyte media were administered in the interim between the initial 
thawing and the addition of cells. The 6 four-well slides were divided into 3 sets: a, b, and c. Each 
well-set was examined with the optical microscope before the introduction of the test solutions and 
at their individual time points post-introduction. Conditions in well-set a were scheduled to be 
investigated one hour after the introduction of the test solutions, conditions in well-set b at 12 hour 
post-introduction, and well-set c 24 hours post introduction of the test solutions.  Although the time 
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points for investigating the conditions in well-sets b and c did follow the initial schedule, the initial 
schedule for well-set a was altered to accommodate the hurdles of using the four-well slides 
mounted on the thick specimen slides bases, the missing Hoechst stain, and the lights in the 
engineering building that housed the confocal microscope being shut off previous to imaging well 
sub-set a2.5-8.   
 4.2.1.3 Duration of Keratinocyte Trial – R1 
 The first round of keratinocyte trials explored two different time-frames. Well-set a 
examined the cell-QD construct interaction and effect of the test solutions on cell viability and 
proliferation for a 24 hour exposure time and well-set b explored the cell-QD construct interaction 
and effect of the test solutions on cell viability and proliferation for a 24 hour exposure time with 
an additional latent period of 24 hours in fresh media. In other words, well-set b underwent the 
same initial conditions as well-set a, but after the initial 24 hours of exposure, the test solutions 
were aspirated off, fresh media was added, and another 24 hours of incubation time was initiated.  
The purpose of this tactic was to assess the longer term consequences of the cells to a discrete 
exposure of the test solutions.  
 The cells were removed from the primary aseptically maintained incubator and examined 
under a white light microscope. Observations of cell confluency and morphology, and the presence 
of any contaminants, were recorded and representative images of each well-chamber were taken 
using a Sony Cyber-Shot digital camera on low light high sensitivity setting at maximum zoom 
without a flash.  After imaging the cells pre-introduction of the test solutions was completed, the 
choice to aspirate or not to aspirate was made. The decision to aspirate off the initial media present 
in the cultures before introduction of the test solutions was dependent upon three factors: the time 
relative to the most recent feeding, the amount of media residing in each of the culture wells, and 
the desired dilution of the test solutions. If the last feeding was more than 24 hours prior to 
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introduction of the test solutions, the initial media was aspirated out of the wells and the 
appropriate amount of media, relative to the desired dilution of the test solutions, was added. If the 
time between the introduction of the test solutions and the most recent feeding did not necessitate 
new media but the wells were full, and therefore did not have room to add the test solutions, the 
media was aspirated off.  Ideally, enough media would be available to support the decision to 
aspirate off the initial media, add fresh media to the test solutions achieving the desired dilution, 
and then add the test solutions to the cell cultures. After the media was aspirated off, using a motor 
powered aspiration system, the test solutions were added to each well, and the cultures were then 
placed in the secondary incubator and maintained at a temperature of 37°C. 
 Twenty four hours after the introduction of the test solutions both well-set a and well-set b 
were removed from the secondary incubator and all wells were aspirated, removing the test 
solutions. Each well of well-set b was then rinsed with 0.5ml of keratinocyte media, aspirated, 
filled with 3 mL of keratinocyte media, re-imaged, and placed back into the secondary incubator.  
Observations of cell confluency and morphology, and the presence of any contaminants were 
recorded with corresponding representative images for each well-chamber. These images were later 
compared with the corresponding confocal images. 1.5mL of keratinocyte culture media was added 
to each well of well-set a and the cultures were again examined under the microscope; no images 
of well-set a were taken at this time. 
 4.2.1.4 Duration of Keratinocyte Trial – R2 
 Three different time points were investigated in the second round of trials: one hour, 12 
hours, and 24 hours post-introduction of test solutions.  The purpose of these time points was two-
fold: to determine the proportion of cell damage relative to time of exposure and to determine the 
rate of attachment and of QD constructs to cell membranes. Each four-well slide was removed 
from the primary incubator and examined using the optical white light microscope. As a result of 
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diminished stores of fresh keratinocyte media on hand, the existing media in each of the wells, 
approximately 1mL, was not removed. All test solutions were introduced to the cultures, 1.5mL per 
well, and the slides were placed in the secondary incubator at 37°C. The L/D stain solution was 
made during the one hour waiting period for the first set of slides to incubate. The Hoechst dye 
material was unavailable for use in well-set a and was therefore not implemented until testing of 
well-set b. At one hour from introduction of the test solutions well-set a was removed from the 
secondary incubator. 
Table 4.3  Keratinocyte Trial Time Points in Round Two 
 
 
4.2.2 Implementation of White Light Optical Imaging 
 At the onset of each trial, the previously prepared four-well flasks were removed from the 
primary incubator and viewed before adding the test solutions. Each well of keratinocyte cell 
cultures was examined using an Olympus CKX41 optical white light microscope at magnifications 
of both 10X and 20X with the intermediate light aperture. Examination of the cells was performed 
to qualitatively classify the general appearance and morphology of the cells within the culture, both 
as individual cells and as a culture population.  Individual cell morphologies were examined by 
assessing cell shape, size, and adhesion according to the characteristics as described by the 
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distributor of the keratinocyte cells, ATCC Primary Cell Solutions. The expected morphology, 
developmental phase, and distribution, indicative of healthy cells, are a cobblestone appearance, 
high mitotic index, colony formation of cells when at near 80% confluency, and cell adherence to 
the well-plate surface (81). A cobblestone appearance is characterized by individual cells that are 
rounded not flat. Mitotic Index refers to the ratio of cells within the culture population that are 
actively undergoing mitosis relative to cells not undergoing mitosis (82). The keratinocyte cell 
culture images in Figure 4.4 show these representation fundamental keratinocyte culture 
characteristics at four different percentages of confluency. In addition to these fundamental cell 
traits, any anomalies found within each well were also assessed and recorded to be later referenced 
in the case of unexpected developments within the cultures at a later time point.   
 
 
Figure 4.4  Microscopic view of neonatal foreskin keratinocytes (NFK) at different stages of 
proliferation and colonization:  a. initiation of NFK cells, day 8 after seeding; b. growing colonies 
at day 11; c day 15; d. confluent area at day 20 (83). 
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4.2.2.1 Optical Imaging – R1 
 A minimum of three initial images were taken for each well in both well-set a and well-set 
b. Multiple images of each well were taken to ensure that an accurate representation of the state of 
the whole culture was recorded pre-introduction of the test solutions. These first images were taken 
with the initial media still present in each well. The purpose of imaging before removing the initial 
media was to ensure that any dead cells or contaminants contained within the media would be 
included in the initial observations.  Had the initial media been aspirated off before imaging, these 
abnormalities would have gone unidentified. The wells were then aspirated and the test solutions 
were then added to both well-sets, 1.5mL per well without additional fresh media, and both well-
sets were placed back into the secondary incubator. At the 24 hour mark well-set b was removed 
from the secondary incubator, the test solution in each well was aspirated off, 1.5mL of fresh media 
was added, and another set of images were taken using the white light optical microscope. After the 
representative images were taken, well-set b was placed back into the incubator for a final period 
of 24 hours.  At this time, after well-set b was returned to the incubator, the test solutions were 
aspirated off of well-set a. After aspiration of the test solutions 0.5mL of keratinocyte was added to 
each well and used to rinse off any remaining test solution. The rinse was then aspirated off and a 
second volume of 0.5mL of keratinocyte media was added.  This additional 0.5mL of media was 
added as part of the preparation for staining the cells with the Calcein/EthD-1 Live/Dead (L/D) 
stain. No images of well-set a were taken after aspiration of the test solutions. Forty eight hours 
after the initial, 24 hours after well-set b had been returned to the secondary incubator with fresh 
media, the optical microscope was once again used to image each well in well-set b.  Through 
visual observation it was determined that little to no change had occurred in the cells during the 24 
hours since the last viewing and therefore no additional white light images of well-set b were 
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taken. To more clearly illustrate the time line of test solution introduction and imaging, Figure 4.5 
gives the sequence of events in detail. 
 
 
Figure 4.5 Sequence of Cell Culture – Test Solution Interaction and Imaging 
  
 4.2.2.2 Optical Imaging – R2 
 The pattern of imaging each well-set in the second round of trials was similar to that of the 
pattern of imaging for the first round of trials, but in this case all well-sets were imaged both before 
and after the introduction of the test solutions.  All three well-sets, a, b, and c, were removed from 
the primary incubator and imaged, before introduction of the test solutions, with the initial media 
still in each well.  After imaging each well, and recording all pertinent observations, 1.5mL of the 
test solution corresponding to each well was added. Unlike the first round of trials the initial media 
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was not aspirated off before the introduction of the test solutions.  Not aspirating off the initial 
media before introduction of the test solutions was the result of having only a limited supply of 
keratinocyte available. All of the well-sets were then placed back into the secondary incubator. At 
one hour after the introduction of the test solutions well-set a was aspirated, rinsed with 0.5mL of 
keratinocyte media, aspirated, rinsed with 0.5mL of keratinocyte media, and then re-imaged with 
the optical microscope before introducing any fluorescence staining. This same series of rinsing 
with the stain-associated media, aspirating, and imaging was applied to well-sets b and c at 12 and 
24 hours respectively. 
4.2.3 Fluorescence Staining  
 Two varieties of fluorescent staining methods were employed for determining the cell 
viability of the keratinocyte cultures post-introduction of test solutions and the degree of cell-QD 
construct interaction: Calcein/Ethidium homodimer-1 (EthD-1) Live/Dead cell viability stain (L/D) 
and Histochoice/Hoechst (H/H) nuclei stain.  The application of the L/D stain was used to 
simultaneously test two separate parameters of cell viability: intracellular esterase activity and 
plasma membrane integrity (84). It is the esterase activity inherent in all live cells that acts as a 
catalyst causing a conversion of the non-fluorescing calcein AM in the L/D stain solution to the 
green fluorescing species calcein (84). As the period of time that a cell has been dead increases, 
less and less calcien AM is available to be converted into calcein, resulting in a corresponding 
decrease of fluorescence. Although the presence of the calcein associated green fluorescence isn’t a 
negative for dead cells, it does indicate that at the time of the introduction of the L/D stain there 
was still intracellular esterase activity in the cell; an indication that the cell was most likely alive at 
the time of the introduction (85). EthD-1 is used to determine the presence of dead cells in the 
culture. EthD-1 can only enter cells with damaged membranes. Previous to entering the cells the 
level of EthD-1 is low enough to be hidden in the background noise. It is only upon invasion in to 
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the cell through the permeable membrane, and binding to the nucleic acids within the cell, that the 
EthD-1’s red fluorescence signature is observed (84). Any amount of red fluorescence in a cell is 
an indication that the cell’s membrane has become permeable as a result of cell death. A cell that 
fluoresces almost entirely green but that does exhibit some red fluorescence is an indication of 
recent cell death; possibly as a direct result contact with the L/D stain.  A cell that fluoresces 
almost entirely red is an indication that cell death was not recent; most probably a result of 
environmental factors unrelated to the L/D stain. The excitation wavelength for both calcein and 
EthD-1 is 495 nm, with calcein having and emission wavelength of 515nm and EthD-1 having an 
emission wavelength of 635nm. The L/D stain solution applied to both R1 and R2 trials was made 
using Invitrogen’s Live/Dead Viability/Cytotoxicity Kit.  
 
Figure 4.6 On the left is the excitation and emission fluorescence spectra of Calcein (495/515), on 
the right is the excitation and emission spectra of EthD-1 (495/635) (86, 87). 
 
 The Hoechst stain used in the R2 trials was Invitrogen’s Hoechst 34580.  This particular 
variety of Hoechst has can be excited using a 405nm wavelength laser and is therefore appropriate 
for use when imaging with a confocal microscope. Hoechst stains are cell permeable nucleic acid 
stains (83). Hoechst 34580 was used in this thesis to positively confirm the presence of 
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keratinocyte cell nucleuses from other biologic entities that may have been present in the cultures 
and which may have reacted with the L/D stain and QD constructs in R1, but were not in fact 
keratinocyte cells. 
  
Figure 4.7 The excitation (solid line) and emission (dotted line) fluorescence spectra of 
Invitrogen’s Hoechst 34580 stain (88). 
  
 4.2.3.1 Calcein/EthD-1 Live/Dead Cell Viability Stain – R1and R2 
 In R1, as well as R2, the L/D stain was made by mixing 20µL of 2mM EthD-1, 10mL of 
keratinocyte media, and 5µL of 4mM Calcein in a 20mL glass vial.  The solution was vortexed and 
the glass vial was wrapped in aluminum foil to prevent a reduction in the stains efficacy resulting 
from over exposure to light. For both rounds of keratinocyte trials the L/D stain was prepared and 
applied to the cultures in the same manner and in the same time frame.  The well sub-set to be 
imaged was aspirated to remove the test solutions, rinsed with 1.5mL of keratinocyte media, 
aspirated again, and another 1.5mL of keratinocyte media was added.  The entire protocol for the 
preparation and use of the L/D stain is given in Appendix B.9. The L/D stain was not added to the 
cell cultures until 10 minutes before imaging with the confocal microscope.  This delay in 
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administering the L/D stain was used as a measure for decreasing the influence that the stain had on 
the health of the cells. 
 4.2.3.2 Histochoice/Hoechst Nucleus Stain – R2 
 The Hoechst stain was applied in the R2 trials only.  The protocol used for the preparation 
of the Hoechst stain was originally created for staining coverslips coated with NIH 3T3 fibroblast 
cells. This original protocol of the Hoechst stain called for preparation of a 2µg/mL concentration 
solution of Hoechst dye using a 5mg/mL stock solution and applying 200µL of the solution to each 
coverslip. This concentration could be achieved by mixing 2µL of the stock solution with 5mL of 
PBS. For the preparation of the Hoechst stain for use in the four-well slides of keratinocyte 
cultures, alterations were made to the original protocol. The Hoechst starting material on hand was 
in powder form, not liquid, and therefore was not measured out by mixing 2µL of Hoechst with 
5mL of PBS. Instead, Hoechst stain was prepared by adding 2 – 4 particles of the Hoechst powder 
with 5mL of PBS in a glass vial and vortexing the solution. The glass vial was then wrapped in 
aluminum foil to prevent a decrease in the effectiveness of the solution as a result of exposure to 
light.  
 Each well-set in R2 had been divided into two subsets: a, b, c1.1-4 and a, b, c2.5-8. In the 
casee of well-set a, well-subset a1.1-4 was to receive the Histochoice fixative and Hoechst stain 
(H/H), well-subset a2.5-8 was to receive the L/D stain. Each stain was to be prepared in a different 
aqueous medium, PBS for the H/H and keratinocyte media for the L/D; therefore, each well-subset 
was to be rinsed with 0.5mL of the media corresponding to the stain that would be administered to 
that particular subset. The same pattern of aspiration, imaging, and rinsing was to be applied to 
well-sets b and c at 12 and 24 hours respectively from the initial introduction of the test solutions 
into the well-sets. The proposed schedule of staining was administered as intended for well-sets b 
and c, however, well-set a did not receive the H/H staining as a result of the Hoechst stain base 
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material being unavailable; instead both sub-sets received L/D stain. Additionally, as a 
consequence of using the alternate four-well slides with the thick specimen slide base, sub-set a1.1-
4 was exposed to the L/D for an extended period of time before imaging with the confocal 
microscope; sub-set a2.5-8 was imaged 24 hours after sub-set a1.1-4 as a consequence of the lights 
in the building being turned off just before the L/D stain was to be introduced. 
4.2.4 Confocal and DIC Imaging 
 An Olympus Fluoview confocal microscope was used to acquire confocal and differential 
interference contrast (DIC) images. Confocal images of the cell cultures exposed to the L/D and 
H/H stains were acquired by applying the Alexafluor 488 filter to detect the Calcein emission, the 
PI filter to detect the EthD-1 emission, the Qdot565 filter to detect the QD construct emission, and 
the DAPI filter to detect the Hoechst stain emission. In the cases of imaging cell viability in wells 
that contained QD constructs, it was not possible to employ both the L/D and QD filters 
simultaneously owing to the overlap between the excitation and emission wavelength ranges 
associated with each filter. In this circumstance separate images were taken of the same field of 
view and then compared side by side.  DIC images provided topological information about the 
structure of the cell cultures in each well.  Using DIC imaging in concert with confocal imaging 
offered an additional method for determining the relative position of the QD constructs with 
respect to the cells. DIC images were obtained by applying the TIC filter.   
 4.2.4.1 Keratinocyte Cell Viability – R1 
 The first round of keratinocyte trials investigated cell viability and cell-QD construct 
interaction using only L/D staining and confocal imaging of the wells. The L/D stain was applied to 
each well sub-set, placed in a closed container out of the light, and allowed to incubate for 10 
minutes before imaging.  Each four-well slide was placed securely above the 20X objective lens. 
Before attempting to acquire an image, the wide-field fluorescence laser was engaged and the 
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sample viewed through the eyepiece while adjusting the vertical position of the four-well slide 
relative to the objective lens until a clear image was achieved. After achieving a clear image in this 
manner, scanning of the image using the confocal laser and appropriate filters was initiated.  A 
strategy of acquiring multiple images, at different focal depths, taken of a single area while 
adjusting the intensity of the laser was applied.  The amount of the excitation laser source incident 
on the sample was adjusted by increasing or decreasing the “laser %” on the control panel. An 
additional adjustment made in an effort to achieve maximum clarity of the cells and minimum 
interference of background fluorescence was manipulation of the high voltage (HV) setting 
associated with each filter. Each well within both well-sets a and b were imaged with this strategy.  
 As a result of the distinct emission wavelength of the QD constructs, CMW of 539 nm with 
a FWHM of 44nm, it was possible to distinguish the QD constructs from the cells when viewing 
the wells with the L/D stain associated filters alone.  For clarification that the particles presumed to 
be QD constructs were in fact QD constructs, images of the same field of view within the wells 
containing the QD construct test solutions were taken using the L/D filters and then again using 
only the Qdot565 filter. These images were then assessed in a side by side comparison. 
 4.2.4.2 Keratinocyte Cell Viability – R2 
 The second round of keratinocyte trials investigated cell viability and cell-QD construct 
interaction using L/D staining, H/H staining, and confocal and DIC imaging of the wells. As stated 
in Section 4.2.4.2, a consequence of using the alternate four-well slides with the thick specimen 
slide base, was that sub-set a1.1-4 was exposed to the L/D for an extended period of time before 
imaging with the confocal microscope. The particular difficulty associated with using the alternate 
four-well slides stemmed from the thickness of the specimen slide base.  The added thickness, 
relative to the four-well slides used in R1, prevented clear and accurate imaging with the confocal 
microscope. To combat this, directly before imaging, the solution within each well was aspirated 
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off and the four-well chamber frame was removed.  Removal of the four-well chamber frame left 
behind the rubber seal that had attached the frame to the slide.  The formation and height of the 
rubber seal was such that when a cover slip was placed over the area previously occupied by the 
frame, there was still a significant gap between the coverslip and the cells.  This gap precluded 
acquiring clear images. This was remedied by removing the rubber seal.  In the case of well sub-set 
a1.1-4, the seal was removed using a metal spatula and tweezers. Removal of the rubber seal for 
well sub-set a2.5-8 and well-sets b and c employed the use of a razor blade and tweezers. The 
progression of slide alterations is given in Figure 4.8.   
 
 
Figure 4.8 Adaptation of four-well with thick specimen slide base for use in confocal imaging of 
R2 keratinocyte trials. A. Four-well slide with well chambers. B. Four-well slide with rubber seal. 
C. Four-well slide ready for imaging. 
 
 As a result of the incompatibility of the Alexa Fluor 488 and PI filters with the DAPI and 
Qdot565 filters, multiple images of the same field of view within each well were taken.  All of the 
wells were imaged with the Alexa Fluor 488, PI, DAPI, Qdot565 and TIC filters to assess cell 
viability, location, and structure. Well sub-sets a, b, c3.5-8, which contained the QD construct test 
solutions, were imaged with the application of the Qdot565 filter as a method for accurately 
distinguishing the QD constructs form the cells.  Wells not containing QD constructs were imaged 
with the Qdot565 filter to assess how non-QD construct entities would appear when the filter was 
applied. The excitation/emission wavelength ranges associated with the Hoechst stain and the QD 
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constructs were very similar. This similarity introduced wavelength of the laser used for the 
excitation of the Hoechst and QD-constructs 
 
4.3 Results 
4.3.1 QD Construct Introduction into Keratinocyte Cell Cultures 
 4.3.1.1 QD Construct Control and Test Solutions – R1 
            Each of the steps in creating the final QD construct solution resulted in alterations of the 
samples CMW, intensity, FWHM, and scattering of the excitation source. The progression of these 
changes is documented in Table 4.4 and Figures 4.9, 4.10, and 4.11. Two different graphs were 
created to illustrate the different CMW and intensities related to each stage in the QD construct 
progression. The graph in Figure 4.9 gives the fluorescence spectrums of the CdSe core sample 
42612wCMBO.2 as well as each of the CdSe core samples from which it was comprised.  The 
general shapes of all of the samples are indicative of the typical spectrum for a white core sample; 
one primary peak at 490 ± 10nm and a broad rolling peak between 550 and 650 nm. Filtering of the 
initial R1 QD construct solution with a 0.45 micron filter resulted in a noticeable difference in the 
CMW, from 552nm to 539nm, of the QD construct solution. Changes in intensity were minimal, 
and changes in FWHM were non-existent. 
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Table 4.4  Progression of Changes in Fluorescence Spectrum During Synthesis of QD Construct 
Solution 42612wEN.2a 
 
Sample Primary 
Peak CMW 
(nm) 
Intensity 
(counts) 
FWHM (nm) Source 
Scattering 
(counts) 
11211AR1.5 486 4200 - - 
2912AC1.0 490 7700 - - 
21412AC1.0 486 6000 - - 
21712AC1.0 473 5500 - - 
22912AC1.0 485 6400 - - 
42612wCMBO.2 487 6600 - 1300 
42612wQD.2a 550 3000 50 500 
42612wEN.2a - NF 552 16500 44 1300 
42612wEN.2a - 0.45µm filter 539 14600 44 > 70000 
PL/krt [10mg/mL] - 0.2 µm filter 524 2400 - > 70000 
PL/krt [10mg/mL] - 0.45 µm filter 524 2400 - > 70000 
 
 
 
Figure 4.9 CdSe combination core sample (42612wCMBO.2 – orange) and the five CdSe core 
samples from which it was composed. 
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Figure 4.10 Changes in CMW, intensity, FWHM, and source scattering corresponding to solutions 
at each step in the QD construct synthesis process. 
 
 
Figure 4.11Changes in CMW, intensity, FWHM, and source scattering corresponding to the 
influence of phospholipid concentration. 
 
A useful option for qualitative assessment of the changes in CMW and intensity of each solution in 
the progression of QD construct development was found to be visual assessment of the samples 
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during exposure to a UV source.  Figure 4.12 provides a visual representation of each of the 
samples fluorescing.   
 
 
Figure 4.12 Progression of QD construct samples during exposure to a 400nm emitting black light. 
From left to right: Original CdSe core combination sample; CdSe/ZnS QD sample shelled at 
160°C; Phospholipid encapsulated QD construct solution after application of 0.45µm filter; 
Phospholipid encapsulated QD construct solution NOT filtered; PL/krt [10mg/mL] NOT filtered; 
PL/krt [10mg/mL] with application of 0.45µm filter. 
  
 4.3.1.2 QD Construct Control and Test Solutions – R2 
 Although more data samples would be needed to definitively determine the effects of 
increased filtering on CMW, intensity, and FWHM of the QD constructs, quantitatively the effects 
appeared to be insignificant. Qualitatively, however, a visual comparison of the filtered samples 
showed a slight difference in the intensities of the two samples, as well as a noticeable shift in 
wavelength.  It appeared as though the sample filtered through the 0.2 micron filter had a decreased 
wavelength relative to the sample filtered through a 0.45 micron filter. 
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Figure 4.13 Fluorescence spectra of QD construct test solutions 42612oEN.1a and 
52312EN45.60b filtered with 0.45 and 0.2 micron filters. 
  
 4.3.1.3 Optical Imaging – R1 
 The initial images of both well-sets of cell cultures, pre-introduction of the test solutions, 
showed a noticeable degree of contamination in each culture. Additionally, a noticeable amount of 
cell-like structures appeared at a higher focal plane and with a different morphology than the cells 
adhered to the surface of the well. Upon shaking of the four-well slide the cell-like structures 
jiggled but maintained their general position in the well. Had the cell-like structures fully detached 
from the surface of the well and freely moved in the upper portion of the media during agitation, 
the condition would have typically indicated that the cells were dead (89).  The series of images in 
Figure 4.14 a representative example of the keratinocyte cell cultures as they appeared after being 
removed from the primary incubator before the aspiration of their initial media and introduction of 
the test solutions.  In both sets of images contamination already appears to be present. 
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Figure 4.14 Digital white light optical images of R1a1.1, fresh media control, taken at different 
light intensities of the well pre-introduction of test solutions while the initial media was still 
present.  
  
 At the 24 hour time point post-introduction of the test solutions, the test solutions in the 
wells of well-set b were aspirated, rinsed with keratinocyte media, and imaged.  All of the images 
show unidentified black orbs of unknown origin. A comparison of well b1.3 before and after the 
introduction of the test solutions is given in Figure 4.15.  Images A1-3 are of the well b1.3, into 
which the test solution of keratinocyte media that had undergone the process involving exposure to 
both CHCl3, heating to 55°C, and evaporation, would later be introduced. Images B1-3 are of this 
same well, b1.3, after a 24 hour exposure to the test solution, aspiration of the test solution and 
addition of fresh media.  
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Figure 4.15 Digital white light optical images of R1b1.3 (keratinocyte media post CHCl3 
evaporation control) taken at different light intensities. A1-3. Pre-introduction of test solutions 
while the initial media was still present. B1-3 Post-introduction of test solutions after aspiration and 
rinsing with fresh media 
  
 4.3.1.4 Keratinocyte Cell Viability and Cell-QD Construct Interaction – R1 
 The confocal equivalents of the white light optical images of well b1.3 are given in figure 
4.16.  Images A1, 2 and images B1, 2 each show two focal depths of a single field of view.  In an 
attempt to discern the effect of the extended exposure of the cells to the L/D stain, a result of the 
time inherent to the process of imaging each well, a series of confocal images of well b1.1 is given 
in figure 4.17. These images taken are of cells that had only been exposed to the L/D stain for 
approximately 10 minutes. Each image is of the same well but at different fields of view and at 
sequentially lower focal planes.  The order of the images is the order in which they were taken; 
approximately one minute passed in between capturing each image. As the images progress toward 
the right an increase in the number of cells fluorescing red, and therefore dead, can be detected. 
This increase in the appearance of dead cells is more influence by the change in focal plane than by 
the minute passage of time. The left most image is of the highest focal plane, the image farthest 
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right is of the lowest focal plane; cells at the top of the culture versus cells closest to the surface of 
the slide, respectively. 
 
 
Figure 4.16 Confocal images acquired of well b1.3 (processed krt media control). A1. Two focal 
planes of one field of view. B1. Two focal planes of one field of view.  Filters: Alexa Fluor 488 
and PI  
 
 
Figure 4.17 Series of confocal images of well b1.1 (fresh krt media control) at different fields of 
view and different focal planes. Filter: Alexa Fluor 488 and PI 
 
Aside from the addition of the black orbs (bos), the average morphology and distribution of the 
cells in well b1.3 did not appear to be noticeably different from their appearance before the 
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addition of the test solutions. The appearance of the orbs was consistent throughout all of well-set 
b.  The orbs appeared at greatest visual clarity at the same focal plane in which the cells appeared 
to be at the greatest visual clarity. The orbs were not distinguishable in the corresponding confocal 
images using the Alexa Fluor 488 and Pi filters shown in Figures  
4.18 C1 -3. 
 
 
Figure 4.18 A1-3: Series of white light images of well b2.6 (PL krt filtered) pre-introduction of 
test solutions at different fields of view. B1-3 Series of white light images of well b2.6 post-
introduction of test solutions at different fields of view. C1-3 Series of confocal images of well 
b2.6 in the same field of view at different focal planes. Filter: Alexa Fluor 488 and PI 
 In both the white light optical images and confocal images of well b2.7 the presence of the 
phospholipids, filtered using a 0.45 micron filter, are clearly distinguishable. A span of images at 
three focal lengths was employed for the detection of dead cells fluorescing red. In the upper left 
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corner of the confocal images in row C, a structure unlike the cells is apparent. This structure could 
be representative of a black orb, made visible by the dense cell coverage. 
 
 
Figure 4.19 A1-3: Series of white light images of well b2.7 (PL krt NF) pre-introduction of test 
solutions at different fields of view. B1-3 Series of white light images of well b2.7 post-
introduction of test solutions at different fields of view. C1-3 Series of confocal images of well 
b2.7 in the same field of view at different focal planes. Filter: Alexa Fluor 488 and PI. 
 
Figure 4.20 gives a progression of images from the cultures exposed to the 0.45 micron filtered QD 
construct solution. Multiple black orbs were detected 24 hours after the introduction of the test 
solution. The structures identified as cells, those fluorescing both red and green with an obvious 
nucleus, show some evidence of interaction with the QD constructs.  The wholly green spheres are 
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may be the orbs and also show interaction with the QD constructs. The upper left sphere in C2 and 
the sphere in figure 4.20 each show a distinct QD halo indicating active interaction with the QDs. 
 
 
Figure 4.20 A1-3: Series of white light images of well b3.10 (QD PL krt filtered) pre-introduction 
of test solutions at different fields of view. B1-3 Series of white light images of well b3.10 post-
introduction of test solutions at different fields of view. C1-3 Series of confocal images of well 
b3.10 in the same field of view at different focal planes. Filter: Alexa Fluor 488 and PI. 
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Figure 4.21 Digital image of well b3.10 as seen through the objective lens of the confocal 
microscope viewed with illumination from the wide-field fluorescence laser 
 
 
Figure 4.22 A1. Confocal image of a seemingly burst cell in well b3.10 (QD PL krt filtered) A2. 
Digital image of burst cell in b3.10 as seen through the objective lens of the confocal microscope 
viewed with illumination from the wide-field fluorescence laser. 
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Figure 4.23  A1-3. Series of L/D filter confocal images of well a3.9 (QD PL krt filtered) A4 
Qdot565 filter.  B1-3. Series of L/D filter confocal images of well a3.9 (QD PL krt filtered) B4 
Qdot565 filter.   
 
 
Figure 4.24 Digital image of well a3.9, representative of the series A1-4 in figure 4.23 as seen 
through the objective lens of the confocal microscope viewed with illumination from the wide-field 
fluorescence laser. 
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Figure 4.25 A1-3: Series of white light images of well b3.12 (QD PL krt NF) pre-introduction of 
test solutions at different fields of view. B1-3 Series of white light images of well b3.12 post-
introduction of test solutions at different fields of view. C1-3 Series of confocal images of well 
b3.12 in the same field of view at different focal planes. Filter: Alexa Fluor 488 and PI 
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Figure 4.26 Series of confocal images of well a3.11 (QD PL krt NF) at the same field over a series 
of focal planes. Filters: A1-4 Qdot565, B1-4 Alexa Fluor 488 and PI 
 
 
Figure 4.27 Digital image of a3.12 (QD PL krt NF) as seen through the objective lens of the 
confocal microscope viewed with illumination from the wide-field fluorescence laser. 
 
  4.3.1.5 Imaging – R2 
 All of the initial cell cultures showed similar levels of minimal contamination and cell 
confluency, approximately 60%, at the time of extraction form the primary incubator and before 
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the introduction of the test solutions. Figure 4.26 gives a sampling of the culture appearance from 
each well-set pre-introduction of the test solutions. At one hour post- introduction of the test 
solutions well-set a showed, on average, two of the spherical unknowns for every three wells.  
There was no apparent correlation between the test solution administered to the well and the 
appearance of the bos. Wells that had contained controls of fresh keratinocyte media, phospholipids 
in keratinocyte media, QD constructs, and both levels of filtration all contained at least one black 
orb when all of the related wells were considered as a group.  Figure 4.27 gives a sampling of the 
culture appearance from each well-set post-introduction of the test solutions. The sample includes 
images representing each of the three time points along with each of the test solutions. 
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Figure 4.28 Representative images taken with a white light optical microscope pre-introduction of 
the test solutions. A. well-set a. B. well-set b. C. well-set c, a single field of view at three different 
focal planes to better illustrate the culture composition. 
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Figure 4.29 Representative images taken with a white light optical microscope post-introduction of 
the test solutions. A1,2. a1.4 QD PL B 0.2 micron filter. A3. a1.2 QD construct A 0.2 micron filter. 
A4. a2.8 PL 0.45 micron filter. A5. c1.3 PL 0.2 micron filter. A6. c1.4 QD construct B 0.2 micron 
filter. 
  
 4.3.1.6 Keratinocyte Cell Viability and Cell-QD Construct Interaction – R2 
 Confocal images of well sub-set a1.1-4 lacked clarity as a result of the first method applied 
in the arrangement of the cover-slip and specimen slide. The two images acquired at one hour post 
introduction of the test solutions are given in Figure 4.28. The images are of well a1.1, which 
contained the keratinocyte media control solution and was prepared with the L/D stain. An 
additional effect of the slide preparation issue was the delayed imaging of well sub-set a2.5-8.  All 
images of well sub-set a2.5-8 were taken 24 hours after the test solutions had been removed; the 
wells were rinsed and subsequently left covered but un-incubated for 24 hours. As a result of the 
Hoechst stain being unavailable for use in well-set a, there are no confocal images of well-set a 
with the DAPI filter applied; all images are of cultures exposed to the L/D stain and the imaged 
using the Alexa Fluor 488, PI, Qdot565, and TDI filters.   
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Figure 4.30 Well a1.1 (keratinocyte media control). A1. Alexa Fluor 488 and PI filter. A2. Alexa 
Fluor 488, PI, and TDI filter overlay. 
 
 
The confocal images taken of the wells exposed to the QD construct test solutions showed a 
minimal presence of QD constructs in the culture.  The yellow arrow in Figure 4.29 indicates the 
single QD construct that was visible in that field of view of well a2.5.  An additional series of 
images using each filter was applied to well b1.4, also exposed to a QD construct test solution. 
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Figure 4.31 Comparison of well a2.5 (QD construct A 0.45 micron filter) in row A with well a2.6 
(keratinocyte media control) in row B. Column 1 - Alexa Fluor 488 and PI filter. Column 2 – 
Qdot565 filter. Column 3 – Qdot565 overlaid with TDI. Column 4 - Alexa Fluor 488 and PI with 
TDI filter overlay. The yellow arrow points to a QD construct. 
 
 
Figure 4.32 Series of confocal images taken of b1.4 (QD construct B 0.2 micron filter). Filters 
applied:  A1- Alexa Fluor 488; A2 – PI; A3 – TDI; A4 – Qdot565; A5 -  Alexa Fluor 488 and PI; 
A6 - Alexa Fluor 488, PI, and TDI; A7 - Qdot565 and TDI. 
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 The series of images in Figures 4.33 and 4.34 both indicate the identification of QD 
constructs. Well b2.5 of figure 4.33 did contain cells exposed to QD constructs. Well b2.6 in Figure 
4.34 did not contain QD constructs. Well b2.6 contained only keratinocyte media. The 
identification of QD contructs in this well is a false identification the result of the Hoechst stain 
being excited by the 405 excitation wavelength and the subsequent emission form the Hoechst stain 
being detected by the Qdot565 filter. Figures 4.35 and 4.36 give a side by side comparison, of the 
same field of view, for images resulting from use of the 405nm excitation source versus that of the 
488nm excitation source.  These images illustrate the false identification of QD constructs when 
the 405nm laser is applied to wells with the Hoechst stain and detected with the Qdot565 filter. 
Additionally these images show that an excitation wavelength of 488nm does not produce a false 
positive for the presence of QC constructs. 
 
Figure 4.33 Series of confocal images taken of b2.5 (QD construct A 0.45 micron filter). Filters 
applied:  A1- DAPI; A2 – Qdot565; A3 – TDI; A4 – DAPI and Qdot565; A5 - DAPI, Qdot565, and 
TDI; A6 - Qdot565 and TDI. 
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Figure 4.34 Series of confocal images taken of b2.6 (keratinocyte media control) comparing 
excitation wavelengths of 405 and 488nm. Row A utilizing 405nm and row B utilizing 488nm. 
Filters applied:  A1- DAPI; A2 – Qdot565; A3 – DAPI and Qdot565; A4 - DAPI, Qdot565, and 
TDI; B1 – DAPI; B2 – Qdot565; B3 – Qdot565 and TDI. 
 
 
 
Figure 4.35 Series of confocal images taken of b2.7 (QD construct B 0.45 micron filter) comparing 
excitation wavelengths of 405 and 488nm. Row A utilizing 405nm and row B utilizing 488nm. 
Filters applied to each column: 1- DAPI; 2 – Qdot565; 3 – DAPI and Qdot565; 4 – Qdot565 and 
TDI; 5 – DAPI, Qdot565, and TDI. 
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 When comparison of the number of live to dead cells was made, comparing the effect of 
each test solution on cell viability, no significant difference was determined to be present. All 
wells, on average, had the same ratio of live to dead cells. Figures 4.36 and 4.37 give a set of 
images representative of the entire culture surface of each analyzed well.  Figure 4.37 compares a 
series of images of wells, using the same application of filters, to determine the relative signatures 
of cells, QD constructs, and phospholipids specific to each filter: Alexa Fluor 488, PI, Qdot565, 
and TDI. Each image contains structures that fluoresced red. Only row B, wells exposed to QD 
constructs, contains a bright yellow structure in images B1 and B3, corresponding to the same 
position of the structure identified in B2 as being a QD.  
 
 
Figure 4.36 Series of confocal images taken of c2.5 (QD construct A 0.45 micron filter) Filters: A1 
- Alexa Fluor 488 and PI; A2 – Qdot565; A3 – Qdot565 and TDI; A4 – Alexa Fluor 488, PI, and 
TDI 
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Figure 4.37 Comparison of confocal images: of c2.6, row A (keratinocyte media control); c2.7. 
row B (QD construct B 0.45 micron filter); c2.8, row C (phospholipid keratinocyte media 0.45 
micron filter).  Filters applied to each column: A1 - Alexa Fluor 488 and PI; A2 – Qdot565 and 
TDI; A3 – Alexa Fluor 488, PI, and TDI. The yellow arrow indicates a QD construct. 
 
An additional series of 405nm versus 488nm images were conducted on the Hoechst stained 
cultures of well-set c.  The subsequent images, given in figure 4.38, return the same results as seen 
previously in the images taken for the Hoechst stained cultures of well-set b. 
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Figure 4.38 Series of confocal images taken of c1.1 (keratinocyte media control) comparing 
excitation wavelengths of 405 and 488nm; images A1-5 utilizing 488nm and image A5 utilizing 
405nm. Filters applied to each column: 1- DAPI; 2 – Qdot565; 3 – TDI; 4 - DAPI and Qdot565; 5 
– DAPI, Qdot565, and TDI; 6 - DAPI, Qdot565, and TDI. 
 
4.4 Discussion 
4.4.1 QD Construct Introduction into Keratinocyte Cell Cultures 
 4.4.1.1 QD Construct Control and Test Solutions – R1 
 Each step in the process for creating the QD constructs had an effect on the CMW of the 
solution. The encapsulation of the QDs in the phospholipid micelles and the filtering of the 
subsequent solution both resulted in a decrease CMW. There are two possible explanations for this 
effect: the QDs inside the micelles have a decreased diameter and/or the phospholipids absorb a 
portion of the energy from the excited electron in the form of phonons, thus reducing the energy of 
the emitted photon. As described in chapter one, a decrease in the size of QDs will result in a 
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decrease in the emission wavelength. It could be possible that during the encapsulation process the 
QDs de-aggregate into smaller particles. However, knowing that exposure to heat, which the 
encapsulation process includes, typically promotes aggregation of QDs and thereby increases 
emission wavelengths; it seems unlikely that the decreased emission wavelength is the result of the 
size of the QD being diminished. The more likely reason is that the presence of the phospholipids 
surrounding the QDs removes energy. Filtering of the test solutions also resulted in a shift of 
noticeable shift in wavelength and intensity; again the result being a decrease. Filtering inevitably 
removes a significant proportion of the QD constructs present; the cause of the decrease in 
intensity. The QD constructs preferentially removed first would be the larger constructs. Removal 
of the larger constructs would mean removal of the larger QDs and therefore removal of the source 
of the larger emission wavelengths, all contributing to the decrease in CMW of the filtered 
solution. 
 4.4.1.2 QD Construct Control and Test Solutions – R2 
 The effect of a more coagulated encapsulation mixture, like the one produced during the 
encapsulations performed in R2, increased the difficulty for achieving an even distribution of QD 
constructs within the keratinocyte media; consequently, less of the actual QD constructs passed 
through the filter. The coagulation may also have led to less QDs actually being encapsulated, 
causing the majority of what was passed through the filter to be congealed phospholipids without 
any QDs. Comparison of the peaks for the filtered QD construct solutions, of R1 and R2, showed 
that the R2 0.45 micron solution to be five times less intense than the R1 0.45 micron QD construct 
solution.  This difference would seem to support the conclusion that the encapsulation of the R2 
solutions was not as effective as the R1 samples and that in future encapsulation proceedings, 
measures should be ensure a less viscous end product. The dilution of the QD construct test 
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solutions, during the encapsulation process, using the native keratinocyte media would be an 
effective method for achieving this.   
 4.4.1.3 Optical Imaging – R1 
 The identity of the orbs that appeared in the keratinocyte cell cultures 24 hours after the 
introduction of the test solutions remains unknown. An extensive literature and internet search of 
common keratinocyte cell culture contaminants, as well as typical cell anomalies, did not return 
any results that appeared similar in appearance or description. Based on the spherical and 
concentric appearance of the orbs it was proposed by Dr. Kristen O’Halloran Cardinal that they 
may in fact have been dead cells, but that without viewing them first hand it could be some 
contaminant.  The confocal images of the same cultures did not reveal an obvious presence of the 
orbs, however, in the cultures that had been exposed to the QD construct test solutions, it was noted 
that some of the structures that the QD constructs had attached to, could in fact be the orbs. The 
image in Figure 4.39 is an example of the QD construct attachment to a structure similar to what 
was previously described. 
 
 
Figure 4.39 Taken with a digital camera through the eyepiece of the microscope with the wide 
field fluorescent laser applied to well b3.10 (QD PL krt filtered). 
  
The images of the seemingly burst cell in Figure 4.22, whether or not the cell had actual swollen up 
to the point of bursting, can be positively identified as a cell.  The interesting quality to notice in 
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that image is that there is still a considerable amount of green visible around the cell from the 
presence of the Calcein stain.  This indicates that the cell was alive at the time of exposure to the 
Calcein. The considerable amount of QD construct attachment around the periphery, and in the 
interior live portion of the cell, supports the hypothesis that the constructs were able to permeate 
the cell membrane. It does not however, provide substantial information from which to conclude 
when the constructs permeated the membrane. One explanation is that perhaps the constructs 
invade live cells causing cell death, and at the point of cell death, as enzymatic activity stops and 
the presence of enzymes declines, the constructs no longer have a point of attachment and therefore 
move out and away from the cells along with the cellular debris.  This explanation could justify the 
lack of QD constructs within the completely red cells and the varying degree of their presence with 
respect to the amount of fluorescing Calcein.   
 The confocal images of the wells containing the unfiltered QD construct test solutions show 
minimal evidence of attachment of QD constructs to culture components. The difference between 
the images of the filtered and the non-filtered QD construct test solutions provide evidence for the 
benefits of filtering the solution as a method for increasing the interaction between the cells and the 
QD constructs.  The nature of the phospholipids is such that when in large amounts they tend to 
aggregate forming particles too large to effectively interact with the cells. The series of images 
applying Qdot565 filter and the Alexa Fluor488 and PI filters for the different focal planes of the 
same field of view indicate that the larger aggregates of QD constructs, though not appearing to 
permeate any of the cells, appear to group around the cells; this is especially apparent in images A4 
and B4 of Figure 4.27.  
 4.4.1.4 Optical Imaging – R2 
 The appearance of the cell cultures used in R2 were, on average, more confluent with larger 
numbers of cell colonies than the cultures in R1.  The appearance of the cultures, with respect to 
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contamination, was similar both before and after the administration of the test solutions. Taking an 
extended series of images of the cells as viewed through the microscope, made the process of 
comparing anomalies found in the confocal images with their possible source in the optical images. 
 4.4.1.5 Keratinocyte Cell Viability and Cell-QD Construct Interaction – R1 
 Confocal images with different focal depths illustrate the degree of and effect of the L/D 
stain, indicating that many of the cells were alive at the time of the L/D stain was introduced to the 
culture.  Additionally different focal planes provide a method for uncovering the effects of the 
EthD-1 stain at the earliest stages by looking at components of the cell both proximal and distal to 
the nucleus. A factor worth noting is that although all of the wells in sub-set b1.1-4 were exposed 
to the L/D stain at the same time, b1.3 was the third well in the sub-set to be imaged and therefore 
had a longer exposure time than b1.1 would have.  Averaging the time it took to acquire a series of 
images for each well, well b1.3 had a minimum exposure of 25 minutes. 
 Direct comparison of the confocal images acquired for b1.1 versus those of b1.3 would 
appear to support the hypothesis that the L/D stain may itself have a detrimental effect on the 
viability of the keratinocyte cells and as a result be a factor in the ratio of dead to live cells, 
however, the particular test solutions that each well was exposed to should also be taken into 
consideration.  Well b1.1 contained a control solution of fresh keratinocyte media whereas well 
b1.3 contained keratinocyte media that had been mixed with CHCl3, heated at 55°C, and then 
presumably had the CHCl3 evaporated off.  It was noticed that the edges of the culture wells had a 
greater density of cell coverage, less cell death via EthD-1 stain, but also less cell-QD interaction. 
 4.4.1.6 Keratinocyte Cell Viability and Cell-QD Construct Interaction – R2 
 Two additional characterization techniques were employed in R2 that had not been used in 
R1: H/H staining and DIC imaging.  Both of these proved to be helpful in distinguishing the 
presence of the cells and the interaction of the QD constructs with the cells. Unfortunately, the QD 
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construct solutions of R2 were not to the standard of the solutions used in R1. Throughout all of the 
confocal imaging it was obvious that there was a decreased presence of QD constructs in the cell 
culture relative to the concentration of QD constructs in the solutions used in R1. Figure 4.31 of 
well a2.5 is especially effective at illustrating the difference between the two sets of QD-construct 
test solutions; only a single QD construct is distinguishable. Use of Hoechst stain was applied as a 
method for decreasing possibility for the misidentification of QD construct attachment to cells in 
the likelihood of a reoccurrence of the QD interaction with possible non-cell entities as seen in the 
R1 trials. 
 A difficulty encountered during the confocal imaging of cells in R2 that was not present in 
R1 was a result of the four-well slides the cells had been cultured in.  To acquire clear images of 
the cells using the confocal microscope it was necessary that there only be a very thin barrier 
between the cells and the objective lens.  The thicker specimen slide base that the four-well in R2 
were attached to prevented this. Among the alterations that had to be made to image the cells was 
aspiration of the solution in each well. Aspiration of the solutions could have very likely 
compromised the environment of the cultures, with respect to imaging, relative to what was seen in 
R1.  The preparation of the slide also introduced extra variables such as dehydration of the 
samples, removal of QD constructs that were previously interacting with the cells, and shock to the 
cells as a consequence of the removal process of the rubber septum. The application of the razor 
blade for well-sets b and c, over the metal spatula used for well-set a, greatly decreased the time 
and damaged, and increased the degree of complete removal of the rubber septum.  This more 
complete removal provided a better surface for the cover slip to attach to, thereby yielding better 
images. 
 Application of the Qdot565 filter, for imaging the non-QD construct wells, aided in 
assessing unknown factors which might be presumed to be QD constructs in the associated wells, 
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but were actually artifacts related to some other presence within the culture.  A subsequent effect of 
using the Hoechst stain was the false registration of QD constructs. The excitation/emission 
wavelength ranges of the Hoechst stain and the QD constructs were very similar. As a consequence 
of this similarity the QD565 filter caught a portion of the emission form the Hoechst stain.  This 
emission was then falsely registered as a QD construct signature when in fact no QD constructs 
were present; a circumstance that was supported by the application of the Hoechst and Qdot565 
filters on wells that had not been exposed to any QD constructs. According to the image results 
using the DAPI and Qdot565 filters on wells that were sans QDs, QD constructs were present.  
Fortunately, the presence of the fluorescence in the image was not the sole factor for determining 
the presence of the QD-constructs; the shape and structure of the image was also a method for 
identification.  The constructs, throughout all of the images in both sets of trials, consistently 
displayed a distinct structure.  This structure varied depending on the degree of filtration of the QD 
construct solutions, but was none the less distinguishable relative to the keratinocyte cells. A 
Hoechst stain affect was to use a higher excitation wavelength. Using an excitation wavelength of 
488nm, rather than 405nm, provided a method for exciting any QD constructs that may have been 
present that was outside the optimal range of excitation wavelengths needed to excite the Hoechst 
stain. 
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Chapter 5 – Discussion and Conclusions 
 
5.1 Overview and Summary   
 Cancer is a prevalent and devastating health issue and the second leading cause of death in 
the United States (2). The most common type of cancer found in the United States is skin cancer 
(4).  Early and accurate detection is the most reliable way to ensure a positive outcome and the 
ultimate survival of the patient (5). Accurate determination of the presence of cancerous cells in a 
biopsy is especially difficult at the early stages when only a small percentage of cells in the 
biopsied mass show the morphological traits associated with being cancerous.  This circumstance 
often results in a false negative (FN), delaying the necessary treatment until the cancer has reached 
a more developed stage (7). For this reason alternative methods for the identification of individual 
cancer cells within a larger population of healthy cells is required; functionalized QD constructs 
can be this alternative method. Already QDs have been investigated in in vitro and in vivo studies 
as a viable method for the detection of cancerous cells within prostate, colon, and breast tissue 
cultures (9, 10). The extensive investigations that are being conducted into the applications of QDs 
for use as biologic tags and vehicles for targeting cancer, demonstrate the value that they offer. 
 Currently the CdSe/Zn QDs being synthesized at Cal Poly generate QDs with a wide range 
of CMWs, intensities, and FWHMs. This ability to synthesize such a range of products 
demonstrates the potential for developing a procedure for the consistent optimization of multiple 
QDs that can then be used in specific biologic applications. By addressing some of the QD 
synthesis challenges encountered and described in chapter 2, such as temporal wavelength shifts 
and lowered intensities post-ZnS shelling, great strides will be made toward achieving a reliable 
method for synthesis of QDs of consistent CMW and intensity. 
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5.2 Challenges, Limitations, and Future Work   
 Of the three different sets of QD construct test solutions created, two of which are detailed 
in this thesis, the third solution presented challenges during the filtration process.  The initial 
encapsulation mixture had an increased viscosity and decreases diffusion within the keratinocyte 
media into which it had been suspended. This along with the introduction of the 0.2 micron filter in 
the third set of trials resulted in QD-construct test solutions of decreased concentration.  The 
confocal images acquired of the keratinocyte cultures associated with this set of QD construct 
solutions showed decrease in the presence of QDs and there interaction with the keratinocyte cells. 
In future experiments every trial should contain test solutions that have been filtered with 0.8, 0.45, 
and 0.2 micron filters to determine the degree to which each filter causes an effect on the QD 
construct concentration and subsequent cell-QD construct interactions. 
 Working with fluorescent stains such as Calcein, EthD-1, and Hoechst presented challenges 
for imaging of the culture trials. As a result of overlapping emission wavelengths the filters applied 
to acquire the confocal images could not be used in concert with one another. the QD filter had to 
be used separately form the Alexa Fluor488 and PI filters for detecting the L/D stain and the 
excitation wavelength corresponding to the Qdot565 filter had to be exchanged for a higher 
wavelength so as to not inadvertently excite the Hoechst stain and misidentify it as a QD.  
Although all of these challenges were eventually overcome, it was by trial and error. In each of the 
trials a new and useful characterization mechanism was added providing a more complete picture 
of the effects of the QD construct test solutions on the keratinocyte cells.  In future trials it would 
be beneficial to add additional staining techniques for the determination of cell proliferation as well 
as cell viability. 
 A long term study of the keratinocyte cell-QD construct interaction was not possible as a 
result of the constraints related to maintaining an aseptic environment. Most of the cell cultures 
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showed an initial amount of contamination pre-introduction of the test solutions and in some 
instances this small amount of initial contamination became a prominent presence in the cultures 
by the end of the 24 hour test period. Not only did the presence of contamination often cloud the 
view, it also clouded the conclusions as to what was the primary factor affecting cell viability; the 
QD test solutions or the contamination. Additionally some of the confocal images acquired of the 
resulting keratinocyte cell-QD construct interactions presented questions as to what the QDs were 
attaching to. Many of the structures that were initially assumed to be keratinocyte cells were, after 
further trials had been conducted, later called into question. It was concluded that there was 
evidence of QD construct attachment to both keratinocyte cells and the unidentified structures 
(USs); even more so to the unidentified structures. This called into question why the QD constructs 
seemed to have a greater affinity for the USs; a question that has remained unanswered.  In future, 
if a QD construct solution can be synthesized that is capable of being filtered through the 
0.2micron filter, which is necessary to prevent contamination, without decreasing the concentration 
of QD constructs within the solution, it may be possible to conduct trials with longer time points 
and less contamination. Ultimately, once the procedure for encapsulating and filtering the QD 
construct test solutions has been optimized, transition in to more complex biologics, such as 
EpiDerm skin substitutes,  will be the next adventure. 
 
5.3 Conclusion  
 Although there are many journal articles describing and reviewing a variety of procedures 
for the solubilization and phospholipid functionalization of CdSe/ZnS QDs for use in a biologic, 
this thesis describes the first attempt of such an endeavor at Cal Poly. This method for synthesizing 
QD constructs has great potential for applications where cellular tagging is desired or where 
monitoring the migration of cellular components in real time is of interest. The current protocol 
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being used at Cal Poly for the synthesis CdSe/ZnS QDs has proved to be a sufficient method for 
supplying QDs that are compatible with phospholipid encapsulation. Further modifications of both 
the CdSe/ZnS QD synthesis and optimization of the encapsulation protocol developed here, will 
provide a multitude of future applications only limited by imagination. 
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Appendix A - Abbreviations 
BOs  black orbs 
Cd  cadmium 
CdSe  cadmium selenium cores 
CHCl3  chloroform 
H/H  Histochoice fixative and Hoechst stain 
krt   keratinocyte  
L/D  live/dead cytotoxicity/viability Calcein/Ethidium homodimer-1 
MeOH  methanol 
ODE  octadecene 
PL  phospholipids 
QD  quantum dots 
R1  round one 
R2   round two 
Se-TOP seleniuom trioctylphosphine 
WFCs   white fluorescing CdSe cores 
ZnS  zinc sulfide quantum dots 
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Appendix B – Protocols and Experimental Details 
B.1 – Cal Poly Standard CdSe/ZnS Synthesis Protocol and Analysis Procedure 
The following CdSe/ZnS synthesis protocol and analysis procedure are the standard protocol and 
procedure documented by Josh Angell and used by Cal Poly’s Biomedical Department.  
 
Appendix A: CdSe Quantum Dot Synthesis 
Reaction and Characterization Procedures 
The first part of this procedure outlines 3 different techniques (Purging, Syringing, & Oil Bath 
Operation) which are required for quantum dot synthesis. 
The second part contains instructions to create the selenium/cadmium precursors and then 
react them to synthesize CdSe quantum dots. 
 
 
Chemicals 
 13 mg Cadmium Oxide Powder 
 33 mg Selenium Powder 
 0.6 mL Oleic Acid (tech grade 90%) 
 15 mL Octadecene (tech grade 90%) 
 0.4 mL Trioctylphosphine (tech grade 90%) 
 Toluene and Acetone for cleanup 
 
Equipment 
 2 – 50mL 14/20 1-neck or 3-neck Round Bottom Flasks 
 2 – 1mL Disposable Plastic Syringes 
 2 – 3mL Disposable Plastic Syringes 
 1 – 5cc Glass Syringe, Luer Lock Tip 
 1 – Veterinary Tip, 18 gauge, 3” SS Needle 
 2 – Small Stir Bars 
 3 to 5 – 7.5 mL Borosilicate Vials 
 1 – Medium-Sized Beaker (150 mL) 
 2 to 4 – Rubber Septa 
 Hot/Stir Plate with RTD Probe 
 Crystallization Dish 
 ~ 200 mL – High Temperature Silicone Oil 
 Chemical Spatula 
 Kimwipes 
 Thermocouple 
 Analytical Balance 
 Stopwatch 
 Latex or Nitrile Gloves 
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Chemical Disposal 
 
All chemicals and equipment used during the quantum dot synthesis must be properly disposed 
of. Currently there is a vessel for liquid waste and a container for solid wastes such as needles, 
syringes, kimwipes, etc. which are stored in the yellow, hazardous chemical cabinet in the 
nanotech lab (Bldg. 41-205). 
 
 
Preparing Chemical Bottles 
 
1.  Fill a clean dry bottle with the desired 
chemical. 
 
2.  Fit a rubber septum into the top of the bottle. 
 
3.  Either purge the solution if it is to be used 
immediately or store it for later use. 
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Purging Procedure 
This procedure is to be used for any chemical and/or reaction vessel needing purging. 
 
1.  Fill a large beaker with water until it is ¾ 
full. 
 
2.  Lower N2 tank gas escape hose into 
beaker. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.  Fully open valve on top of tank. 
 
4.  Fully open left knob on valve. 
 
5.  Open middle knob on valve (“increase”) 
until bubbles start to appear in the beaker. 
Maintain this gas flow throughout the 
procedure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6.  Insert N2 purge needle into center of 
septum. Make sure the needle is above 
the level of the liquid. 
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7.  Insert a vent needle into the septum next 
to the N2 purge needle. Make sure it is 
above the level of the liquid. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
8.  After inserting the vent needle, lower the 
purge needle so that the tip is submerged 
in the liquid. Bubbles should begin to 
form in the liquid. If the needle cannot be 
submerged below the level of the liquid, 
either more chemical can be added or the 
bottle can be carefully tilted. 
 
9.  Allow to bubble for at least 10 minutes to 
remove oxygen from the chemical. 
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Syringing Procedure 
 
This procedure is a method of transferring a chemical from one purged vessel into another 
without the introduction of oxygen. All solutions must be properly purged with N2 before 
using this procedure. 
 
1.  Remove a disposable plastic syringe from 
its packaging. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.  Pull the N2 purge needle up so that it is 
above the level of the liquid. No bubbles 
should be forming at this point. 
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3.  Insert the tip of the syringe into the 
venting needle. 
 
4.  Draw N2 gas up into the syringe. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.  Remove the N2 filled needle and syringe 
from the septum and fully expel all the 
N2 gas by plunging the syringe down. 
Make sure to expel the syringe away from 
yourself in the hood. 
 
6.  Reinsert the needle and syringe into the 
septum. 
 
7.  Repeat the filling and expelling process 
twice more. This removes any oxygen in 
the syringe. 
 
8.  Reinsert the needle and syringe then pull 
up the syringe to once again fill the 
syringe with N2. Do not remove the 
syringe from the flask. 
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9.  Fully pull out the N2 purge needle. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10. Plunge down the N2 filled syringe to 
create positive pressure in the vessel. 
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11. Invert the chemical vessel and syringe. 
 
12. Slowly draw out the desired amount of 
solution into the syringe. Make sure to 
keep the needle tip in the liquid to prevent 
gas from entering the syringe. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13. Quickly and carefully insert the needle 
into the center of the septum of the 
desired vessel and slowly plunge down 
until all the liquid is expelled. 
 
14. If more of the purged chemical is needed, 
quickly reinsert the syringe into the 
purged solution and draw out more 
chemical. 
 
15. Chemicals must be repurged if left for 
longer than 10 minutes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
152 
 
 
Oil Bath Operation 
 
1.  Fill crystallization dish with ~200 mL 
high temperature silicone oil. 
 
2.  Place dish on hot plate. 
 
3.  Put paper clip into dish, which will act as 
a stir rod for the oil. 
 
4.  Clamp RTD probe in clamp on ring stand 
so that it is in the oil bath without 
touching the glass. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.  Press heater button on plate. 
Set to desired temperature. 
Allow ~30 minutes to reach temperature 
and stabilize. 
Temperature in flask will be offset from 
setting on plate by ~17 °C lower. 
(i.e. set: 225 °C  flask: ~208 °C) 
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6.  Put stir bar into reaction flask. Put 
thermocouple into the flask at this point if 
necessary, sealing it between the glass 
and the septum. 
 
7.  Put septum onto flask to seal it. 
 
8.  Clamp reaction flask in 3-finger clamp. 
 
9.  Lower the reaction flask into the oil bath. 
Make sure the flask is not touching the 
bottom of the dish. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10. Press stirrer button on plate. 
Set to desired stir speed. 
 
11. When finished with reaction, turn off 
heater and stirrer. 
 
12. Raise clamped flask out of oil bath and 
clean oil off with kimwipe with toluene 
and then acetone. 
 
13. Allow oil bath to come to 
room temperature. 
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Se-TOP Procedure 
 
1.  Purge Octadecene (ODE) following the 
Purging Procedure for ~15 minutes. 
 
2.  Weigh out 33 mg Se powder into a 50 
mL round bottom flash. Make sure the 
flask is clean and dry. 
 
3.  Drop a small stir bar in the flask. Cap 
flask with a rubber septum. 
 
 
 
 
 
Do NOT breathe in Selenium fumes.  
 
4.  Clamp the neck of the flask in a 3-finger 
clamp on ring stand. 
 
5.  Set heat to 150 °C. 
 
6.  Purge the flask with N2 gas by inserting 
the purge needle followed by a venting 
needle. Allow to purge for 10 minutes. 
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7.  Transfer 5 mL ODE into the flask using  
      the Syringing Procedure. 
 
8.  Lower flask into oil bath. 
 
9.  Set stir to 500 rpm. 
 
10. Begin purging trioctylphosphine using 
the Purging Procedure. 
Purge for ~15 minutes. 
 
11. Using the Syringing Procedure, add 
0.4 mL of purged TOP to the Se-TOP 
reaction flask. The majority of the 
selenium should dissolve immediately. 
 
12. Continue stirring at 150 °C until the 
solution is completely clear. If all the 
selenium does not dissolve, it may be a 
sign that oxygen was introduced into 
the reaction and oxidize the TOP 
before the selenium and TOP can 
react. 
 
13. Remove the solution from the oil bath 
and pull out the N2 needle and vent 
needle. 
 
14. Once it has cooled, clean the outside 
of the flask with toluene and acetone. 
This SeTOP solution can be stored for 
up to a week and makes enough 
SeTOP precursor for five QD 
syntheses. 
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Cd-Precursor Procedure 
 
1.  Weigh out 13 mg of CdO into a 50 mL 
round bottom flask. 
 
2.  Put a small stir bar into the bottom of 
the flask. 
 
 
 
 
 
 Cadmium Oxide is Toxic. Do NOT breathe fumes. 
 
3.  Insert a thermocouple so that the wire 
almost touches the bottom of the flask. 
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4.  Place a rubber septum onto the flask 
and fold over the edges to firmly 
secure the thermocouple. 
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5.  Clamp the flask in a 3-finger clamp on 
a ring stand and begin purging with N2 
using the Purging Procedure. 
Purge for ~10 minutes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6.  Set heat on oil bath to 242 °C 
(Adjust as needed to achieve 225 °C in 
flask). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7.  Using the Syringing Procedure, add 10 mL of purged ODE into the flask. 
 
8.  Lower the flask into the oil bath. 
 
9.  Set the stir function to 500 rpm. 
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10. Purge the Oleic Acid using the Purging Procedure for ~10 minutes. 
 
11. Using the Syringing Procedure, add 0.6 mL Oleic Acid to the Cd reaction flask. 
 
12. Heat until solution becomes optically clear. CdO has a tendency to stick to the walls of 
the flask, so the flask should be agitated occasionally to prevent build up on walls. 
 
 
 
 
 
The chemicals in this reaction mixture become volatile around 200 °C. 
Do NOT breathe fumes. 
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Sample Removal 
 
 
Caution: This process requires safely handling high-temperature organic, volatile 
chemicals. Two people must be present and all those present must wear appropriate 
safety equipment at all times. 
 
 
Prepare syringes and vials while the Cd precursor is heating. 
 
1.  Attach one metal needle tip securely to 
a plastic 3 mL syringe and one to a 
glass 5 mL syringe with Luer lock. 
 
 
2.  Remove the caps from clean, dry vials. 
 
3.  Once the Cd precursor becomes 
optically clear, ensure that its 
temperature is stable at 225 °C (adjust 
hot plate setting as needed to achieve 
stability at 225 °C). 
 
 
4.  Once stable at 225 C, quickly inject 1 
mL of room-temperature Se-TOP 
precursor into the hot Cd precursor. 
 
Start timing when the SeTOP precursor 
is injected. 
 
A white fog will immediately form and 
the solution will begin changing color to 
a pale yellow. 
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5.  Using the glass syringe, carefully 
remove samples of 0.5 to 3 mL at 
desired time intervals. 
 
6.  Put samples into separate vials. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7.  Cap and label the vials, indicating 
quantum dot type, date synthesized, 
reaction time, and absorbance 
wavelength. 
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   388nm  LED 
   Spectrometer 
   Sample Holder 
LED Power     
Supply 
This procedure is a method for gathering quantitative information about the distribution of quantum dots 
relative to their size when suspended in solution by utilizing photon excitation and fluorescence. 
 
1. Make certain that the 388nm LED is plugged in and turned on to its maximum brightness to warm 
 up the light source before data acquisition is initiated. 
 
2. Connect the sample holder to the spectrometer and the spectrometer to the computer. Open the 
 Spectra Suite software. 
 
 
     Fiber Optic 
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3. With the LED on, but the sample holder empty,  
 take a dark spectrum reading by clicking on the unlit 
 light bulb icon. 
 
4. Click on the icon containing both a “-“ and an unlit 
  light bulb. This subtracts the  background noise  
 preventing its influence on the QD readings.  
 
5. Place a minimum of 2 mL of the QD solution to be  
 tested into a clean cuvette. Place the  cuvette inside the  
 cuvette holder making certain to secure it in place. 
 
6. Click on the icon of two line pieces of paper to copy the resulting fluorescence spectra  onto the 
 clip board, then transfer this data onto an Excel spread sheet for further  analysis. 
 
7.  Using the cursor, click on the fluorescence peak at its maximum value; this is your center max 
 wavelength (CMW). Divide the intensity value associated with the CMW by two. Find the 
 wavelength values on each side of the peak associated with this new intensity value. The difference 
 between the two wavelength values is the full width at half max (FWHM). 
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B.2 - Absorbance Measurement Procedure 
Materials:  
 Spectra Suite Software 
 Ocean Optics USB 4000 UV-Vis spectrometer 
 DH 2000 BAL light source: combines the output of deuterium and tungsten halogen sources 
into a single optical path from 215 – 2000nm. 
 Quartz cuvette – 1cm path length (glass or disposable plastic cuvettes may also be used) 
 Two 400 micron optical fibers 
 Sample holder 
*When not actively taking measurements turn the toggle switch on the light source to the close 
position to prevent inadvertent exposure to the light source. 
Procedure: 
1. Use two 400 micron optical fibers at 180° relative to one another, one to transmit light from 
the source to the sample and one to transmit light from the sample to the spectrometer. 
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2. Load the Spectrsuite software, and then turn on the light source by flipping the power switch 
at the back. 
 
3. Press the blue button to turn on the deuterium source.  
The light will blink momentarily while the source is warming up. When the light stops blinking 
turn on the tungsten halogen source by pressing the red button. Allow the light source 20 to 30 
minutes to completely warm up. 
 
4. Moving the toggle switch to the open position will open the magnetic shutter and allow the 
light to move through the optic fiber and interact with the sample. 
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5. To create a reference spectrum insert a cuvette with 3mL of the solvent into the sample holder. 
When using CdSe/ZnS QDs synthesized using the standard protocol, the reference solvent will 
be ODE. 
6. Open a new “Absorbance” file. 
7. Move the toggle switch to the open position. 
8. Click on the yellow light bulb icon in the control panel. This will store the reference spectrum. 
 
 
 
9. Move the toggle switch to the closed position. 
10. Click on the grey light bulb icon in the control panel. This will store the dark spectrum. 
The processing mode icons will now turn dark blue indicating that they are active. 
 
 
11. Click on the “ ” icon in the control panel. 
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Once the absorbance processing mode has been initiated, a spectrum similar to the one shown 
above should appear, indicating an absorbance measurement of zero. 
12. Remove the reference sample cuvette of solvent. 
13. Place in the test sample cuvette. 
14. Set the integration time to a value where the entire spectrum can be seen. For ODE this is 
approximately 5ms. 
 
15. Set the scanning average value to 10. This reduces the signal to noise ratio. 
16. Set the box car value to 2. This smooths out the signal. 
The absorbance spectrum for ODE should appear to be similar to the spectrum shown below. 
 
Additional Information 
For additional methods of acquiring absorbance measurements refer to the tutorial provided on 
the Ocean Optics website at http://www.oceanoptics.com/videos/absorbance.htm. 
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Appendix B.3 - Wavelength Specific CdSe and CdSe/Zn Synthesis 
All of the following synthesis directions are given with the assumption that the standard 
CdSe/ZnS synthesis procedure given in Appendix B.1 has been read and understood. 
Procedures: 
White Fluorescing CdSe Cores 
1. Use single batch amounts of Cd and Se-TOP precursor, 10 and 1mL respectively. 
2. Heat Cd precursor to a minimum of 215°C and add 1mL of the Se-TOP precursor. 
3. Extract a 5mL sample no more than 15 seconds after injection of the Se-TOP precursor and 
deposit the sample into a 15mL glass vial. 
*Temperatures greater than 215°C can be used. 
545 ± 5nm CdSe Cores 
1. Use single batch amounts of Cd and Se-TOP precursor, 10 and 1mL respectively. 
2. Heat Cd precursor to 215°C and add 1mL of the Se-TOP precursor. 
3. Extract a 5mL sample 60 seconds after injection of the Se-TOP precursor and deposit the 
sample into a 15mL glass vial. 
555 ± 5nm CdSe Cores 
1. Use single batch amounts of Cd and Se-TOP precursor, 10 and 1mL respectively. 
2. Heat Cd precursor to 225°C and add 1mL of the Se-TOP precursor. 
3. Extract a 5mL sample 60 seconds after injection of the Se-TOP precursor and deposit the  
sample into a 15mL glass vial. 
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495 ± 5nm CdSe/ZnS QDs 
1. Heat 5mL of white fluorescing CdSe cores to 110°C for 10 minutes. 
2. After 10 minutes of heating add 1mL ZnS precursor drop-wise over a period of 2 minutes; 
heat for an additional 8 minutes for a total synthesis time of 20 minutes. 
3. Remove the solution from the heat and when the internal temperature reaches 60°C, quickly 
add 1mL of butanol. 
540 ± 5nm CdSe/ZnS QDs 
1. Heat 5mL of white fluorescing CdSe cores to 160°C for 10 minutes. 
2. After 10 minutes of heating add 1mL ZnS precursor drop-wise over a period of 2 minutes; 
heat for an additional 8 minutes for a total synthesis time of 20 minutes. 
3. Remove the solution from the heat and when the internal temperature reaches 60°C, quickly 
add 1mL of butanol. 
560 ± 5nm CdSe/ZnS QDs 
1. Heat 5mL of 550nm CdSe cores to 110°C for 10 minutes. 
2. After 10 minutes of heating add 1mL ZnS precursor drop-wise over a period of 2 minutes; 
heat for an additional 8 minutes for a total synthesis time of 20 minutes. 
3. Remove the solution from the heat and when the internal temperature reaches 60°C, quickly 
add 1mL of butanol. 
570 ± 5nm CdSe/ZnS QDs 
1. Heat 5mL of 550nm CdSe cores to 160°C for 10 minutes. 
2. After 10 minutes of heating add 1mL ZnS precursor drop-wise over a period of 2 minutes; 
heat for an additional 8 minutes for a total synthesis time of 20 minutes. 
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3. Remove the solution from the heat and when the internal temperature reaches 60°C, quickly 
add 1mL of butanol. 
 
Additional Information 
White fluorescing CdSe cores have an emission shift over time; therefore, if they are synthesized 
for later ZnS shelling they should be used within 10 days of synthesis. ODE can be added to 
CdSe/ZnS QDs with low intensities as a means of increasing the intensity but care should be 
taken to record and tract these alterations for future sample comparisons. 
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B.4 - Precipitation and Resuspension of CdSe/ZnS Quantum Dots 
Materials: 
 Absolute ethanol 
 Chloroform 
 2 – 4 capped 15mL centrifuge tubes 
 Premiere Centrifuge XC-2000 
 3mL syringe  
 Vortex  
 Metal reagent spatula 
Procedure: 
Precipitation 
1. Select CdSe/ZnS QD sample of interest suspended in ODE. 
2. Divide the QD sample among an even number of centrifuge tubes with equal amounts of QD 
solution in each tube.  
3. Add an amount of ethanol to each centrifuge tube that is equal to twice the amount of QD 
solution in each tube. 
4. Cap and vigorously shake each tube. 
5. Place all tubes, evenly distributed, in the centrifuge and spin at 4000 RPMs for 10 minutes. 
6. Remove the supernatant. Begin removal with the syringe’s needle at the surface of the 
supernatant to ensure the removal of the ODE. 
7. Add an additional quantity of ethanol equal to the initial amount used in step 3. Inject the 
ethanol quickly to promote agitation of the solution; if available vortex the solution. 
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8. Repeat step 5 through 7 until a pellet of QDs have been securely precipitated into the tip of the 
centrifuge tube.  
9. When an adequate precipitate is achieved, pour out the remaining supernatant.\ 
10. Place the centrifuge tubes, uncapped, in the fume hood for complete evaporation of any 
remaining supernatant. 
Resuspension 
1. Select a centrifuge tube with a completely dry precipitate in the tip. 
2. Using a metal reagent spatula, carefully remove any black precipitate that may be present. 
3. Add an amount of chloroform to the precipitate equal to the initial volume of QD solution; i.e. 
if the initial solution in each centrifuge tube was 2.5mL, add 2.5mL of chloroform. 
4. Wait for QD precipitate to be completely suspended in chloroform. 
Additional Information 
If after addition of the chloroform the QDs continue to precipitate out of solution it may be 
necessary to perform the precipitation procedure a second time. Continual precipitation of the 
QDs out of the chloroform indicated that ethanol may still be present. 
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Appendix B.5 - Quantum Yield Calculation 
Materials: 
 1 mg of fluorescein reference standard 
 6mL of ethanol 
 Sonicator 
 6mL of octadecane (ODE) 
 9mL of a CdSe/ZnS QD sample 
 10 cuvettes (disposable plastic cuvettes may be used) 
 Cuvette tray 
 UV – Vis spectrometer 
 Spectra Suite software 
Procedure: 
Fluorescein Dilution 
The optimal concentration is 20µg/mL of fluorescein/ethanol. As a result of the limits of 
measurement inherent to many analytical scales, larger amounts of fluorescein may be measured 
out and the appropriated concentration arrived at through a series of dilutions. For instance, 1mg 
fluorescein diluted in 5mL of ethanol yields a concentration of 200µg/mL.  Further dilution can 
be achieved by taking 1mL of this and adding to it 9mL of ethanol. The resulting solution will 
have the desired concentration of 20µg/mL of fluorescein/ethanol. 
1. Put on gloves! 
2. Weigh out 1mg of fluorescein on an analytical balance. Place in a 10mL glass vial. 
3. Add 5mL of ethanol and securely cap the glass vial. 
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4. Lower the solution into a sonicator for 30 seconds. 
5. Remove 1mL of the fluorescein/ethanol solution and place it in a 15mL glass vial. 
6. Add 9mL of ethanol and securely cap the glass vial. 
7. Lower the solution into a sonicator for 30 seconds or until an even distribution is observed. 
This is your starting stock solution of fluorescein to be later diluted for the purpose of 
achieving a graphed linear line from which the slope will be used to calculate quantum yield. 
CdSe/ZnS Quantum Dot and Fluorescein Dilution 
Starting with a stock solution to be used as the 100% concentration standard from which all other 
dilutions will be made, 5 different concentrations, of both the QD sample and the 
fluorescein/ethanol sample, will be created: 100, 80, 60, 40, and 20%. 
1. Set aside 3mL of the 9mL stock QD solution, this will be used as your 100% concentration 
solution. Set 3mL of this solution aside in a cuvette. 
2. Take the other 6mL of the QD sample and add 1.5mL of ODE for a total of 7.5mL of an 80% 
concentration. Set 3mL of this solution aside in a cuvette to be used as your 80% 
concentration. 
3. Take the other 4.5mL of 80% solution and add 1.5mL of ODE for a total of 6mL of a 60% 
concentration. Set 3mL of this solution aside in a cuvette to be used as your 60% 
concentration. 
4. Take the other 3mL of the 60% solution and add 1.5mL of ODE for a total of 4.5mL of a 40% 
concentration. Set 3mL of this solution aside in a cuvette to be used as your 40% 
concentration. 
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5. Take the other 1.5mL of the 40% solution and add 1.5mL of ODE for a total of 3mL of a 20% 
concentration. An example of the progression of dilutions where 6mL of 100% concentration 
+ 1.5mL of ODE = 7.5mL of 80% concentration is given in Table B.5.1. 
Table B.5.1 Concentration and Dilution Calculation Table 
 
 
6. Repeat this same series of dilutions starting with 6mL of 100% concentration 
fluoresceing/ethanol, adding 1.5mL of ethanol for a total of 7.5mL of 80% concentration, etc. 
Excel Spreadsheet Calculation Using Fluorescence Spectrums 
1. For greater ease, line up the cuvettes containing each set of concentrations in the cuvette trays 
in order from 100 to 20% concentration.  
2. Set the UV-Vis spectrometer to measure fluorescence.  
3. Obtain a fluorescence spectrum for each of the ten samples and store the raw data in a well-
organized and labeled Excel spreadsheet. 
4. Calculate the area under each fluorescence peak. This can be accomplished by using the 
sequence “=(SUMPRODUCT(C3:C6,B4:B7)-SUMPRODUCT(B3:B6,C4:C7)+B7*C7-
B3*C3)/2” as it corresponds to the example data given in Table B.5.2. In this example the 
area under the peak would be 4100 (no units). 
 
QD (mL) % ODE (mL) QD (mL) %
3 100 0 3 100
6 100 1.5 7.5 80
4.5 80 1.5 6 60
3 60 1.5 4.5 40
1.5 40 1.5 3 20
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Table B.5.2 Sample Data for Calculating the Area Under a Fluorescence Spectral Peak 
 
Absorbance Spectrum Analysis 
1. Set the UV-Vis spectrometer to measure fluorescence. 
2. Obtain an absorbance spectrum for each of the ten samples and store the raw data in a well-
organized and labeled Excel spreadsheet for later reference if necessary. 
3. For each sample set pick one wavelength value, for example 388nm, and find the         
corresponding O.D. value on the y-axis as illustrated in Figure B.5.1. Use the same 
wavelength value for each spectrum within the set. 
 
Figure B.5.1 Corresponding O.D. and wavelength values on an absorbance spectrum. 
B C
wavelength 
(nm)
intensity 
(counts)
3 10 10
4 20 100
5 30 200
6 40 100
7 50 10
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4. Make a table in Excel of the paired values of each set for each concentration. 
5. For each set of five concentrations, QD sample and fluorescein/ethanol sample, you will plot   
the fluorescence area value versus the O.D. absorbance value at each concentration. Do this 
for the QD data and for the fluorescein/ethanol data. Add a regression line with equation on 
each plot. The resulting equation will look something like y = -4
E07
x + 2.3566 for the QD 
sample set and y = 3
E07
x – 0.0596 for the fluorescein/ethanol sample set. The value in front of 
the x, for example -4
E07
, is your slope m for the QD sample set and slope mR for the 
fluorescein/ethanol sample set. 
Quantum Yield Calculation 
Using the quantum yield value associated with the fluorescein reference standard as QR, the 
index of refraction of the QD solvent n, the index of refraction of the reference solvent nR, and 
the corresponding QD and fluorescein slopes obtained from the previously plotted data, m and 
mR respectively, use Equation B.5.1 to calculate the comparative quantum yield of the QD 
sample, Q. 
 
      (
 
  
) (
  
  
 )                  Equation B.5.1 
 
Additional Information 
When using CdSe/ZnS QD samples of less than 10mL, additional concentration and dilution 
scenarios can be easily calculated using the Dilution Calculator of Mass Concentration found at 
the website:  http://endmemo.com/bio/dilution.php 
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A less exact but preliminary quantum yield can be calculated for a single concentration, instead 
of the previous example using a series of five concentrations, using Equation B.5.2 where I is the 
integrated fluorescence intensity of the fluorescence spectrum and OD is the optical density 
value of the absorbance spectrum. 
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Appendix B.6 Solubilization and Phospholipid Encapsulation of CdSe/ZnS Quantum Dots   
The following is a standardized protocol for creating a solution of phospholipid (PL) 
encapsulated QDs (QD constructs) in an aqueous medium at a concentration of 10mg/mL of 
phospholipids relative to the aqueous medium. The ratio of QDs to PLs and the concentration of 
PLs relative to the aqueous medium can be further adjusted to suit particular needs, however, it is 
recommended that a concentration of 10mg/mL of PL/aqueous medium is not exceeded.  
Materials: 
 Fonterra 700 Phospholipid Mix 
 Chloroform (CHCl3) 
 Aqueous medium (AM) 
 50mL glass beaker 
 15mL glass vials (minimum of 2) 
 Silicon oil heat bath 
 Magnetic spin vane 
 Analytic scale 
 QDs precipitated from a 5mL sample 
Procedure: 
1. Wear gloves! 
2. Resuspend the QDs in chloroform using the procedure given in Appendix B.4. This will result 
in 5mL of QDs suspended in chloroform. 
3. Weigh out 100mg of phospholipids in a 15mL glass vial. 
4. Add 10mL of chloroform to the vial containing the phospholipids. 
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5. Mix the QD/CHCl3 and phospholipids/CHCl3 together in the 50mL Beaker. 
6. To maintain the initial concentration of PL, add an amount of AM equal to that of the 
chloroform used in the original suspension. In this case add 10mL of the AM. 
7. Set the magnetic stirrer to 200 RPM and place the beaker into the silicon oil bath after the bath 
has reached an equilibrium temperature of 55°C. Position the beaker at an angle in the bath to 
promote agitation of the solution thereby increasing the rate of evaporation of the chloroform. 
8. Monitor the solution for a change in consistency. The higher the concentration of PL the 
thicker the resulting solution will be.  
9. Raise the beaker out of the silicon bath after 15 minutes and inspect for the presence of 
chloroform. When all chloroform appears to have been evaporated remove the beaker and 
place the solution into a clean 15mL glass vial. 
Additional Information 
Concentrations of PL/AM of 2.5mg/mL using a 2:1 milliliter ratio of PL/CHCl3:QD/CHCl3 was 
seen to have the most consistent results in previous trials and should be further investigated for 
use in any biologic applications. 
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Appendix B.7 Introduction of QD Construct Test Solutions to Keratinocyte Cell Cultures 
Materials: 
 Keratinocyte cells cultured on thin four-well slides 
 QD construct test solutions 
 Keratinocyte media 
 Aspirator 
 Incubator 
 Optical microscope 
 Digital camera or image capturing software and connected laptop 
*All used with and aspirated off of the keratinocyte cells should be disposed of properly in a 
biohazard waste receptacle in accordance with Cal Poly guidelines and State law. 
Procedure: 
1. Place all test solutions in a water bath set to 37°C for at least 10 minutes before introducing 
them to the cell cultures. 
2. Inspect cell cultures under an optical microscope to check confluency and to inspect for 
evidence of contamination. Cells should be at least 60% confluent with minimal 
contamination. 
3. If the cells are deemed to be appropriately confluent, inspect each culture using the optical 
microscope; do this before removing any of the culture media. Note confluency, cell colony 
density, and cell shape throughout the culture as well as any abnormalities or unidentified 
entities that may be present.  
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4. Take three images of each culture for an accurate and thorough representation of all cell and 
culture characteristics. *If using a digital camera, use the highest focus, no flash, and position 
the camera’s lens just above the microscope eyepiece adjusting the aperture of the microscope 
as needed. Taking an initial picture of the four-well slide before commencing with taking 
images of the cells can aid in maintaining an accurate record.  
4. Aspirate off the old culture media and add test solutions. Each round of trials should include at 
least one well, in every four-well set, that is kept as a control and therefore receives only fresh 
media.  
5. Place the cells back into the appropriate incubator for the prescribed time point. 
6. At the end of the experimental time point, remove the cells from the incubator and repeat steps 
2 and 3, recording observations as well as taking images before removal of the test solutions. 
7. Aspirate off the test solutions and rinse the cells twice with 1.5mL of keratinocyte media 
leaving the second 1.5mL of media in place. Repeat steps 2 and 3. 
8. Using the procedures outlined in Appendices 8 and 9, fix and stain the cells for inspection 
under the confocal microscope. 
Additional Information 
The following are possible test solution and time point arrangements, previously described in 
Chapter 4, that can be used exactly as described or altered as needed: 
Table 4.2 Summary of Round Two QD Construct Control and Test Solutions 
Well  Test Solution Filter Stain 
(a) 
Stain 
(b) 
Stain 
(c) 
a, b, c1.1 Control - krt media  H/H L/D H/H 
a, b, c1.2 42612oEN.1a: PL/krt     [10mg/mL] 0.2µm H/H L/D H/H 
a, b, c1.3  PL/krt                            [10mg/mL] 0.2µm H/H L/D H/H 
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a, b, c1.4 52312EN45.60b: PL/krt [10mg/mL] 0.2µm H/H L/D H/H 
a, b, c2.5 42612oEN.1a: PL/krt     [10mg/mL] 0.45µm L/D H/H L/D 
a, b, c2.6 Control - krt media  L/D H/H L/D 
a, b, c2.7 52312EN45.60b: PL/krt [10mg/mL] 0.45µm L/D H/H L/D 
a, b, c2.8  PL/krt                             [10mg/mL] 0.45µm L/D H/H L/D 
 
Table 4.3 Keratinocyte Trial Time Points in Round Two 
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B.8 - Preparation and Application of Histochoice and Hoechst Stain 
The following protocol was acquired and adapted from the Cal Poly BMED 515 Fluorescence 
Imaging Lab#1. 
Materials: 
 Four-well slides of keratinocyte cells at 60% or greater confluency 
 Phosphate-buffered saline (PBS), pH 7.4 
 Histochoice 
 Hoechst Stain – Invitrogen 34580 (392/440) 
 15mL glass vial 
 Aluminum foil 
Procedure:  
Fixation of Cells 
1. Put on gloves! 
2. Aspirate off the existing media. Gently wash cells twice with 1.5mL of PBS. Aspirate off 
PBS after each rinse including the last. 
3. Add 1.5mL Histochoice to each well. Fix the sample in Histochoice for 30 minutes at room 
temperature and covered. Prepare the Hoechst stain while incubating the cells in 
Histochoice. 
4. At the conclusion of the 30 minute incubation time aspirate off the Histochoice, rinse twice 
with PBS, and aspirate off the PBS. 
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Preparation of Hoechst Stain 
1. Prepare a 2µg/mL concentration of the Hoechst dye; 1µL of stock solution to 2.5mL of PBS. 
The stock solution is 5mg/mL. Prepare 400µL of solution for each well. 1µL of stock 
solution to 2mL of PBS. 
2. Mix solution in 15mL glass vial, securely cap, and vortex. Wrap vial in aluminum foil and 
store in a dark container until use. 
3.  Pipette the staining solution on to the surface of each well and incubate covered inside a 
darkened container for 15 minutes. 
4. Remove the stain by gently rinsing the well twice with 1.5mL of PBS, aspirate off the PBS 
each time including the last. 
5. When finished, aspirate off all remaining solutions and dispose of the four-well slides in the 
designated biological waste container.  
Additional Information 
Image the cells of each well using the confocal microscope filter setting DAPI. If using the DAPI 
filter in concert with a Qdot filter, set the excitation wavelength of the Qdot filter to 488nm to 
reduce excitation of the Hoechst stain. 
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B.9 - Preparation and Application of Live/Dead Viability/Cytotoxicity Stain 
The following protocol was acquired and adapted from the Cal Poly BMED 515 Fluorescence 
Imaging Lab#2. 
Materials: 
 Four-well slides of keratinocyte cells at 60% or greater confluency 
 Keratinocyte cell media 
 Live Stain: Invitrogen Calcein AM (495/515nm) 
 Dead Stain: Invitrogen Ethidium homodimer-1 (EthD-1) (495/635nm) 
 15mL glass vial 
 Aluminum foil 
Procedure: 
Prepare Live/Dead Viability/Cytotoxicity Stain 
1. Put on gloves! 
2. Add 20µL of the supplied 2mM EthD-1 stock solution to 10mL of keratinocyte media in a 
15mL glass vial.  This gives an approximately 4µM EthD-1 solution. Cap and mix the 
solution thoroughly via vortexing. 
3. Combine the reagents by transferring 5µL of the supplied 4mM Calcein AM stock solution. 
Cap and mix the solution thoroughly via vortexing. This results in an approximately 2µM 
Calcein AM and 4µM EthD-1 working solution.  
4. Wrap vial in aluminum foil and store in a dark container until use. 
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Cell Preparation 
1. Aspirate off the media in each well. Gently wash each well twice with 1.5mL of keratinocyte 
media.  Aspirate off the media each time. Add an additional 1.5mL of media to each well. 
2. Cover each four-well slide until application of the fluorescence stain. 
Label Cells 
1. Gently add the fluorescence stain to cells. Add 1.5mL of Live/Dead working solution to each 
well of the four-well slide no more than 15 minutes before imaging; this gives a final 
concentration of 1µM Calcein AM and 2µM EthD-1. 
2. Incubate the cells for 5-15 minutes at room temperature in a covered container protected 
from light. 
3. Image cells using the confocal microscope with filter settings Alexa Fluor488 for Calcein 
live stain and PI for EthD-1 dead stain. 
4. When finished, aspirate off all remaining solutions and dispose of the four-well slides in the 
designated biological waste container.  
Additional Information 
The effect of the L/D stain on the cells can be monitored by examining the cells at multiple 
intervals of time after the introduction of the stain. This temporal monitoring can aid in the 
determination of the initial cell viability and the influence, if any, of the stain on the viability of 
the cells. 
 
 
 
 
